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ABSTRACT

Apoptosis plays a crucial role in sculpting the developing central nervous system (CNS)
but can, under certain conditions, contribute to neurodegeneration in the mature CNS. Metabolic
disturbances have long been associated with apoptosis-inducing agents, however, the mechanism
underlying such changes remains controversial. In this study, our hypotheses was that decreased
ATP turnover may bring about other metabolic changes in apoptotic neurons. Accordingly,
change in metabolic reactions other than ATP turnover may not be important in the study of
apoptotic mechanism. In a living cell, metabolic reactions are highly connected and thus are
highly sensitive to kinetic change in one or more reaction, making analysis of direct kinetic
change in ATP turnover is experimentally infeasible. For these purposes, a comprehensive
detailed map of the control distribution in healthy neurons using the metabolic control analysis
was obtained for the first time. This information was important to distinguish the direct kinetic
changes caused by the apoptotic stimulus from those occurring indirectly because of changes in
the levels of key metabolites to which the reactions respond
Our results showed kinetic inhibition in ATP consumers (ATC) in response to Apoptosis.
However, and despite the observed kinetic inhibition in ATC, this kinetic change could not fully
explain the decreased rates of glucose uptake, glycolysis, mitochondrial substrate oxidation and
mitochondrial phosphorylation. Kinetic stimulation of the oxidative pentose phosphate pathway
by apoptosis was a major contributor to the decrease in glycolysis, while kinetic inhibition of
mitochondrial phosphorylation was a major contributor to the decrease in mitochondrial
ii

substrate oxidation. Direct inhibition of mitochondrial ATP synthesis coupled with direct
activation of mitochondrial proton leak resulted in the neurons becoming more reliant on
glycolytic ATP. Direct stimulation of the pentose phosphate pathway as well as proton leak
could be consequences of increased oxidative stress that is commonly associated with apoptosis.
These findings didn't prove our initial hypotheses, but implying a directly targeted
metabolic reactions by apoptotic stimulus. On the other hand, early reactive oxygen species was
suggested to stimulate oxidative phase of pentose phosphate pathway oxidative phase of pentose
phosphate pathway and proton leak rate which were suggested to play an antioxidant role to
maintain neuronal redox status. Despite kinetic activation of oxidative phase of pentose
phosphate pathway, glycolysis was stimulated in response to low K stimulus implying a shift of
the reliance of ATP sources from mitochondrial to glycolytic.
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CHAPTER 1: APOPTOSIS: PHYSIOLOGICAL
SIGNIFICANCE, AND MECHANISMS OF
CONTROL

A. Significance
A.0. Introduction
Apoptosis, the Greek word meaning leaves falling from a tree, was first coined and
described by Kerr et al, 1in 1972 as a controlled mechanism of cell death involved in regulation
of animal‟s cell population. Apoptosis is one mode of programmed cell death (PCD)
characterized by morphological and molecular changes including shrinkage of the cell, nuclear
membrane breakdown, DNA fragmentation and the formation of apoptotic bodies that are small
membrane-bound vesicles phagocytosed by resident macrophages2,3 . In contrast to necrosis, a
form of cell death due to cellular insult, PCD is not accompanied by an inflammatory response,
as the cells do not release their contents in the interstitial fluid, and are phagocytosed rabidly by
the surrounding macrophages4 .In contrast, necrosis is typically associated with cell swelling the
results in loss of membrane integrity and an inflammatory response in the extracellular
surroundings due to release of the cell‟s contents. Apoptosis is tightly controlled process that
depends on the activities of a number of pro-and anti- apoptotic proteins that can be affected by a
diverse array of environmental and physiological factors.
Apoptosis is beneficial to organisms as it takes place during the embryonic
developmental stages to eliminate excess cells due to over-proliferation of progenitor cells, and
throughout the life of mature tissues to eliminate damaged or dysfunctional cells. Aberrant
1

regulation of apoptosis can contribute to pathologies such as neurodegenerative diseases
(inappropriate apoptosis) and cancer (insufficient apoptosis)5.
Although the interactions of key pro- and anti- apoptotic proteins have been determined,
the regulatory mechanisms that affect these interactions remain unclear. Of particular interest is
the role that glucose metabolism may play in affecting the activities of pro-apoptotitc Bcl-2
family proteins. Depressed glucose metabolism has long been associated with apoptosis, but it
remains a matter of speculation if this is a cause or consequence of apoptosis.
Glucose metabolism could have a causal role in apoptosis because it critically affects the
cell‟s redox state (by both producing reactive oxygen species (ROS), and producing reducing
equivalents which protect against ROS), which is known to activate a number of pro-apoptotic
Bcl-2 proteins.
To clearly resolve what role, if any, glucose metabolism has, it is first necessary to
identify the reactions within the pathway that are responsible for the perturbed metabolism, and
to understand the how the reactions are affected. This information is critical to developing
rational, focused hypotheses on the molecular mechanism that couple metabolism to apoptosis.
The goal of this dissertation is to study the cerebellar granule neurons metabolic behavior during
healthy and apoptotic conditions and to distinguish the metabolic defects that are facilitating
apoptotic mechanism from those that occur in response to apoptotic stimuli. The information
from this work is useful for identifying apoptotic targets within the neuronal glucose metabolic
pathway. This, ultimately, opens the door for therapeutic strategies to many incurable diseases
caused by unregulated apoptosis and associated with altered cellular metabolism such as cancer
and neurodegenerative disease.
2

A.1. Physiological relevance of apoptosis to non-neuronal tissues
In mutli-cellular organisms, the cell community is highly organized and controlled. The
cell number is not only controlled by the rate of cell division but also by the rate of cell loss.
Apoptosis is the form of programmed cell death through which billions of cells commit to
suicide in developing and adult vertebrates. Although it seems wasteful, particularly for healthy
cells to die, cell death is found to be beneficial for those organisms. Apoptosis occurs as a
physiological mechanism in embryonic tissues (i.e. establish organs morphology), and in adult
tissue (i.e. tissue homeostasis, and immune response). It has been identified in the remodeling of
the arterial wall in animals after birth6, and in cultured vascular smooth muscle cells of normal
humans and rats7 . Also, it is involved in establishing the architecture of many body organs such
as kidney8,and hollowing certain ducts in the reproductive system, and mammalian
gastrointestinal tract9. Furthermore, apoptosis is involved in metamorphosis in amphibian and
insects to remove the unwanted cells in the transition from the amphibian tadpole or in larval
locomotion (Figure 1-A, A.).Also, it plays a key role in carving out paw digits in many
vertebrates. (Figure 1-A, B.)10. Apoptosis occurs as a repair or a quality control mechanism
during development that corrects genetic and developmental errors. For instance, the
mispatterning and outgrowth of drosophila embryos due to impairment inthe anterior
bicoidmorphogen, is eliminated during the development into normal larvae11.In adult animals,
apoptosis occurs to balance cell division where it maintains organs size (i.e. in adult human
approximately 10 billion cells are formed per day to compensate cell loss by apoptosis). For
example, the removal of a part of a rat liver leads to an increase in liver cells proliferation to
3

compensate for the lost cells. Similarly, treatment of the liver with a cell division stimulator
(phenobarbital) is usually followed by severe cell loss. This cell loss continues until the liver has
returned to its normal size. Such balance between the regulation of both cell division and cell
loss is important in maintaining adult organ size. Moreover, apoptosis can be considered as a
defense mechanism for certain cell types against viruses and microbes12 .It provides a powerful
tool to reduce viral replication and spread throughout the host cells, by facilitating the cell‟s
death either through an intracellular or extracellular mechanism (i.e.by activation of cytotoxic T
lymphocytes).

A)

B)

Figure 1-A. Physiological apoptosis during development. A) During development of a tadpole into a frog,
tadpole tail cells undergo apoptosis which results in sequential loss of the tail. B) A human embryo paw stained
with a dye (in red) specific for apoptotic cells. Death of interdigital cells leads to eventual loss of interdigital
tissue between developing digits. [Adapted from 10]
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A.2. Physiological relevance of apoptosis to development of neuronal tissue
In the developing nervous system, at least half of the original nervous system population
including neurons, glial cells, and neuronal progenitor cells ,are eliminated13. Several lines of
evidence indicate that developing neurons die through apoptosis14,15.The elimination of
overproduced immature neurons occurs by two major rounds of apoptosis. The first apoptotic
period occurs in the ventricular and subventricular zones (where stem cells differentiate into
neurons and glial cells) before the migration and population of the immature neurons to selected
regions of the brain and spinal cord 15. This apoptotic period has recently been identified but its
mechanism is poorly understood. The second apoptotic period, the most characterized one,
includes loss of approximately half of the newly born neurons due to failure to form synapses
after migration to their final destinations. During this period apoptosis plays a key role in
sculpting certain brain regions (before and within a few weeks after birth).
Apoptosis occurs during development of both the central and peripheral nervous systems
in a time that coincides with the formation of synapses with target cells. The central nervous
system (CNS) in particular shows great rates of apoptosis in vertebrates during and after birth.
Apoptosis in the human CNS was first described in 2000 at early embryonic stages

16

where the

apoptotic index was found to be the highest at the first trimester of gestation in the proliferative
zones (ventricular, subventricular, and ganglionic zones). Occurrence of apoptosis is correlated
with the distribution and density of some key anti-and pro-apoptotic proteins in different parts of
nervous system. The anti-apoptotic protein Bcl-2 is highly expressed in the CNS during
neurogenesis, while it remaines unchanged within the PNS. Regions of CNS undergoing
5

postnatal neurogenesis and differentiation such as the cerebellum, hippocampus, and olfactory
bulb express high levels of Bcl-2, which may explain the initial survival of excess cells that will
undergo apoptosis at later stages. Apoptosis in the cerebellum and substantia nigra of mice
occurs during the second postnatal week while in the cortex it lasts between 15th ED (embryonic
day) and 14th PD (postnatal day) 17. In the thalamus, apoptosis is severe during the first postnatal
week. High levels of Bcl-2 expression are found in postmitotic granule neurons precursors that
reside at the outer layer of the developing cerebellum. After differentiation and migration of
those cells through the internal layer, Bcl-2 expression dropped which parallels formation of
axons and synapses. The same pattern of Bcl-2 expression is observed in developing cortical
layers of the forebrain and neurons of olfactory epithelium. Furthermore, the ratio of antiapoptotic: pro-apoptotic and estrogen level are found to play key role in regulating sexually
dimorphic cell numbers in certain brain areas 18. The sexually dimorphic nucleus of preoptic area
(SDN-POA) is found to be larger in volume with more neurons in early postnatal and developing
males compared to same age female rats. Whereas, the anteroventral periventricular (AVPV)
nucleus, another sexually dimorphic nucleus, is larger in females than in males. These findings
are reversed in adulthood so that the number of cells and size of SDN-POA and AVPV are
increased in female and male rat respectively18. This pattern of cell loss is accompanied by
fluctuation in Bcl-2 proteins implying a potential role of BcL-2 in mediating apoptosis during
development 16. On the other hand, in developing and adult PNS,Bcl-2 expression is maintained
at a invariant level, which may contribute to PNS axon survival and ability for axonal re-growth
of neurons within the PNS. Studies on transgenic mice, cell cultures and cell lines provide
supportive evidences for the occurrence of apoptosis in different regions of both developing and
6

adult nervous system. Severe cell loss has been observed in sympathetic neurons, dorsal root
ganglion neurons, superior cervical ganglion and facial motor neurons in Bcl-2 knockout mice 19.
Deletion of the pro-apoptotic Bax protein from developing neonatal cortex, facial motor neurons,
and superior cervical ganglion (SCG) neurons is found to support their survival and induce cell
growth (2.5 fold more SCG neurons and 51% increase in facial motor neurons)

20

. Knockout of

the pro-apoptotic caspases-9 in mice results inectopic cellular overgrowth in the forebrain but not
brainstem and spinal cord due to restricted apoptosis 21. Similarly, knockout of the pro-apoptotic
protein Apaf-1 resulted in cranioschesis and exencephaly22. Withdrawal of neurotrophic growth
factor (NGF) and serum deprivationresulted in apoptosis in cell linesof developing neurons
including sympathetic neurons,23 hippocampal neurons24, cortical neurons

25

and cerebellar

granule neurons (CGNs)26.Furthermore, apoptosis in cell lines of cerebral cortical neurons is
induced by activation of death receptors (Fas/Apo)
pathways (AKT/PI3K)

28

27

and/or inactivation of certain survival

. Studies of in vitro neuronal apoptosis not only provide supportive

evidence about the occurrence of apoptosis during neuronal developmental stages but also clarify
many causes and mechanisms that facilitate this process.

A.3. Factors dictating neuronal apoptosis
A.3.1. Neutrophins
Neurotrophins, including nerve growth factors (NGF), brain-derived neurotrophic factor
(BDNF), neurotrophin-3 (NT-3), and neurotrophin-4(NT-4) are paracrine factors produced by
glial cells as well as peripheral tissues innervating the nervous system and function to prevent
neuronal PCD. According to the neurotrophic theory29, limited availability of neurotrophic
7

factors due to relatively limited production along with an overabundance of immature neurons
constitutes the major cause of apoptosis during nervous system development. It has been found
that during the first post neonatal week, sympathetic neurons undergo PCD due to low nerve
growth factor (NGF) supply30. The death rate of dorsal thalamus neurons of wild mice is reduced
due to increased cortical brain derived neurotrophic factor (BDNF) while it is increased in
mutant mice (lacking functional BDNF receptors)31. There are two major types of neurotrohpins
receptors differentiated according to their binding affinity: the high affinity tyrosine kinases
receptors (Trk) A, B, and C; and the low affinity P75 receptors20. Three isoforms of the high
affinity TrK are known to specifically bind to each neurotrophin (i.e. TrK T & A binds to NGF;
TrK B binds to BDNF and NT-4; TrK C binds to NT-3). The P75 receptors (a cell surface
glycoprotein) which belong to tumor necrosis factor superfamily, bind with low affinity to each
of these neurotrohpins. Both TrK and P75 are usually present on the surface of same cell where
their interplay (which may oppose each other) controls the neuronal response to neurotrophins
exposure. Interestingly, while TrK receptors induce survival signal transduction that promotes
cell survival and growth, P75 receptors induce both survival and death signal transduction20.
The death (apoptotic) signaling of P75 is found to be a TrK-independent pathway,
however, its physiological role remains unclear mainly due to the direct interaction with TrK
receptors which affects its signaling capacity32. On the other hand, the interaction of P75 and
TrK, which signals neuronal survival and growth, have gained more attention in research during
the past few years33,34. Neurotrophins in many neuronal populations including sensory, motor,
and cerebellar play a key role in neuronal survival. The development of these populations either
in vivo or in culture is greatly dependent on the presence of optimal concentration of
8

neurotrohpins32. Activation of neurotrophin receptors directly activates the small GTP-binding
protein Ras which is known to be recruited in neuronal survival35,36.As a consequence, activation
of Ras induces neuronal survival through the recruitment of two major signaling pathways,
MEK/MAPK and PI-3K/Akt. Survival induced by the Ras-MEK/MAPK pathway is promoted
via up regulation and/or increased expression of anti-apoptotic Bcl-2 proteins and the
transcription factor cAMP response element binding protein (CREB). The second survival
pathway is Ras-PI-3/Akt which accounts for approximately 80% of neutrophin- regulated cell
survival

37,38

. This pathway activates and recruits several signaling proteins, of these is the

serine/threonine kinase Akt (or protein kinase B). In sympathetic neurons, Akt is responsible for
as much as 80% of NGF-dependent survival

38

whereas it accounts for approximately 20% of

neurotrophin dependent survival in cerebellar neurons39. Akt regulates neuronal survival through
phosphorylation and inactivation of direct targets including Bad (a pro-apoptotic protein known
to inhibit the anti-apoptotic Bcl-2 proteins), pro-caspase-9 (a pro-apoptotic pro-enzyme that is
activated during apoptosis), and forkhead protein, a pro-apoptotic protein that increases
transcription of the apoptotic Fas ligand (FasL)32. Additionally, Akt induces survival by
stimulating the influx of Ca 2+ through L-type calcium channels in cerebellar neurons39, whereas
it promotes survival of sympathetic neurons by acting downstream both L-type calcium channels
and Ras-PI3K activation32. Activity of calcium channels and level of intracellular calcium are
directly affecting neuronal energy metabolism (see section C.). This Akt activity is considered as
a convergence point between signaling pathways(see section B.2.5.) which promote neuronal
survival on levels of both signaling pathways and neuronal energy metabolism.

9

A.3.2. Excitatory neurotransmitters
In addition to neurotrophins, excitatory neurotransmitters are considered as survival
factors because of their role in affecting the plasma membrane potential and cytoplasmic Ca2+
concentration40.Neurons are excitable cells that are highly sensitive to electrochemical changes.
In the CNS, glutamate, which is the main excitatory neurotransmitter, induces Ca

2+

influx

directly by activating glutamate receptors (i.e. α-amino-3-hydroxy-5-methylisoxazole-4propionate acid (AMPA) and N-methyl-D-aspartate (NMDA) ) and indirectly by activating
voltage-dependent and ligand gatedCa2+ channels

41

.The influx of Ca

2+

is important for the

process of neurotransmitter release from pre-synaptic terminals and for the postsynaptic neurons
responses. One of these responses is the change in membrane potential and energy metabolism of
neurons. Membrane depolarization at high potassium level and electrical stimulation has been
found to support neuronal survival and development in vitro. Cultured cerebellar granule neurons
(CGNs) showed PCD upon switching from a non- physiological 25mM (high K) to a
physiological 5mM extracellular potassium42,43. In vitro high K mimics the physiological
depolarization of CGNs by excitatory neurotransmission (L-glutamate release) from mossy fibers
during development of the cerebellum(see section C.). Pre-synaptic neurotransmission in vivo as
well as high K in vitro results in alteration in intracellular calcium level, [Ca2+]c, in the postsynaptic neurons. The [Ca2+]c is a dynamic balance between influx rate determined by the
number of opened Ca2+channels, and efflux rate determined by activity of plasma membrane and
mitochondrial Ca2+pumps. Calcium acts as a second messenger that affects a number of survival
kinases including PI3K-Akt and Ca2+- calmodulin dependent kinase (which mediate activity of
downstream targets such as BcL-2 proteins see section A.3.2). Increased concentration of [Ca2+]c
10

stimulates survival kinases (i.e. PI3K-Akt and Ca2+- calmodulin dependent kinase) as well as
promotes CGNs energy metabolism (see section C. )

A.3.3. Cellular oxidation-reduction (redox) state
Oxidative stress due to imbalance between reactive oxygen species (ROS) production and
anti-oxidant system scavenging constitutes one of the most potent threats to a neuron‟s viability
that may ultimately leads to apoptosis in developing, adult, and aged cells. Treatment with low
doses of oxidants such as hydrogen peroxide, redox-active quinones, or tert-butyl-hydroperoxide
is sufficient to induce apoptosis44. In addition to exogenous ROS, intracellular ROS-mediated
damage accumulated overtime as a byproduct of cellular metabolism especially in post-mitotic,
non-dividing cells (i.e., neurons, muscle fibers, and cardiac myocytes) is considered an inducer
of apoptosis. Of particular interest, brain tissue is highly vulnerable to ROS due to its natural
biochemical composition, exposure to and metabolism of excitatory amino acids and
neurotransmitters. High content of unsaturated lipids (highly targeted by free radicals), high
oxygen consumption (brain uses 20% of total body oxygen intake), and high iron content
increase the brain„s susceptibility to ROS45,46,47.

High levels of ROS particularly in non-

dividing, post-mitotic excitable cells such as neurons leads to oxidative injury (i.e. damage of
vital cellular proteins) which facilitates apoptosis and is responsible for many neurodegenerative
diseases48.Oxidative stress may result from high ROS production or disturbance in the cellular
antioxidant system or both.
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The Electron transport chain (ETC) within mitochondria constitutes the main source of
intrinsic ROS as it reduces about 1-2% of total cellular oxygen into superoxide49. The produced
ROS can be released to the cytoplasm through voltage gate anion channels (VADC) located on
the outer mitochondrial membrane. Strikingly, ETC and other mitochondrial components are the
main targets of ROS which exacerbate ROS levels, leading to eventual loss of mitochondrial
integrity and more damage cell-wide50. Among ROS susceptible mitochondrial components are
key metabolic enzymes including complex I (NADH dehydrogenase), complex III (cytochrome c
oxireductase),

complex

II

(succinate

dehydrogenase),

aconitase,

and

α-ketoglutarate

dehydrogenase (a-KGDH)51. Damage to such proteins disturbs their redox status which in turn
alters matrix NADH/NAD pool leading to perturbed mitochondrial membrane potential (ΔΨm).
Altered ΔΨm facilitates formation of mitochondrial permeability pore (MMP), a non-selective
permeabilization of mitochondrial inner membrane that facilitate the release of pro-apoptotic
proteins into the cytoplasm, which ultimately increase the leak rate of superoxide anions52,53. In
addition to mitochondrial sources, peroxisomes provide another source of ROS especially H2O2.
Additionally, the redox active metals Fe2+ and Cu2+ participate in ROS generation through the
Fenton reaction. The highly active nitric oxide radical (NO·) generated by nitric oxide synthase
isozymes can react with superoxide forming the highly reactive peroxynitrite radical ONOO(Figure 3-A). Formation of such free radicals (molecules containing unpaired electron in the
outer shell) leads to initiation of a chain of reactions which result in damaging the cell‟s
macromolecules such as DNA, RNA, membrane lipids, and leading to mitochondrial
dysfunction54.
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Random or inherited mitochondrial mutations increase respiratory complexes defects
causing increased superoxide leakage. As a result, increased ROS facilitate further mtDNA
mutations thereby initiating positive feedback loop of ROS production and further mitochondrial
damage55. The cell‟s redox status may affect neuronal survival through regulation of apoptotic
effector proteins including caspases, BcL-2, and cytochrome c(see section B.2.5.).Oxidative
stress can be due to dysfunction of one or more of cellular antioxidant systems. Cellular
antioxidant defenses are classified into enzymatic and non-enzymatic systems. The enzymatic
systems include two distinct superoxide dismutases that catalyze superoxide anion dismutation
into H2O2. The cytoplasmic dismutase form is a homodimer copper and zinc containing enzyme,
SOD1 (CuZnSOD), while the mitochondrial form is tetramer manganese containing enzyme,
SOD2 (MnSOD). Knockout of the mitochondrial form, SOD2, is found to be lethal in mice
56

whereas, knockout of cytoplasmic form SOD1 induces familial amyotrophic lateral

sclerosis57.The produced H2O2 is further reduced to H2O by the action of catalase enzyme, which
is located primarily in the peroxisomes. Furthermore, the clearance of H2O2 is catalyzed by
peroxiredoxin (PRX) enzyme and glutathione peroxidase (GPX).The resulted oxidized form of
peroxiredoxin is reduced by thioredoxin enzyme (TRX) which is further reduced via thioredoxin
reductase (TRXR). The reduction of H2O2throughGPX involves the conversion of reduced
glutathione (GSH) into the oxidized form (GSSG) which can be further reduced to GSH by
glutathione reductase (GR) catalysis. Both thiol-containing enzymes; TRXR and GR are
dependent on continual supply of NADPH, a product of pentose phosphate pathway (PPP), to
maintain the reduced forms of both peroxiredoxin and GSH respectively (Figure 2-A).
Accordingly, the cellular redox status is tightly maintained by PPP flux which is dependent on
13

glucose-6-phosphate supply, a product of glucose phosphorylation catalyzed by hexokinase
enzyme58,59.

Figure 2-A. Reactive oxygen species (ROS) production and consumption pathways. Superoxide anion produced in
peroxisomes by the catalysis of oxidase enzyme which then dismutated by cytoplasmic Cu-Zn-SOD to H2O2.
Superoxide anion produced in mitochondria due to proton leakage from electron transport chain is released to
cytoplasm (where it is dismutated by Cu-Zn-SOD) through voltage dependent anion channel (VDAC). Mitochondrial
O2-.can be dismutated by Mn-SOD to H2O2 which further reduced by glutathion peroxidase (GPX). In cytoplasm,
H2O2can produce another ROS (hydroxyl radical) through Fenton reaction. It can be reduced through enzymatic
reactions including GPX (involving glutathione (GSH) oxidation) and peroxiredoxin (PRX). Reduced PRX is
maintained by thioredoxin (TXR) enzyme. Reduced forms of GSH and TXR are maintained by NADPH level
produced from pentose phosphate pathway (PPP) through which glucose-6-phosphate is oxidized by glucose-6phosphate dehydrogenase (G6PDH).

The non-enzymatic antioxidants include glutathione (GSH), vitamin E, uric acid,
ascorbate, α-tocopherol, creatine, arginie, vitamin C, NADPH, and β-carotene. Also, they are
called antioxidants ROS sequestrants as they inhibit the progression of free radical chain reaction
and limiting their direct deleterious effect on cell proteins. They neutralize ROS and free radicals
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in general by either accepting or donating an electron to terminate their unpaired status. The
resulting unpaired antioxidant is normally less reactive either due to its nature as large structure
molecule or due to the continual termination of its unpaired status by other antioxidant
molecules. Antioxidants supplementation to neurons seems to have a neuroprotective effect
against oxidative damage. Increased endogenous antioxidant, uric acid, is found to prevent
neuronal damage due to oxidative stress by suppressing the damage effect of oxyradicals and
maintaining Ca2+ homeostasis

60

. Furthermore, embryonic hippocampus supplemented by

vitamine E and β-carotene showed protection against oxidative stress due to ethanol exposure 61.
Other compounds participate in antioxidant system through chelation of transition metals thereby
reducing the formation of free radicals. For example, transferrin and ferritin are iron-binding
proteinsthat reduce ROS levels by iron sequestration

54

. Other chemical elements such as

selenium and zinc are necessary for the activity of certain antioxidant enzymes (i.e. peroxides
and reductase)

62

.The tripeptide (glu-cys-gly) glutathione (GSH) is the most effective and

abundant cellular antioxidant that mainly controls and regulates cellular redox state. Drops in
cellular GSH pool and parallel high ROS levels during apoptosis have been reported63.
Glutathione is found to inhibit cytochrome c activity(oxidation after its release to cytosol) and
inhibit apoptosis derived by high ROS in NGF-deprived neurons64.The high energy reducing
equivalent molecule NADPH is one of the main antioxidant molecules that regenerate the
reduced forms of many defense systems indicating the importance of NADPH in stabilizing the
cellular level of ROS. In addition to its role in nucleotides biosynthesis, PPP provides an
important route through which glucose is oxidized into ribose-5-phophate producing NADPH. In
long–lived post-mitotic cells like neurons, most of the produced NADPH is consumed in the
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maintenance of the cellular redox status65. Inhibition of pentose phosphate pathway (PPP) by 6anicotinamide (6-AN)or dehydroepiandrosterone (DHEA) is found to elevate cellular ROS and
facilitate cytochrome c-mediated apoptosis in neurons 58.Furthermore, PPP activity is stimulated
in response to exogenous ROS in neurons suggesting an anti-oxidant role of PPP

66

. High

endogenous ROS due to activation of monoamine oxidase in response to neurotransmitters such
as dopamine or catecholamie can stimulate PPP activity in synaptosomes67.In addition to the
direct link between cellular metabolism and ROS, the redox status of the cell has a signaling
effect that mediates the cellular fate (see section B.2.5.)68.
A.3. Physiological relevance to nervous system pathologies
Neurons, in contrast to other cells of proliferative tissues, exhibit very little regeneration
over an animal‟s life. This feature is thought to be vital to maintaining neuronal circuits and
proper brain function. For instance, long-term memories and skeletal muscle function require
stably maintained neuronal circuits. To date, there is no consensus about which form of cell
death (apoptosis vs necrosis) predominates during nervous system pathologies as the aging
nervous system degenerates. Additionally, because apoptosis rapidly occurs (i.e. several hours to
a day) and apoptotic cells are neatly phagocytosed and removed from tissues this makes it hard
to identify whether apoptosis or necrosis has occurred in postmortem samples. Also, living
humans cannot be used in experiments to determine certain biochemical and molecular pathways
characteristic to apoptosis. Accordingly, studies that provide supporting evidence about
apoptosis as a mode of cell death during neuronal pathologies use experimental animals and cell
cultures as models of human pathologies. Age-related degeneration including glutamate
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excitotoxicity (stroke), traumatic brain injury, and neurodegenerative diseases(ND) are caused by
both forms of death (apoptosis and necrosis).Nevertheless, studies used post-mortem tissues of
ND patients, cell culture and animals imply apoptosis is one of the primary forms of cell loss
during ND. In addition, apoptosis participates in severe cell loss in early-onset forms of
Alzheimer‟s, Huntington‟s and amyotrophic lateral sclerosis implicating its role in
neuropathologies69. Although apoptosis plays a crucial role in sharpening and patterning
neuronal circuits during development, it results in loss of function of such circuits when
deregulated during adulthood. What follows is a discussion on neuronal cell loss by apoptosis in
different types of neurodegenerative disorders.
Alzheimer‟s disease (AD) is one of the most pronounced neurodegenerative diseases and
can occur either sporadically or genetically, with the sporadic form as the most common.
Selective death of neurons in the hippocampus, neocortex, and forebrain cholinergic system that
lead to dementia, cognitive, and emotional disturbances, are major characteristics of AD.
Familial AD, the early onset form, is caused by autosomal dominant inheritance of one or more
mutations in: amyloid precursor protein (APP), presenilin-1 (PS1) and presenilin-2 (PS2)70.
Cellular inclusions, neurofibrillary tangles resulting from hyperphosphorylated tau protein, and
extracellular senile plaques of β-amyloid peptide (Aβ) are detected in postmortem samples from
AD patients. The sporadic form, the most common type, has late onset associated with a lot of
hallmarks which make it hard to determine the precise mechanism of death in this form. High
levels of Aβ were detected in mutant APP transgenic mice with higher levels of Aβ deposited in
the hippocampus and cortex with age71. Furthermore, doubly mutated (APP and PS1) transgenic
mice showed greater Aβ deposits in cerebral cortex and hippocampus. However, several lines of
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evidence have shown that oxidative stress is critical in the induction of AD by affecting one or
more signaling pathways in the cell. With aging, oxidative stress is facilitated by imbalance
between the increased production of ROS and defects in the anti-oxidant machinery. Since
mitochondria are the main source of ROS, mitochondrial dysfunction in AD patients has long
been suspected. Key enzymes in citric acid cycle (α-ketoglutarate dehydrogenase and pyruvate
dehydrogenase complex), complex I, and cytochrome oxidase (terminal enzyme in RC) are the
most affected72.A low percentage of viable mitochondria compared to the number of completely
damaged ones is observed in AD when compared to a control group at the same age73.
Interestingly, mitochondria are found to be favorable targets for Aβ and APP accumulation in
both brain slices of AD transgenic mice and cell lines expressing human mutant APP. Strikingly,
high hydrogen peroxide levels as well as decreased cytochrome c activity has been found to be
associated with high Aβ when compared to age matched wild type controls74. These findings
suggest that both familial and sporadic AD may be facilitated by early mitochondrial dysfunction
and oxidative damage. Accumulation of defective tDNA and decreased mitochondrial enzyme
activities in muscle, liver, and brain of aged-primates provide supportive evidence for the former
hypothesis. Mutated mtDNA is found to be selectively accumulated in various cortical regions
and basal ganglia in aged human brain75. Oxidative damage and consequently reduction of
cellular bioenergetic capacity was found to cause such mutation in mtDNA with age in both
human and mouse76.
Excessive neuronal death in dopaminergic neurons of nigrostraiatal circuit lead to
Parkinson‟s disease development (PD) which involves lewy bodies, intracellular inclusions,
formed due to the accumulation of α-synuclein. Most of PD cases are sporadic; however, some
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early onset cases include many genetic mutations such as genes encoding α-synuclein, parkin,
PTEN-induced kinase 1 (PINK1), and DJ-177. Such mutation resulted in mitochondrial
mutations, protein misfolding, impaired ubiquity-proteasome system and oxidative stress. Some
of these proteins were found to be important to cell viability such as the mitochondrially
localized PINK1. The ubiquitin E3 ligase, parkin, is one of the ubiquitin-proteasome systems
while DJ-1 protein participates in the response of oxidative stress.
Early mitochondrial dysfunctions due to translocation and accumulation of mutated αsynuclein into mitochondria which in turn reduces activity of complex I and induces oxidative
stress have been observed in PD vulnerable brain areas78.At different levels of its metabolism,
dopamine is able to produce various endogenous toxins. At normal pH, dopamine can autooxidized to hydrogen peroxide, superoxide radicals, and dopamine-quinone79. Also, it can be
oxidized by monoamine oxidase (MAO) producing hydrogen peroxide which can be converted
to highly reactive molecules if not dismutated by SOD enzymes

80

.Reactive oxygen species are

main byproducts of impaired complex I function and dopamine metabolism which may explain
the cellular damage found in most postpartum PD samples. Elevated ROS due to inhibited
complex I leads to ubiquitin-proteasome system dysfunction and facilitates Lewy body
accumulation81. Furthermore, the interaction between oxidized metabolites of dopamine and αsynuclein is found to potentiate cell death 82. Natural and synthetic environmental chemicals (i.e.
1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin, MPTP, and the pesticide rotenone) are found to
cause PD and parkinsonism in humans and rodents

83

. Several lines of evidence suggest that

oxidative stress is the main cause of the selective neuronal death of dopaminergic neurons due to
those parkinsonism-inducing toxins. For instance, the plasma membrane dopamine transporter
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(DAT) in dopaminergic terminals is transporting the active metabolites of MPTP, 1-methyl-4phenylpyridinium (MPP+) which inhibit complex II of electron transport chain leading to cell
death similar to that in sporadic PD patients84. Also, MPP+ can selectively transport to
dopaminergic vesicles due to its high affinity to vesicular monoamine transporter 2 (VMAT2)
leading to redistribution of dopamine and facilitating dopamine-mediated oxidative stress85. The
pesticide rotenone is known to block complex I activity leading to loss of cultured dopaminergic
neurons86. Anti-oxidants treatment and dopamine depletion partially prevent dopaminergic
neurons death due to MPP+. Interestingly, supplementation with energy preservative to the
former condition is enough to prevent neuronal death completely indicating that MPP+ mediats
neuronal cell death on two levels (i.e. ROS and mitochondrial bioenergetics)87. The selectivity of
dopminergic neurons loss by ROS-mediated mechanism is rendered to the nature of such cells
(i.e. large number of mitochondria, observed accumulation of iron in PD patients, accumulation
of auto-oxidation byproducts of dopamine, and lack of or altered anti-oxidant enzyme
glutathione peroxidase). Early mitochondrial dysfunction, oxidative stress, and protein
mishandling seem to be common steps within PD cellular mechanism.
Mitochondrial defects have been detected in Huntington‟s disease (HD), an autosomal
dominant disease caused by increased levels of mutated the Huntington gene (Htt), in striatal,
and cortical neurons. This mutation includes a CAG trinucleotide expansion which encodes a
protein with long polyglutamine repeats. Polyglutamine repeats accumulate and aggregate as
cytoplasmic and nuclear inclusions which are facilitating cell death. Extensive cell loss in
striatum and cerebral cortex results in HD symptoms including impaired cognitive function and
uncontrolled body movement. Although Htt is distributed in peripheral and central nervous
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system, the function of both normal and mutated Htt is not fully understood. However, several
studies suggest a toxic gain of function of the mutated form, resulting in selective degeneration
in the striatal neurons88,89.Disrupted energy metabolism as well as mitochondrial dysfunction
have been detected in pre-symptomatic HD patients90. In the basal ganglia and occipital cortex of
HD patients, reductions in glucose metabolism as well as elevated lactate production have been
measured91. However, increased lactate production is not found in all pre-symptomatic HD
patients suggesting an early metabolic alteration before HD actual symptoms. Additionally,
impaired energy metabolism and elevated ROS which results in mitochondrial dysfunction have
been observed in cortical pre-symptomatic HD samples. Mitochondrial complex II activity is
altered in HD patients. Interestingly enough, the pathological hallmarks of HD samples and
selective degeneration of striatal neurons have been observed in animal models that are
systemically injected with complex II inhibitor, 3-nitropropionic acid92.
Ischemic stroke (one of the leading cause of disability and death worldwide) is another
neuropathologic condition that includes severe cell loss. Although necrosis has long been
considered as the main death form in ischemic stroke, apoptosis occurs in neurons of peri-infract
zone (ischemic penumbra) after long times (several hours to weeks) of ischemic stroke93. The
onset of ischemic stroke is followed by dramatic reduction of blood flow accompanied by loss of
energy stores, release and inhibition of reuptake of neurotransmitters, and ionic imbalance
leading ultimately to necrosis. The ischemic penumbra is a less severe zone that surrounds the
necrotic core and has been found to possess apoptotic hallmarks including DNA fragmentation,
caspase activation, expression of pro-apoptotic genes and cytochrome c release. Apoptosis
through excitotoxicity occurs due to excess glutamate released from necrotic core. Stimulated
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glutamate receptors, NMDA, promote calcium influx, an event which increases [Ca

2+

] to the

limit that induce cell death an event that is found to initiate intracellular activation of proapoptotic proteins and signaling pathways

94,95

. Loss of cellular energy, due to limited substrates

(i.e. oxygen and glucose), along with prevention of reuptake excitatory neurotransmitters (by
pre-synaptic neurons) lead to disrupted ionic homeostasis and compromise membrane
potential96,97. Mitochondrial dysfunction is one of the key steps that facilitates post-stroke
apoptosis; however, the complete mechanisms have yet to be fully identified. Also, mitochondria
are recognition sites for pro-apoptotic proteins including Bax, Bad, and Bid that are activated
upstream of mitochondrial dysfunction. The anti-apoptotic BcL-2 proteins play a key role in
mediating apoptosis after stroke. Whereas, overexpression of the anti-apoptotic protein BcL-2 or
administered BcL-xL to wild-type animals leads to stroke resistance in such animals

98

.High

mitochondrial ROS either due to various events (i.e. Ca2+ overload, excitotoxicity, and hypoxia)
or lack of function of superoxide dismutase is one of the leading causes of apoptosis in ischemic
brain injury 93.
Although causes for neurodegenerative diseases seem to be divergent, their pathogenesis
have a common convergent mechanism including oxidative stress, metabolic defects and
mitochondrial dysfunction. The goal of my research is to determine the extent to which
physiological apoptosis alters glucose metabolism and whether or not such metabolic changes
are a cause or a consequence of apoptosis.
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B. Apoptosis regulation and cellular mechanism
The occurrence of apoptosis during development ina wide variety of animals from worms
to human has supported the fact that it is regulated by an evolutionarily conserved genetic
program. This genetic program works by turning the activity of specific genes on or off based on
the prevailing extracellular or intracellular conditions. This program is greatly affected by, and
tightly linked to, interconnected cellular signaling pathways. There are two distinct apoptotic
pathways: extrinsic and intrinsic “mitochondrial” pathways. Both pathways converge on a
common execution step that involves the release of some mitochondrial components (i.e.
cytochrome c, Smac/DIABLO and endonuclease G) which in turn directly or indirectly cause
fragmentation of DNA, and degradation of most cellular proteins. Both extrinsic and intrinsic
pathways have been found to be recruited in neurodegenerative conditions, whereas intrinsic
pathway is found to be the main mode of cell death during development.

B.1. Extrinsic pathway
This pathway is induced via interaction between transmembrane receptors (death
receptors) and their corresponding ligands. The death receptors are members of tumor necrosis
factor (TNF) family that share cysteine rich domains. Each member of the TNF family
hastrimeric or multimeric functional receptor complexes that assemble by formation of disulfide
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bonds between cysteine domains. The most characterized receptors and their corresponding
ligands include TNFR1/TNF-α, FasR /FasL, DR3/Apo3L, DR4/Apo2L, DR5/Apo2L. Activation
of death domain by its corresponding ligand leads to recruitment of receptor associated death
domain, FADD (Fas receptor associated death domain) or TRADD (TNF receptor associated
death domain) (Figure 3-A). Apoptosis in developing ratcerebral cortical neurons was found to
be induced by recruitment of Fas/Apo1L
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. Additionally, Fas-induced apoptosis mediated by

caspase-8 activation in human embryonic primary cultures has been reported100. However,
apoptosis in trophic factors deprived sympathetic neurons and K+ deficient CGNs didn‟t include
Fas-mediated signaling, despite its high expression in these cells. Caspases are aspartate-specific,
cysteine-dependent proteases that are recruited during many apoptotic mechanisms. Seven
caspases (four initiators and three executioners) are known to play key role in apoptosis in
mammals

101

. Caspase-8 and -10 are considered as initiator caspases that can further activate

downstream executioner caspases-3,-6, and -7 which in turn initiate a point of no return in the
extrinsic pathway in many apoptosis conditions

102

. However, both initiator and executioner

caspases can be inhibited by inhibitor of apoptosis (IAP) proteins which are in turn controlled by
mitochondrial proteins(i.e. XAF1 (XIAP-associated factor1), Smac, and Omi (a.k.a HtrA2) that
are released during apoptosis

103

. Procaspase-8 is activated when it comes in close proximity to

the dimerized death effector domain (DED) of receptor associated domains. The assembly of
these proteins results in death-inducing signaling complex (DISC) formation which induces
procaspase-8 autocatalytic activation (Figure 3-A). From this point, apoptosis may occur via two
different paths. First path involves the direct activation and recruitment of caspase-3, -6, and 7which facilitate the final apoptotic stages including proteolytic digestion of key cellular proteins
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and DNA104. The second path, involves the activation of executioner caspases through a
mitochondria-mediated rout. This rout started by cleavage of the full length of the pro-apoptotic
BcL-2 protein, (P22) Bid, by caspases-8. The resulted cleaved Bid (c-terminal (P15) truncated
Bid (tBid)) translocates to mitochondria leading to cytochrome c release into cytoplasm which in
turn recruits the mitochondrial “intrinsic” apoptotic pathway105. This pathway considered as a
cross-talk point between the receptor- mediated extrinsic pathway and the mitochondrial
“intrinsic” pathway.

B.2. Intrinsic pathway
This pathway is recruited by various non-receptor mediated stimuli which affect
mitochondrial targets (Figure 3-A). The mechanism of action of each stimulus may include
positive or negative signaling events. Positive signaling events include stimuli such as free
radicals, toxins, radiation, viral infections, and hypoxia. Whereas, negative stimuli include loss
of factors that maintain apoptosis suppression such as deprivation of neurotrophic factors,
cytokines and hormones4. The main cellular response to such stimuli is the release of cytochrome
c from the mitochondrial intermembrane space to the cytoplasm. The released cytochrome c
triggers formation of wheel like heptameric apoptosomes upon binding to apoptotic protease
activating factor-1 (Apaf-1).

The apoptosome, a wheel of death, is a 1 MD a heptamer

composed of seven molecules of each cytochrome c, Apaf-1, procaspase-9, and (d)ATP106. The
apoptosome
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Figure 3-A.The extrinsic and intrinsic pathways of apoptosis. The extrinsic pathway started by activation of the death
domain FADD due to ligand/receptor interaction. Close proximity of procaspase-8to activated domains and the
formation of death-inducing signaling complex lead to its auto-cleavage to caspae-8. Activated caspases-8 further
activates executioner caspases-3 either directly or indirectly through mitochondria mediated rout. The mitochondriameditated route started with pro-apoptotic protein Bid cleavage and activation to tBid which translocates to
mitochondria. Translocation of tBid facilitates the release of cytochrome c from intermitochndrial space to the cytoplasm
where it can activate a series of downstream executioner caspases. The intrinsic pathway induced by various stimuli (i.e.
loss of trophic factors, oxidative stress, DNA damage due to radiation or toxic chemicals). The pathway proceeds by the
activation of BH-3only proteins which further activate pro-apoptotic BcL-2 proteins, Bax, Bak. Also, BH-3only proteins
neutralize the activity of the anti-apoptotic proteins leading to formation of the mitochondrial outer membrane pore
(MOMP) which facilitate the release of cytochrome c protein. The released Cytochrome c further activate the
executioner caspases-3 which facilitate DNA and cellular proteins fragmentation leading to apoptosis.
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activates procaspase-9 that activates executioner caspases that catalyze hydrolysis of cysteinylaspartyl peptide bonds found in many cellular proteins. Forebrain extrusions have been observed
in Apaf-1, caspase-9, and caspase-3 deficient mice suggesting a crucial role of these apoptosome
protein components in CNS development2. Cytochrome c release occurs upon formation of
mitochondrial outer membrane pores (MOMP) that are controlled by Bcl-2 proteins. In health
conditions, cytochrome cis located in the intermembrane space of mitochondria function to
transfer electrons between complexes III and IV of ETC. The Bcl-2 family proteins are classified
according to the presence of Bcl-2 homology domains (BH1-4) or according to their function
into anti-apoptotic proteins and pro-apoptotic proteins (Figure 4-A)107. Chemical interaction
between anti-and pro-apoptotic proteins is found to neutralize their function.

B.2.1. Pro-apoptotic proteins
The pro-apoptotic proteins facilitate apoptosis by inactivating anti-apoptotic proteins and
allowing mitochondrial outer membrane permeability (MOMP) formation that facilitate
cytochrome c release. Of this group the most characterized proteins are two death effector
molecules, Bak and Bax that share four BH domains. In healthy neurons, Bakis a cytosolic
monomer associated with the cytoplasmic side of mitochondrial outer membrane (MOM),
whereas, Bax is a cytosolic monomer that translocates to mitochondria upon induction of
apoptosis where it aggregates, homoligomerizes and permeabilizes the MOM. During apoptosis,
Bax and Bak are thought to be activated by BH3-only proteins, and undergo conformational
changes that cause them to oligomerize and form MOMP108.Despite many years of research, the
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exact mechanism through which Bax and Bak are activated during apoptosis as well as the
molecular content of MOMP and how it is regulated is controversial 109.

Figure 4-A. Bcl-2 family proteins. BcL-2 proteins can be classified according to their function into anti-apoptotic
BcL-2 proteins (proteins that induce cell survival and sharing 4 BcL-2 homology domains (BH)), and proapoptotic proteins (proteins that induce apoptosis). The pro-apoptotic proteins group is further subdivided
according to BcL-2 homology domain (BH) content into BH3 only proteins (those which containing BH3 domain
only) and death effector proteins (Bak and Bax, those that are sharing 4 BH domains). [Adapted from106]

Separate from their pro-apoptotic function, Bax and Bak are integrated in cellular
homeostasis mechanisms. In healthy neurons, Bax and Bak are mediating processes of
mitochondrial fission and fusion through their effect on mitochondrial tubule dynamics. Such
processes are critical in regulation of Ca

2+

buffering, ATP synthesis, and respiration
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. In

agreement with such findings, studies on non-apoptotic hepatocytes promote the crucial role of
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Bax in regulating mitochondrial bioenergetics

111

. Furthermore, Bax is reported to regulate

mitochondrial ROS production in healthy sympathetic neurons
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. This involvement of Bax and

Bak in cellular housekeeping duties suggest critical quality control role if the cellular
homeostasis is perturbed.
Either pro-survival or pro-apoptotic, Bax and Bak are directly or indirectly activated by
other BcL-2 proteins, BH3-only proteins. Activation of BH3-only proteins is linking the signal
transduction of apoptosis to the formation of MOMP.

B.2.3. BH3- only proteins
These proteins contain only one BcL-2 homology domain, the third domain (BH3), an
amphipathic helical motif that is found in all Bcl-2 proteins. All identified BH3-only proteins are
pro-apoptotic i.e. BAD, BID, BIM, BMF, Noxa, and PUMA. Of these proteins, Bid, Bim, Puma
are critically important for pro-apoptotic Bak and Bax activation, however, their apoptotic effect
is negligible in the absence of Bax and Bak suggesting that BH3-only proteins working upstream
to Bax and Bak. In support of this idea, double knock out Bax/Bak cell lines that over-express
BH3-only proteins survived apoptotic insults when compared to the wild type cells113. Although
some of BH-3 only proteins seem to directly target Bax and Bak, others (i.e. BAD, NOXA,
BMF, HRK, and BIK/BLK) display a strong preference in binding to anti-apoptotic proteins. For
example, anti-apoptotic proteins Bcl-2 and Bcl-xL that prevent cytochrome c release from
intermitochondrial space are neutralized and heterodimerized with Bad 114.
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In the presence of growth factors, phosphorylated Bad (phosphorylation occurs at three
serine sites; S155, S136, S112) allows docking of the cytoplasmic chaperone molecule14-33which prevent its binding to anti-apoptotic proteins and ultimately prevent cell death.
Dephosphorylation of one of the serine sites is sufficient to prevent growth-factors mediated
survival of cerebellar granule neurons

115

. Additionally, mutated S155 which mimics a

phosphorylated Bad, mediates protection against apoptosis despite the phosphorylation status of
S112 and S136, implying a critical role of S155 in Bad apoptotic function115.This
phosphorylation status of Bad is regulated by cellular kinases depending upon the cellular status.
For example, in presence of growth factor, the survival signaling pathway PI3K is targeting Bad
at S136 whereas MAPK is targeting Bad at S112 and S155 sites. While in absence of growth
factors, Bad is targeted by JNK (death signaling pathway belongs to MAPK) which prevents its
docking to 14-3-3 protein promoting Bad apoptotic function by neutralizing anti-apoptotic
proteins

116

. Additionally, other BH3 proteins (i.e. Bim, Bmf) activities are modulated by death

signaling pathway in response to apoptosis (i.e. UV radiation, oxidative stress)116,59.
In addition to its phosphorylation status, the pro-apoptotic function of Bad can be directly
regulated by initiator caspases through a mechanism mediated by death receptors activation.
Similar to Bid response (see section B.1.), cleavage of Bad by activated initiator caspases
produce truncated Bad which shows high affinity for BcL-xL and mitochondrial membrane
allowing cytochrome c release

117

. In addition to its apoptotic function, phosphorylated Bad

(particularly at S155 site) plays a key role in glucose metabolism in β-cells118. During survival
conditions, phosphorylated Bad translocates to mitochondria forms a protein complex with
glucokinase enzyme, which catalyzes glucose phosphorylation and mitochondrial ATP
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consumption. This complex is dissociated upon dephosphorylation of Bad (i.e. in absence of
growth factors) which encourages the binding of Bad to the partner anti-apoptotic proteins 118.
Similar to Bad activity, other BH-3 only proteins like Bim exhibit subcellular
translocation during apoptosis, which is connected to the cytoskeletal component of dynein light
chain 8(LC8) in healthy conditions. During apoptosis, Bim is dissociated from LC8 and
translocated to mitochondria where it is suggested to interact with and neutralize the
corresponding anti-apoptotic BcL-2 proteins119.As mentioned previously, Bid is thought to
trigger oligomerization of Bak that facilitates MOMP during apoptosis

105

.Noxa has been shown

to interact with Bcl-2 at the cytosolic side of mitochondria leading to formation of MOMP and
then activation of caspase-9107. Both Noxa and Puma are mediators of P53-induced apoptosis
which is triggered in response to cellular stress or oncogene activation. Overexpression of Puma,
in vitro, is shown to be associated with highly expressed Bax that translocates to mitochondria
which in turn depolarizes leading to cytochrome c release120. Many practical and hypothical
explanations proposed the mechanism through which Bcl-2 proteins interact to commit cell‟s
fate, however, the exact mechanism remains poorly understood109,121,109.

B.2.4. Anti-apoptotic proteins
Anti-apoptotic BcL-2 proteins contain four BcL-2 homology domains (BH1-4) and
integrated within the outer membrane of some cellular organelles like mitochondria, endoplasmic
reticulum and nucleus. The most characterized forms are Bcl-2, Bcl-xL, and Bcl-w. The main
function of anti-apoptotic proteins is to preserve the cellular compartments membrane integrity
by preventing the formation of MOMP. However, the exact molecular mechanism through which
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anti-apoptotic proteins achieve this function is controversial. One model (unified model)122
recently proposed both direct and indirect interactions between anti-apoptotic proteins (BcL-2
and BcL-xL) and pro-apoptotic proteins Bax and Bak. The direct interaction includes direct
inhibition of pro-apoptotic proteins (Bax and Bak) by anti-apoptotic proteins which explain some
of the observed phenomena during apoptosis such as prevention of mitochondrial fusion

122

.In

healthy cells, Bak and/or Bax is proposed to mediate the process of mitochondria fusion
123

.However, this mode cannot be applied in healthy cells due to the different subcellular

compartmentalization of each protein (i.e. Bax is cytosolic)124. Most recently

125,126

, Bax has

been proposed to be localized to mitochondria and retro-translocated to the cytosol of healthy
cells through a BcL-xL-mediated mechanism. This retro-translocation activity of Bax is thought
to be inhibited after an apoptotic stimulus leading to Bax accumulation on mitochondria which
facilitating apoptosis progression.
The indirect interaction (derepression mode), however, includes sequestration of BH3only proteins, Bid, Bim, and Puma, that are activating pro-apoptotic proteins. This unified
mechanism which is the first to relate MOMP formation to mitochondrial dynamics
(mitochondria tend to stop fusion during apoptosis), proposed that the direct interaction is
dominant over the indirect one. Other mechanisms (i.e. embedded together, displacement model,
etc) were evolved before the unified mechanism, that propose either direct or indirect interaction
between pro-and anti-apoptotic proteins

127

. The embedded together model, however, assume an

equilibrium among both modes of interactions where one mode may dominate over the other
according to the physiological status of the cell127.
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In general, the balance between pro- and anti- apoptotic proteins of the Bcl-2 family and
their activity status is important in determining the cell fate. The removal of one or more of Bcl-2
family proteins may affect the cellular decision to commit apoptosis. For instance, in Bax (one of
Bcl-2 family protein)-deficient sympathetic neurons, the release of cytochrome c is delayed
following the removal of NGF (and hence delaying the process of apoptosis) implying the role of
Bax in facilitating the release of cytochrome c 128. In Bcl-XL–deficient mice, severe apoptosis is
reported in the differentiated postmitotic immature neurons of the spinal cord, dorsal root
ganglia, and brain, which leads to death of the embryos at day 13 129. Significant degeneration of
sympathetic neurons, dorsal root ganglion neurons, and facial motor neurons have been observed
in a Bcl-2 -/- mice implying the importance of Bcl-2 for PNS survival 19
In addition to the prevention of pro-apoptotic proteins, anti-apoptotic proteins promote
cell survival through different mechanisms of action. For example, BcL-xL enhances the
efficiency of energy metabolism in hippocampal neurons

130

. This activity was rendered to a

possible interaction between BcL-xL and the beta subunite of the F0F1 ATP synthase a
mechanism which may explain the enhanced synaptic metabolism in cells overexpressing BcLxL. Furthermore, BcL-xL is suggested to promote metabolites exchange in and out mitochondria
through a voltage-gated anion channel (VDAC)-mediated mechanism131.Interestingly, the antiapoptotic proteins have antioxidant activity not only by preventing generation of free radicals but
also by preventing oxidative damage of cellular components

132,133

.Also, their anti-apoptotic

mechanism includes maintenance and organelles sequestration of cellular anti-oxidants such as
GSH. For example, cellular level of GSH and its nuclear localization is maintained in cells
overexpressing BcL-2134,135.
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B.2.5. Cellular Signaling pathways
Neurotrophic factors deprivation, the major trigger of apoptosis during development,
inactivates the PI3K/Ak survival pathway as well as cAMP/protein kinase A(PKA) and Rasmitogen-activated protein kinase (MAPK) pathways that contribute to suppression of apoptosis.
The neuronal cell type and survival factor are the major determinants of the type of signaling
cascade that is recruited. The PI3K/Akt pathway has been found to be central for the survival of
a wide variety of cell types. Trophic factors such as NGF, BDNF, and insulin-like growth factor
1 (ILG-1) bind to their tyrosine kinase receptors leading to activation of PI3K. Also, PI3K can be
recruited by direct interaction with the proto-oncogene Ras. Active PI3K catalyzes
phosphorylation of the plasma membrane phosphoinositides producing phospatidylinositol 3,4
bisphosphate (PI3, 4P) and phosphatidylinositol 3,4,5 trisphosphate (PI3,4,5P)within the inner
surface of the plasma membrane.Once this happens, the generated phospholipids activate several
downstream serine/threonine kinases, including Akt. The PI3K/Akt pathway suppresses
apoptosis in many different ways including transcriptional and post-translational mechanisms.
The post-translational pathway has been proposed to act upstream and downstream of the release
of cytochrome c by regulating the activity of Bcl-2 proteins and components of the apoptosome,
respectively. In the presence of survival factors, Akt phosphorylates and inactivates the proapoptotic protein Bad136 (see section B.2.3.). Similarly, removal of survival factors inactivates
Akt which leads to Bad dephosphorylation, which neutralize the anti-apoptotic protein Bcl-xL,
thereby preventing its pro-survival effect. GSK-3β, an isoform of the metabolic GSK-3 enzyme
which negatively regulates glycogen synthase, is one of the downstream substrates of Akt
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pathways that are activated upon removal of neurotrophins. Active GSK-3β regulates the activity
of Bax through phosphorylation and facilitates cytochrome c release, which induces the intrinsic
apoptotic pathway

137

.Additionally, the Akt pathway can act downstream of cytochrome c

release; however its substrates which are thought to be components of the apoptosome have yet
to be identified. Human caspases-9 is an Akt substrate, however, this relationship has not been
proven in rodent models115,138.
On the transcriptional level, the PI3K-Akt pathway activates expression of genes
encoding glucose transporter (Glut-4) which promotes cellular glucose uptake139.The
transcription factor NF-kB is one of Akt substrates that is activated in response to survival
signaling. NF-kB stimulates the transcription of the anti-apoptotic proteins, Mn-SOD, and the
inhibitors of apoptosis (IAPs) 140.This pathway is inactivated upon removal of survival factors.
Mitogen-activated protein kinase (MAPK) pathway is induced in response to a wide
variety of cellular stimuli. This may result in diverse cellular activity including growth,
differentiation and PCD. There are three major pathways included in the mammalian MAPK
form: P38/MAPK, c-Jun N-terminal kinases/stress-activated protein kinases (JNKs/SAPKs), and
extracellular signal-regulated kinases (ERKs). In the presence of survival factors, ERK/MAPK is
activated and mediates the phosphorylation of Bad and the activation of CREB (transcription
factor that induce anti-apoptotic Bcl-2 proteins transcription)141. Collectively, although both
PI(3)K–Akt and MAP kinase survival pathways seem to be divergent, they are activating the
same set of some proteins (i.e. BcL-2 proteins) to prevent apoptosis.
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A shortage of neurotrophins during development as well as elevated ROS activates the
JNK/SAPK pathway. JNK is one of the mitogen-activated protein kinases (MAPKs) that mediate
intracellular signaling in response to various cellular activities. JNK induces apoptosis by both
post-translational and transcriptional modifications. The post-translational modifications by
activated JNK include phosphorylation of both pro-and anti-apoptotic proteins. The
transcriptional modifications include upregulation of pro-apoptotic proteins through activation of
the transcription factor c-Jun(one of the transcription factor activator protein-1(AP-1) family
members)116.Additionally, c-Jun promotes Fas-L expression in motor neurons and CGNs142,143.
These findings provide evidence for JNKs/c-Jun participation in both intrinsic and
extrinsic apoptotic pathways. JNK is activated not only due to lack of survival factors but also in
response to UV radiation, and oxidative stress. P38 pathway is one of MAPK that is activated in
response to cellular stress, or pro-inflammatory cytokines. Both JNK and P38 pathways have
been found to be implicated in neurodegenerative diseases including AD and PD supporting the
role of ROS in apoptosis induction. Studies on different JNK isoforms (JNK1-3 in human and
murine) in hippocampal neurons provide supportive evidence of the critical role of JNK in
regulating apoptosis144.
The tumor suppressor gene, P53 plays an important role in regulating cell fate decision
by promoting gene transcription leading to cell-cycle arrest, or by inducing apoptosis, and
regulating cell differentiation. DNA damage and/or oxidative stress can activate P53 on both
transcriptional and post-translational levels

145

. Furthermore, P53 plays a crucial role in

mediating apoptosis in developing neurons. During neural development, P53 is found to
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participate in the clearance process of unwanted neurons that fail either to differentiate from
progenitor to postmitotic state or to compete for the available neurotrophins. Evidence
supporting the role of P53 in apoptosis in neuronal development provided by several studies on
P53-/- mutated mice, showed craniofacial abnormalities, and exencephaly due to neural tissue
overproduction

146,147

. In sympathetic neurons, over-expressed P53 is found to be sufficient to

induce death in presence of NGF 148. Interestingly, cultured P53-/- postnatal sympathetic neurons
are survived in absence of NGF suggesting a crucial role of P53 in controlling cell cycle

149

.

However, in a P53-/- transgenic mice, cell death is found to be delayed but not prevented. In
immature mice cerebellum, P53-mediated apoptosis due to gamma-irradiation but not
developmental have been reported 150.
P53 promotes apoptosis on both transcriptional and post-translational levels. On the
transcriptional level, P53 induces expression of pro-apoptotic proteins such as Puma, Noxa, Bid,
Bad, Bax, and apoptogenic proteins (i.e. cytochrome c andApaf1). Recently, there is a growing
body of evidence for a post-translational effect of P53 mediated by mitochondrial and metabolic
changes145, 151, 152.The post-translational effect of P53 involves its direct effect on mitochondria.
The cytoplasmic P53 is translocated to MOM due to stress signaling where it directly interact
with pro-and anti-apoptotic proteins in a way similar to BH3-only proteins

145,153

.Such

interactions consequently facilitate MOMP formation and cytochrome c release. In developing
sympathetic neurons, P53 lie upstream to Bax activation and is a downstream substrate in
MAPK/JNK which is activated by P75 neurotrophin receptors in response to neurotrophins
withdrawal which in turn can be inhibited by active Trk154.
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Oxidative stress (due to increased ROS, impaired anti-oxidant systems or both)not only
causes oxidative damage of cellular components but also has signaling activity which facilitates
cell death. Oxidative stress can induce activity of both kinases and phosphatases in different
signaling pathways. Protein kinases either receptor dependent or independent are sensitive to
redox status of the cell. The redox sensor, apoptosis-regulating signal kinase 1 (ASK1) which is
activated in response to oxidative stress initiates the signaling cascade of JNK/Stress-activated
protein kinases (SAPKs; also called c-un NH2-terminal kinases [JNKs]). In healthy conditions,
ASK1 is held inactive and sequestered by thioredoxin (TRX) protein which promote ASK1
ubiquitination155. However, this ASK1/TRX complex is dissociated due to redox modification of
the Cysteine residue in TRX leading to liberation of ASK1 which activate a number of
downstream kinases

156

.Active JNK/SAPK inactivates and phosphorylates anti-apoptotic BcL-2

proteins which facilitate the activation of pro-apoptotic proteins

157

. Furthermore, the survival

signaling pathway PI3K/Akt is sensitive to the redox status of the cell. In health conditions, Akt
phosphorylates and inhibits ASK1 which further prevent stress-induced apoptosis. Modified
redox status inactivates Akt and other downstream redox sensitive protein kinases 68. Activation
of JNK as well as down-regulation of Akt pathway due to oxidative stress converges on the point
of activation of pro-apoptotic proteins and inactivation of anti-apoptotic proteins.
In addition to the signaling transduction, oxidative stress may induce apoptosis by
directly modulating activity of redox sensitive molecules in the intrinsic or extrinsic pathways.
One of those molecules is cytochrome c which is released to the cytosol in a mitochondriamediated mechanism. Due to its nature as an electron donor/acceptor protein in ETC,
cytochrome c is highly sensitive to the cell‟s redox status. Oxidative stress induces the
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peroxidation activity of cytochrome c which oxidizes cardiolipin (a molecule that interacts with
and stabilizes cytochrome c in intra-mitochondrial space). Oxidized cardiolipin reduces its
binding affinity to cytochrome c which increase cytochrome c dissociation and release

68

.

Cytochrome c release needs mitochondrial outer membrane permeabilization, the latter is
facilitated in response to diverse array of stimuli including high ROS. Once it is released,
cytochrome c can induce apoptosis only if it is oxidized. During oxidative stress conditions, the
released inactive cytochrome c is oxidized and activated facilitating activation of downstream
apoptotic molecules such as caspases

158

. Additionally, high endogenous as well as exogenous

ROS levels may directly or indirectly activate caspases. Caspases activation, a hallmark of
apoptosis, in response to apoptotic stimuli occurred either through extrinsic or intrinsic pathways
(see section B.2.). Active caspases involves activation of a series of downstream caspases
(caspases cascade) which initiating cleavage of vital cellular macromolecules leading ultimately
to degradation of DNA, and loss of plasma membrane integrity. Caspases are activated indirectly
due to cytochrome c release or increased expression of FasL which lead to activation of
caspases-8 upon docking to its receptors. Interestingly, expression of FasL and cytochrome c
release is mediated by cellular redox status in the cell line of Jurkat T cells.159.Direct activation
of Caspases is due to its sensitivity to redox cellular status which is rendered to the presence of
the reduced Cysteine at the active site. It has been reported that H2O2introduced at low doses is
enough to activate caspases and hence induce apoptosis, however, high doses induce oxidative
inactivation of caspases leading to cell necrosis 160.
Cellular metabolism is directly regulated by survival pathways and hence expected to be
directly or indirectly targeted by apoptotic signaling. For example, the activation of GSK-3β
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(mentioned earlier) which is involved in glycogen synthesis in hepatic cells occurs upstream to
Bax activation during apoptosis. Active GSK-3β (due to absence of growth factors and inactive
Akt) phosphorylates pyruvate dehydrogenase complex which basically converts pyruvate to
acetyl-coA (the first step in citric acid cycle)

161

.Additionally, the pro-apoptotic protein Bad

which is considered as a convergence point for many signaling pathways, has shown to play an
important role in the cellular metabolism in presence of growth factors in hepatic162 and
pancreatic cells(see section B.2.3.).Interestingly, glucose metabolism is suggested to be
controlled by Akt at multiple points through which Bax is controlled

139,163

.Furthermore, Akt

promotes glucose metabolism in neurons by inducing GLUT4 translocation to membrane and
thus facilitating the process of glucose uptake. Glucose metabolism particularly in neurons could
be one of the earlier events of apoptotic pathway (which expected to facilitate further
downstream events) mainly due to its role in regulating the neuronal redox status and in energy
supplementation. Perturbed glucose metabolism in apoptotic neurons (either due to pathological
or developmental events)has long been determined

164,58,141,161,165–167

, however, the molecular

mechanism through which neuronal metabolism may facilitate apoptosis has to be determined.
B.2.4. Neuronal metabolism and apoptosis
Neurons differ from most somatic cells as they mainly depend on glucose as an energy
source for ATP generation. Neurons of CNS are highly energy demanding cells as they consume
20% and 25% of the total body oxygen and glucose respectively, while they constitute only 2%
of the total body weight168. The produced energy represented in ATP is required mainly for
maintenance of ionic gradients and synaptic communication. Cellular ATP is synthesized mainly
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by mitochondria, the process of oxidative phosphorylation, and by glycolysis, conversion of
glucose into three carbon sugars. In neurons, mitochondria play a crucial role not only in energy
production but also in Ca2+ buffering, maintaining plasma membrane potential, neurotransmitters
release and reuptake at synapse, and their transportation through neuronal processes169.
Mitochondrial membrane potential (ΔΨm) is generated due to proton pumping across the
impermeable mitochondrial inner membrane. The higher proton concentration outside the
mitochondrial matrix than inside establishes an electrochemical gradient, or the proton motive
force (ΔP), which drives ATP formation, ATP/ADP exchange, proton leak and regulates the rate
of mitochondrial substrate oxidation. In addition to its pivotal metabolic role, mitochondria are
central in apoptosis commitment as they sequester the pro-apoptotic protein, cytochrome c and
interact with the Bcl-2 protein family. As previously mentioned (Section A.3.), early metabolic
defects and mitochondrial dysfunction have been found to be associated with inappropriate
apoptosis in neurodegenerative diseases. Such defects are thought to facilitate or even be
responsible for neuronal loss by apoptosis or necrosis. Inactivated citric acid cycle enzyme,
complex I, as well as cytochrome c oxidase (complex IV) in AD cells may be one of the key
factors that are facilitating neuronal loss72. Such inactivation of metabolic enzymes may directly
perturb energy metabolism and enhance the production of ROS164. Elevated ROS due to
inactive complex I in PD may directly affect some other ROS susceptible metabolic enzymes in
and out mitochondria. Furthermore, the findings that the disruption in energy metabolism is an
upstream event, which precedes the irreversible apoptotic events in HD are supportive to this
hypothesis (see section A.3.).
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In developing neurons, neurotrophin deprivation has been found to be associated with
early metabolic disturbances, early mitochondrial dysfunction, and increased ROS level141.
Apoptosis in hippocampal neurons triggered by oxidative stress is found to be mediated by the
aldehydic product of membrane lipid peroxidation, 4-hydroxynonenal (HNE). This type of
apoptosis is prevented by treatment with GSH and Bcl-2 implying the role of ROS as key
mediator of cell death170. In sympathetic neurons cultures, ROS is suggested to have early
signaling role in triggering apoptosis rather than a non-specific toxic role.23,171. Such signaling
effect of ROS occurs prior to cytochrome c release. The mitochondrial cytochrome c protein is
one of the early discovered points at which both cellular metabolism and apoptosis converge. Its
well defined metabolic function as an electron carrier between the respiratory chain complex III
and IV is lost during apoptosis. Although the release of cytochrome c is regulated basically by
BcL-2 proteins, its apoptotic activity (induced right after the release) is even highly dependent on
the neuronal redox status and hence glucose metabolism

172,58

.In agreement with these findings,

tumor cells, with Known up-regulated PPP, are resistant to cytochrome c-mediated apoptosis.
Both neurons and tumor cells undergo cytochrome c-mediated apoptosis when PPP is inhibited
by dihydroepiandrosteone (DHEA)58. This is implying a crucial role of glucose metabolism
particularly PPP not only in regulating neuronal redox status but also in regulating the proapoptotic activity of cytochrome c.
Glycogen synthase kinase-3β (GSK-3β)which phosphorylates and inactivates the
metabolic enzyme, pyruvate dehydrogenase complex (PDC)161,165, is one of the downstream
substrates in both MAPK and PI (3) K pathways that is activated upon removal of neurotrophins.
Active GSK-3β regulates the activity of Bax by phosphorylating it and facilitating cytochrome c
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release which induces the intrinsic apoptotic pathway providing a potential link between
apoptotic signaling and neuronal energy metabolism137. Activation of Bax is suggested to be an
upstream event of high ROS produced in cytochrome c-mediated apoptosis

173

. Another link

between metabolic defects and apoptosis is provided by the pro-apoptotic protein Bad.
Phosphorylated Bad in response to survival factors and activation of survival kinases (Akt and
Ras/MAPK) cannot bind to the anti-apoptotic proteins BcL-xL (see secion B.2.3.) allowing cell
survival. In addition to be targeted by signaling pathways, phosphorylated Bad binds to
glucokinase (a hexokinase (HK) isozyme, HKIV) in hepatocytes and pancreatic β-cells at its
BH3 domain revealing a metabolic activity of Bad. The metabolic activity of Bad through the
association of glucokinase (GK) is critical to maintain mitochondrial respiration and ATP
production through GK activation118. In neurons, hexokinase II (HKII)was recently

166

found to

act as a molecular switch that determines the cell‟s fate according to the metabolic status.
Interestingly, mitochondrial HKII promotes neuronal survival through a GSK-3β-dependent
mechanism suggesting another link between neuronal metabolism and apoptosis signaling 167.
Hexokinases are normally bound to the cytosolic side of the MOM at VDAC by an Aktmediated mechanism. Surprisingly, the pro-survival effect of Akt pathway is found to be tightly
dependent on the activity of the first step in glucose catabolism (conversion of glucose into
glucose 6 phosphate catalyzed by hexokinase)174. The mitochondrial location of HK allows rapid
access to mitochondrial ATP pool which is transported through VDAC

175

.This is suggesting a

tight coupling between the pro-survival signaling and metabolic activity of HK. Consistent with
these findings, forced dissociation of HK and MOM is found to inhibit the pro-survival activity
of Akt and induce cytochrome c release and hence, apoptosis176. Furthermore, MOM
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permeability occurs in response to HK and MOM dissociation in Bax and Bak deficient cells
implying a dual function of HK as a key signaling and metabolic effector. Complementary to the
role of HK in apoptosis, HK II is highly expressed in rapidly growing tumors that exhibit a high
rate of anaerobic glycolysis177,178. Both cancer cells and healthy neurons show tight control of the
intracellular redox status through high GSH provided by PPP 58. A mechanism proved to prevent
cytochrome c-mediated apoptosis and hence allowing cancer cell evasion of apoptosis and lifelong survival of neurons

58

. In addition to Bad, some of anti-apoptotic proteins provide more

links between apoptosis and metabolism regulation. For example, in healthy neurons, BcL-xL
interacts with F0F1 ATP synthase and regulates metabolite exchange from and to mitochondria
(see section B.2.4.). Furthermore, the crucial role of BcL-xL in promoting ATP/ADP
transportation through VDAC in healthy cells support the hypothesis that Bcl-xL has a metabolic
function in addition to its ant-apoptotic function. In addition to its role in transporting the
metabolic solutes in and out the MOM, VDAC regulates the activity of some pro-apoptotic
proteins (i.e. Bax and Bak)179,180 in healthy neurons implying another role of VDAC in
preventing apoptosis through blocking MOMP-dependent formation. The same dual nature of
BcL-2 proteins is reported for Noxa, a pro-apoptotic BH-3 only protein. In non-neuronal
apoptotic cells, the pro-apoptitic function of Noxa is suppressed in presence of high glucose due
to posttranslational modifications181. Strikingly, this protective role of Noxa in presence of high
glucose is rendered to its ability to promote glucose conversion into ribose-5-phosphate and its
glycolytic recycling through pentose phosphate pathway (PPP) which generates NADPH and
prevent oxidative damage by elevated ROS181, 182.
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To date, despite the growing body of evidence of early metabolic alterations in apoptotic
neurons, the question of which reaction(s) in glucose catabolism is (are)controlling these
alterations has to be answered. Furthermore, whether this alteration is a cause or a consequence
of an apoptotic stimulus hasn‟t been confirmed yet. For example, early mitochondrial
dysfunction has have been observed with reduction in ATP synthesis and basal cell respiration
rate in potassium/ serum deprived cultured CGNs26.This reduction of ATP synthesis was
rendered to altered utilization of ATP. Both synthesis and utilization of ATP establish the
cellular ATP level which is maintained in healthy conditions. Accordingly, the cellular ATP
level is not only a function of its production but also of its utilization. Altered ATP utilization is
expected to directly affect the rate of glycolysis (glycolytic flux) partly due to the fact that
glycolysis is one of the cellular sources of ATP. Also, the first step of glycolysis which involves
utilization of ATP (glucose phosphorylation by HK) is suspected to be a direct target by
apoptosis signaling that may occur upstream the BcL-2 proteins recruitment. This means that
altered ATP utilization as well as changes in other metabolic enzymes within the glucose
catabolic pathway may facilitate and propagate the apoptotic stimulus cell-wide. However, these
alterations of metabolic sites may superimpose on or be masked by the observed alteration in
ATP utilization.
Although the contribution of glycolysis to total ATP production is known (8-12%) which
cannot explain the reported ATP reduction 26, the degree to which glycolysis may exert a control
over ATP utilization as well as the degree to which glycolysis (and other metabolic reactions) is
sensitive to early changes in ATP levels has to be determined. Furthermore, whether or not HK
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and/or other reactions within the glucose catabolic pathway (in addition to altered ATP
utilization) in CGNs are directly targeted by apoptotic stimulus has to be answered.
The metabolic changes within the energy metabolism during apoptosis may be due to
direct post-translational changes resulted in alterations in enzymes kinetics (that may affect their
catalytic activity (Kcat) or their affinity toward their substrates (Km)), or due to indirect changes
in metabolites concentrations to which they are sensitive. Accordingly, by taking into account
the participation and effect of other reactions embedded in the neuronal metabolic flux on the
glycolytic flux and on the whole catabolic flux, more informative map of the primary sites
targeted by apoptotic signaling will be obtained.
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C. CGNs as a model
Cerebellar granule neurons (CGNs) constitute the most homogenous population of
neurons in the mammalian brain (~90% of cerebellum neurons)183. In the developing cerebellum,
CGNs are initially located in the outer layer of the cerebellar cortex but then migrate into the
deepest internal granular layer during development. In general, the developing brain undergoes
two major steps: 1) neurogenesis followed by migration, and 2) formation of neural circuits and
synapses184. In small rodents as well as humans, development of granular neurons is mostly
postnatal (Figure 4-A) and starts with neurogenesis and proliferation in the external granular
layer primarily during the first postnatal week (P0-P7)185. By the beginning of the third postnatal
week (P14) a large pool of immature CGNs exit the cell cycle, differentiate, and migrate to their
final destination (internal granular layer) where they innervate Purkinje cells, and are in turn
innervated by mossy fibers terminals originating from brain stem interneurons184. A large
number of immature CGNs undergo apoptosis during their migration to the internal granular
layer. The process of developmental death precedes the maximal synaptogenesis that takes place
during the third postnatal week supporting its role in adjusting the number of neurons to the
available synaptic endings. Primary CGNs cultures are successfully shown to recapitulate such
cerebellar developmental events and have been advantageously used for over 30 years186–
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188

.Since then, CGNs have become widely used as the most common in vitro system in all studies

of neuronal death, whether developmental or pathological.
CGNs survival in vitro requires the presence of fetal bovine serum (FBS), as a source of
growth factors, and non-physiological depolarizing levels of K+ (25 mM, high K) in the culture
media40,42. Upon removal of FBS as well as the reduction of potassium concentration to (3.55mM), CGNs show the morphological and biochemical hallmarks of apoptosis such as DNA
fragmentation,

cell

shrinkage,

chromatin

condensation

and

formation

of

apoptotic

bodies189.Depolarizing conditions are unnecessary for the first 2-3 days of CGNs culture;
however, high K is vital beyond 3-4 days in vitro as the neurons are fully differentiated. This is
consistent with the in vivo invasion of mossy fibers into the internal granular layer and
establishment of excitatory synapses with the differentiated CGNs. The incidence of apoptotic
elimination of the differentiated CGNs in vivo closely matches the formation of mossy fiber
synapses with CGNs185. High potassium promotes the opening of the voltage-gated L-type Ca2+
channels by depolarizing the plasma membrane potential (ΔΨp) from ≈ -75 mv (resting potential)
to ≈ -35 mv and so raises the intracellular Ca2+ concentration ([Ca2+]c)40.In low K a decrease in
respiration occurs which parallels changes in [Ca2+]c where the majority of L-type Ca2+ channels
are closed due to hyperpolarized plasma membrane. It has been found that an immediate
reduction in respiration occurs upon exposure to low K with additive effects of combined
K/serum removal26.The reduction in respiration is mainly affected by [Ca2+]c, as lowering
external [Ca2+]e to 0.02mM in high K, a condition that lowers [Ca2+]c to mimic that which occurs
in low K, results in a similar decrease in respiration26.
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Figure. 5-A. Cerebellum developmental stages characterized by metamorphosis in cerebellar circuitry: (a) 1 st postnatal
week, (b) 2nd postnatal week, (c) adult in rodent. (a) During the 1 st postnatal week, progenitor cells differentiate to a
large population of immature CGNs (in blue) in the external granular layer (EGL). In (b) reduced number of
differentiated CGNs migrate to internal granular layerthrough the molecular layer (ML) and purkinje cell layer
(orange oval). In (c) mature CGNs receive synaptic inputs from mossy fibers (green lines) and form axons to synapse
164
with purkinje cells. [Adapted from ]

The reduction in [Ca2+]c results in decreased Ca2+-ATPase pumps activity, an important regulator
in maintaining low [Ca2+]c, which in turn affect the cellular ATP level. As mentioned in section
B.2.4., cellular ATP level is a function of both ATP production and consumption (i.e. through
Ca2+-ATPase pumps). In addition to affecting the cellular level of ATP, [Ca

2+

]c plays a pivotal

role in controlling neural metabolism, axon extension and neuronal elimination by apoptosis
during development190.Some of the regulatory enzymes and/or protein kinases in survival
signaling pathways targeting metabolic enzymes are sensitive to [Ca2+]c level as well. For
example, PI3-K/Akt, P38 MAPK, and calcium calmodulin-dependent signaling pathways
involved in cell survival and directly regulate certain metabolic enzymes are Ca2+-dependent
49

kinases

191,192

. Furthermore, the neuronal energy metabolism has many [Ca+2]c responsive sites

that may be affected. Mitochondrial metabolic enzymes such as isocitrate dehydrogenase, and αketo-glutarate dehydrogenase complex are directly regulated by [Ca2+]c whereas, pyruvate
dehydrogenase complex (PDC) is indirectly affected by Ca2+-dependent phosphatases193,194.
Interestingly, these mitochondrial dehydrogenases are critically regulated by the mitochondrial
levels of ADP/ATP and NAD/NADH suggesting another link between [Ca2+]c and cellular ATP
level. The F0-F1 ATP synthase is also activated by [Ca2+]c which strongly correlates the cellular
bioenergetics to the [Ca2+]c level169. Low ATP demand, due to reduced activity of Ca2+-ATPase
pumps, may directly affect the glucose metabolism of CGNs by targeting certain pathways (i.e.
glycolysis, see section B.2.4.). Additionally, it can indirectly down-regulate the metabolic
enzymes via changes in their intermediate concentrations. To date, the degree to which each
mechanism mentioned above contributes to the observed decrease in glycolysis and
mitochondrial

oxidative

phosphorylation

(approximately

by

20%

and

40%,

respectively)26remains unclear.
In addition to K+-mediated, Ca2+ dependent changes in metabolism, growth factor
withdrawal may have further effects on metabolism. Growth factors induce activation of receptor
tyrosin kinase (RTKs) which activate several cellular signaling pathways, most important of
which are PI3-K/Akt and MAPK. Both pathways include activation of many metabolic enzymes
(see section B.2.4.). In sympathetic neurons both NGF and KCl synergistically promote Akt
activity suggesting a cross-talk between NGF and KCl signaling pathways195. Interestingly,
glycolytic flux is targeted by PI-3K/Akt163,196 (see section B.2.4.) which may partly explain the
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measured apoptosis and even cancer-associated flux changes within glycolysis. Glycolytic
changes, as well as the suspected changes in mitochondrial metabolic enzymes, during apoptosis
may partly explain the observed alterations in glucose metabolism. However, the extent to which
each may participate to the observed change is unclear.
Assuming alterations in ATP demand (due to survival factors/K deprivation) are the only
direct effect of apoptotic signaling so that changes propagated throughout the metabolic pathway
are considered as secondary (indirect) changes (i.e. changes in metabolite concentrations) to the
apoptotic signaling. Such changes in metabolites concentrations may occur in healthy cells
metabolism. However, activated phosphatases and kinases mentioned above during apoptosis
(survival factors/K deprivation) are important pieces of the puzzle that are suspected to directly
target metabolic enzymes in CGNs. The resulted direct changes may be superimposed by the
indirect ones, those due to changes in intermediates concentration. For this reason, it is critical
that the changes in flux resulting from kinetic defects are distinguished from those resulting from
changes in metabolite concentrations (either due to a kinetic defect, or simply to a change in
ATP demand), which can be considered as secondary effects. The control a reaction has on the
flux of another reaction within a multi-step pathway (i.e. glycolysis on glucose catabolism), as
well as the dependence of fluxes on the concentrations of substrates and products, have not been
considered in studies on the link between apoptosis and metabolism. Metabolic control analysis
(MCA) is an approach which quantifies the sensitivities of reaction fluxes to small changes in
substrates and products. By quantifying these sensitivities, it is also possible to determine the
control a reaction has on the flux through other reactions in the pathway197. Application of MCA
51

on CGNs during both health and apoptosis conditions will be used to differentiate early changes
(primary targets) due to post-translational modifications in metabolic enzymes from those due to
changes (secondary changes)in intermediates concentrations. The goal of this work is to identify
and rank the reactions whose fluxes are altered because of direct kinetic changes after accounting
for indirect flux changes due to the metabolites after induction of apoptosis in cerebellar granule
neurons.
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CHAPTER 2: METABOLIC CONTROL
ANALYSIS

A. Introduction
Metabolic control analysis (MCA) is a means of quantitatively understanding the
behavior of a system through identifying the interactions occurring among the components of the
system It provides the mathematical and theoretical framework for describing any system at any

given degree of complexity and architecture. Metabolic control analysis was initially developed
in the 1970s by two independent groups of Kacser and Burns1and Heinrich and Rapoport2.
Application of MCA has changed the old assumption that a single “rate-limiting step”
determines the flux through a multi-step pathway, to the conclusion that the control of flux is
distributed among multiple reactions. This was supported by the findings that overexpression 3 of
what were considered rate limiting enzymes within different pathways had marginal effects on
flux, whereas over-expression of many enzymes within a system leads to many-fold flux
increment 4. These findings lead to the replacement of the intuitive qualitative description of rate
limiting steps with a quantitative measure of how multiple enzymes contribute to establishing a
system flux. The main advantage of MCA is that it relates the local behavior of the system‟s
components (i.e. how enzyme velocities are affected by substrates, products, and allosteric
effectors) to the global behavior of the whole system (i.e. how changes in the kinetics of an
enzyme propagate throughout a system to affect pathway flux). The information gained from
MCA is essential to understanding how an unknown parameter (e.g. an apoptosis trigger) acts to
perturb a metabolic system.
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To successfully apply MCA, the system must meet the following criteria: 1) the system is
a single connected unit (i.e., all the reactions comprising the system must be linked together
through a common set of metabolites); 2) reaction velocities (i.e., reaction rates) are affected by
changes in the concentrations of explicit metabolites (those linking the reactions together), but
not by metabolites which reside within a reaction (a situation which occurs with top-down MCA,
where a reaction may consists of two or more enzymatic steps that are linked by one or more
„implicit‟ metabolites; 3) individual reactions interact with one another only through the explicit
metabolites (i.e. an enzyme affects the rate of another enzyme by altering the concentration of an
explicit metabolite, and does not affect the rate through effects such as protein-protein
interactions); 4) the system is at a steady state such that the fluxes and metabolite levels do not
change over5. The variables within a metabolic system are the metabolite concentrations and
reaction fluxes, both of which can be affected by the parameters of the system (e.g., the amount
of an enzyme, the kinetics of an enzyme, the temperature, the concentration of a hormone).
Given a fixed collection of parameters, the concentrations of metabolites are the critical variables
that establish the system‟s steady state fluxes.
For a simple pathway (Figure 1-B, A)6, composed of two reactions catalyzed by enzymes E1 and
E2, the source of metabolite X (a parameter) is converted to the variable metabolite M which in
turn is converted to the sink metabolite Y (a parameter). The steady state of the system is reached
when the rate of M supply equals the rate of its consumption so that the flux from X to Y is
constant and the concentration of M is stable. If fluxes E1 and E2 are plotted against the
concentration of M (Figure 1-B, B), the steady state occurs at the intersection of lines reflecting
the kinetics of each enzyme to metabolite M.
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Figure 1-B. Steady state of a simple metabolic pathway. A, For a two step metabolic pathway catalyzed by enzymes
E1 and E2, metabolites X and Y are considered parameters external to the system, and thus are considered as infinite
sources and sinks whose levels remain constant as the system proceeds to the steady-state, as well as after it has
reached the steady-state. The first step of the pathway (catalyzed by E1) includes the formation of M metabolite and
consumption of X. The second step of the pathway (catalyzed by E2) involves consumption of M and production of
Y. B, The hypothetical kinetics of E1 and E2 to M depicted by the red lines illustrate that E1 is subject to product
inhibition as M accumulates, while E2 is subject to substrate activation in a Michaelis-Menten-type fashion. The
steady state is reached at a point in which the rate of M production equals rate of M consumption.
[Adapted.Brand.J.Exp. Biology. 1997 5].

The system‟s variables (concentration of metabolite M, and rates of its production and
consumption) change (i.e., a new steady-state occurs)when a parameter either internal (e.g., the
kinetics or amount of E1 or E2) or external (e.g., pH, temperature, availability of or hormones)
to the system changes. For example, addition of a specific inhibitor of E1will result in reduction
of the enzyme‟s velocity (Figure 2). Consequently, the rate of M consumption will exceed the
rate of its production. This will cause a decrease in the concentration of M, which will lower the
rate of E2 thereby reducing feedback inhibition of E1 until a new steady-state is achieved. This
new steady state will be at a new intersection point based on the inhibitor-induced change in
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kinetics of E1 (an internal parameter change that can be considered a direct kinetic change to
e.g., the enzyme's catalytic rate constant), and the metabolite-induced changes in the kinetics of
both E1 and E2 (a change in a system variable that indirectly changes the enzymes‟ kinetics).
From this example, it can be seen that a parameter which perturbs a metabolic system does so by
first directly affecting the kinetics of one or more reactions, and secondly by indirectly affecting
other reaction fluxes because of the changes in concentrations of metabolites connecting the
reactions. In this way, reactions sharing a metabolite exert control over each another by affecting
the concentration of the shared metabolite. A system evolving to a steady-state therefore does so
through both local enzymatic properties(i.e. the dependence of an enzyme‟s velocity on the
concentrations of its substrate and product, as well as any other explicit metabolites which have
allosteric effects), which involve parameters such as Km and Kcat constants that occur
independent of the system, and global system interactions that are dependent on the system‟s
structure and variables (i.e. the control that a reaction has on establishing the concentration of
another reaction‟s substrate , product, or allosteric effector).
The essential feature of control analysis is to quantitatively describe the enzymatic
system properties of a multi-step metabolic pathway whose structure and stoichiometric
relationships are known. With this information, the processes most important in controlling a
system flux or metabolite concentration can be determined. The use of MCA has significant
advantages; first, it provides quantitative understanding of the interactions occurring between the
system components, which provides objective insight into the behavior of the system, and
second, it provides a means to identify and rank those reactions whose kinetics are directly
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Figure 2-B. Steady state change due to kinetic inhibition of producer. Progressive addition of an M-producer
inhibitor causes changes in its kinetic parameters, which are reflected by the parallel lines. Successive new steady
states evolve that correspond to different intersections of the lines representing the kinetics of the M producer.
[Adapted.Brand.J.Exp. Biology. 1997 5].

affected by parameters that perturb the system in ways that are not apparent by inspection of the
new state Such advantages are important in identifying enzymes or target sites affected by
chemical or genetic factors which cause pathophysiological states. This can be done using MCA
as a tool to extensively characterize how the behavior of a metabolic system in a disease state
differs from that in a healthy state (e.g., forms of diabetes, cancer and neurodegenerative
diseases)7. For example, a strong association has been found between the high control coefficient
glucokinase (GK) and a specific form of diabetes (the monogenic diabetes)8. This diabetes form
occurs due to a mutation in a GK allele that results in autosomal dominant inheritance.
Application of MCA provided insight into how the single mutated GK (with high control
coefficient) affects the synthesis of hepatic glycogen in monogenic diabetic individuals.
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Additionally, MCA relates dominance of mutant alleles to the control coefficients of the
enzymes that they encode 9. Furthermore, targeting certain enzymes that exert high control over
the metabolism of parasites that cause incurable fatal diseases such as trypanosomes (causing
sleeping sickness) may kill the parasite without threatening the host‟s life (corresponding forms
of targeted enzymes in host must have low control over human metabolism)10. Understanding the
metabolic nature of cells under certain pathological conditions using MCA could ultimately open
the door to identify new drug targets. Using MCA, the control structure of a system is
quantitatively expressed in a few key coefficients which are described below in Sections A.1A.3.

A.1.Concentration control coefficients
Concentration control coefficients are global features of a system as they measure the
extent to which each reaction determines the concentration of a specific metabolite M change
𝑀
(within the system boundaries) in response to changes in reaction rate (𝐶𝐸1
).
𝑑𝑀 𝑀

𝑀
𝐶𝐸1
= 𝑑𝑉

𝐸1

(1)

𝑉𝐸1

Where, dV is the change in enzyme velocity VE. According to the summation theorem11,12 there
is no net change in a metabolite concentration in the steady-state, as production and consumption
are equal. Accordingly, it follows that:
𝑛
𝑀
𝑖=1 𝐶𝐸𝑖

=0

(2)

Where n is the number of reactions within a system. According to the summation theorem, the
level of metabolite M is affected by all enzymes in the system indicating a positive and negative
control.
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A.2.Flux control coefficients
Flux control coefficients are a system feature as they reflect the interactions occurring
among the reactions within the metabolic network because of their connectedness through the
explicit metabolites. Flux control coefficients 13, previously known as sensitivity coefficients1, or
control strengths 14, quantify the extent to which a reaction/ enzyme dictates flux through another
reaction in the pathway. This concept can be illustrated with the following example of a
hypothetical, linear series of reactions forming a metabolic pathway.
E1

E2

E3
Scheme 1

In this pathway, assume that X and Y are infinite source and sink metabolites, respectively, such
that their concentrations do not significantly change, while M and N are the variable metabolites
explicitly considered.
Since M is the product of the reaction catalyzed by enzyme E1,but is also the substrate of
enzyme E2, the concentration of M is partly determined by activities of both E1 and E2. Thus E2
exerts partial control over the flux through E1 by virtue of E2‟s effect on consuming M, thereby
relieving feedback inhibition on E1. Reactions that do not share a common metabolite can still
exert control over their respective fluxes. In this example, E3 consumes N, and so affects the
extent of product inhibition on E2, which in turn influences the rate of M consumption. Thus, by
indirectly affecting the concentration of M, E3 exerts some degree of control over the flux
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through E1. The control that E2 exerts over flux through E1 is quantified as the flux control
𝐸1
coefficient 𝐶𝐸2
:

𝐸1
𝐶𝐸2

𝑑𝐽 𝐸1

= 𝑑𝑉 𝐸2

(3)

𝐽 𝐸1
𝑉𝐸2

From the equation above, the flux control coefficient mathematically equals the fractional
change in a specific flux (JE1) in response to a fractional change in the velocity of another
enzyme (VE2). The rate of E2 is denoted V indicating that it has been manipulated by an external
effector, while, the rate of E1 is denoted J indicating the measured flux rate is a function of the
changes in metabolite concentrations in the system. Fractional changes are used to make the
coefficients unitless and dimensionless. It should be emphasized that dJE1 reflects the change in
flux from the original steady-state to a new steady-state upon addition of an effector (specific for
E2) that causes an infinitesimally small change in the rate of E2 (dVE2). Flux control coefficients
are thus valid only around the infinitesimal change in flux from the original steady-state.
Because of the non-linear nature of enzyme reaction rates as a function of their metabolite
concentrations, an effector that produces large changes in VE2 (VE2) will cause a proportionally
different perturbation in JE1 (JE1), and thus a change in the flux control coefficient. In practice,
flux control coefficients are often approximated by making a perturbation that is sufficiently
large to produce an experimentally measurable change in flux.
According to the summation theorem11,12, the sum of the flux control coefficients of each of the
enzymes (E1, E2, and E3) on the flux catalyzed by E1 at a given steady state is unity,
𝐸1
𝐸1
𝐸1
𝐶𝐸1
+ 𝐶𝐸2
+ 𝐶𝐸3
=1

(4)
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This means that a change in the control that a specific reaction exerts over flux through another
reaction leads to compensatory changes in the control exerted by one or more reactions within
the same pathway. If the control coefficient of a specific enzyme were close to one, this would
indicate that the enzyme is rate limiting while the control coefficient for the other enzymes will
be close to zero. However, the extensive application of MCA indicates that most pathways do
not have a rate-limiting enzyme

15

. This means that most of reactions within a linear pathway

have values range from 0 to less than 1. However, in the case of pathways containing branches
(where two reactions compete for the same substrate) and cycles, negative control coefficients
will occur.
The global properties of the system, including both concentration and flux control
coefficients, are dependent primarily on the system‟s status. Indeed, quantitative measurements
of control coefficients provide valuable information about the distribution of enzymes with the
highest control over a given flux within a metabolic network. This allows further manipulation of
such enzymes to control the outcome of the metabolic flux. For example, quantifying flux
control coefficient was beneficial in studying regulation in many metabolic pathways such as the
respiration flux, and oxidative phosphorylation in isolated mitochondria 16, in vitro identification
of activities of enzymes isoforms in living Drosophila17, and enzymes within the glycolytic
pathway of in vitro liver extracts18.
Metabolic control analysis relates the overall system properties (global properties) to its
local properties of its component parts (enzymatic properties). Unlike global properties, the local
properties are dependent mainly on the kinetic response of each enzyme to each metabolite.
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A.3. Elasticity coefficients
The Elasticity coefficient (ε) quantifies the degree to which an enzyme‟s velocity is
affected by a change in the concentration of a metabolite (substrate, product, or allosteric
effector), as all other metabolites within the system are held constant. Elasticities are inherent
features of enzymes, but can be modified by factors such as covalent modification and proteinprotein interactions. Mathematically, the elasticity coefficient is the fractional change in rate of a
reaction in response to an infinitesimal change in the concentration of a metabolite (dM).
Accordingly, it is equivalent to the normalized slope of the relationship between an enzyme‟s
reaction rate and the concentration of the metabolite M (figure 1). For the multistep reaction
above (Scheme 1) the elasticity of E2 to M is

𝐸2
𝜀𝑀
=

𝑑𝑉𝐸2 /𝑉𝐸2

(5)

𝑑𝑀 /𝑀

where dV is the change in enzyme velocity (V) resulting from an infinitesimal change (dM) is
the metabolite M concentration. The values of ε are positive for metabolites that are substrates or
allosteric activators, while they are negative for metabolites that are products or allosteric
inhibitors.
The local properties of a system (i.e. elasticity coefficients) was related to its global
properties (i.e. flux and concentration control coefficients) through the connectivity theorem19.
The connectivity theorem is one of the most important MCA theories as it provides explanation
on how local enzymes features (elasticity coefficients) can affect the systemic behavior (flux and
concentration control coefficients). For example, the flux control coefficient of a specific enzyme
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(i.e. E1 from Scheme 1 above), tends to be relatively small if its elasticity to the pathway
metabolites (i.e. X and M) is high13. This can viewed as an increase in the enzyme E2 activity
(i.e. due to external stimulator) will cause reduction in substrate X and increase in product M.
Assuming high elasticity of E2 to X and M, the preceding change in their concentrations will
compensate for the increased activity of E2. In this sense, the increased activity of E2 due to
external perturbation will exert a small effect over the steady state flux meaning that E2 has low
flux control coefficient. Likewise, if E2 elasticity to X and M is low, its flux control coefficient
will be high. An effect that can be rendered to the low effect (low elasticity) of X and M in
maintaining the steady state flux of E2. Consequently, E2 has high flux control coefficient. This
relationship between flux control coefficient and elasticity coefficient was derived by Kacser and
Burns1 as follows
(6)
𝐽 𝑖
𝑛
𝑖=1 𝐶𝑖 𝜀𝑚

=0

Using the bases of summation and connectivity theories, the systemic properties (flux and
concentration control coefficients) can be determined in terms of the components features
(elasticity coefficients) for any given system. Reder20 has developed proofs of the matrix
relationships that exist between the elasticity coefficients, concentration control coefficients, and
flux control coefficients for a system of any complexity, provided that the structure of the system
and the corresponding stoichiometric relationships between the reactions are known.
In a more complex metabolic system like CGNs where metabolic pathways consist of
many reactions, elasticity and flux control coefficients cannot practically be measured for all
reactions, but can be measured by simplifying the number of explicit reactions considered using
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a top-down approach. Our goal is to quantify the enzymology of blocks of reactions to a limited
number of metabolites, and the important interactions that occur between the blocks which
establish the steady-state catabolism of glucose in healthy CGNs using a modified, top-down
approach to MCA. The information gained will be used to identify how metabolism is perturbed
in trophic factor derived CGNs.
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B. Top-down control analysis
The top-down approach considers the system behavior without having to account for all
the reactions that are involved in metabolizing glucose. Conversely, the complementary “bottom
up” analysis explicitly considers every reaction within a metabolic pathway. The top-down
approach is much favored for MCA application to complex systems having a large number of
metabolites and enzymes as occurs in intact cells. In the top-down approach, the complexity of a
system composed of many reactions (enzymatic/ non-enzymatic) that may include feedback
loops, cycles, and branches can be simplified by grouping such reactions into a relatively small
numbers of blocks21,22. The control distribution among blocks of the system can be calculated
using the connectivity and summation theorems from elasticity coefficients of such blocks to the
common metabolites to which they are responding (see Section D).
Top-down control analysis was first applied by Brand and his group in 1988 on a simple
system (isolated mitochondria) of two blocks (producers and consumers) interconnected with
single metabolite (proton motive force)23. Years later, producers block of this system (isolated
mitochondria) was further broken into respiratory chain and phosphorylation blocks to describe
the control of mitochondrial respiration24. More detailed picture of the control pattern of
mitochondrial respiration has been obtained by further subdividing the respiratory chain block
into succinate consumers and cytochrome oxidase and considering two intermediates
76

(cytochrome c redox state and proton motive force)25. The use of top-down analysis has been
extended to analyze the energy metabolism in intact cells (i.e. hepatocytes) with limited number
of blocks and metabolites26. Furthermore, it has been advantageously used to study control of
metabolism in perfused whole organs (i.e. liver, heat)27,28.The control of ATP turnover,
glycolysis, and oxidative phosphorylation have been mapped in hepatocytes where metabolism
was grouped into 9 blocks connected with 5 explicit metabolites29.
This approach makes the application of control analysis within cells experimentally
feasible so that the behavior of metabolism within healthy neurons can be described
quantitatively, and the primary kinetic changes perturbing the metabolism of apoptotic neurons
can be identified and ranked.
In the simplest case glucose metabolism can be divided into reactions that produce and
consume ATP30. Since the function of the ATP producers is closely associated with neuronal
viability, more detailed information about the kinetic state of the producers is desired by
partitioning them into eleven blocks connected by six explicit metabolites (Figure 3). The
reactions are grouped so that kinetic information on mitochondrial function (blocks 3, 4, 6, and
7), on substrate supply to mitochondria (blocks 1, 2, and 11), and on substrate supply for
antioxidant defenses (blocks 9 and 10) will be obtained. The blocks are grouped similar to the
model developed by Ainscow and Brand 29 for hepatocytes with a few important exceptions due
to differences in the metabolic nature of each cell. First, the oxidative pentose phosphate
pathway and NADPH oxidation blocks are included because apoptosis in neurons is associated
with oxidative stress, which has the potential to cause significant glucose consumption through
this pathway. Second, the non-oxidative pentose phosphate pathway is included as recent
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evidence indicates that recycling of carbon through this pathway may be substantial, which will
affect calculation of glycolytic flux as well as the yield of glycolytic ATP. Third, media glucose
is consumed by neurons, unlike hepatocytes that release glucose into the media from internal
glycogen stores. Fourth, the transport and subsequent cytoplasmic oxidation of malate from the
tricarboxylic acid cycle through cytoplasmic malic enzyme is included, as this block serves as an
alternative source of NADPH for protection against oxidative stress. Additionally, inclusion of
the malic enzyme block was necessary to account for the 13C-lactate labeling pattern (which was
used to determine non-oxidative pentose phosphate pathway flux) with CGNs consuming 1,2-13C
glucose (See Section B.1.9).
Our metabolic model fulfills the MCA requirements in that all the blocks (reactions) are
interconnected by explicit metabolites, so the system is a single interconnected unit. Substrates
out of the system boundaries (glucose, lactate, and oxygen) change minimally over the
experimental time frame (See Chapter 3) and thus have little effect on the system. Glucose and
oxygen are considered as the source substrates while lactate is the sink product (i.e., these are the
„edge‟ metabolites that are not variables within the system). A second important requirement for
the analysis to be valid is that the system maintains a steady state. Indeed, cultured CGNs
triggered to undergo apoptosis by serum/K+ deprivation have been shown to maintain a steady
state in early phases of apoptosis (i.e. respiration rate maintained constant for 3-5 hours before
cells undergoing apoptosis
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Figure 3-B. A simplified model of cerebellar granule neurons energy metabolism. Dashed and bold blue arrows refer
to explicit reaction blocks where Jx denotes the flux occurring through the respective blocks and x is the number of
the block as follows; 1) glucose transport and phosphorylation; 2) glycolysis; 3) pyruvate oxidation; 4) NADH
oxidation; 5) lactate production; 6) mitochondrial phosphorylation; 7) proton leak; 8) ATP consumption; 9)
oxidative pentose phosphate pathway; 10) NADPH oxidation; 11) non-oxidative pentose phosphate pathway; 12)
malic enzyme. Asterisks refer to explicit metabolites including; glucose-6-phosphate (G6P), pyruvate (Pyr),
mitochondrial membrane potential (ΔΨm), ATP/ADP ratio, NADH/NAD ratio, and NADPH/NADP ratio. Ribulose5-phosphate (R5P) is not considered as an explicit metabolite, as NADPH is the primary product regulating the
oxidative pentose phosphate pathway. Fructose-6-phosphate (F6P) is not included as an explicit metabolite, but is
assumed to rapidly equilibrate with G6P to form a single pool of hexose phosphates.

morphological changes)

30,31

. The explicit metabolites connecting the blocks, as well as the

implicit ones within the blocks will change in response to a parameter that perturbs the original
steady-state, but the implicit metabolites within a block are presumed to not affect the flux
through other blocks. The system contains 6 explicit metabolites that connect twelve blocks
together as follows: (1) glucose-6-phosphate (G6P) product of

the glucose transport and

phosphorylation block and substrate for both the glycolytic and oxidative pentose phosphate
pathway blocks; (2) pyruvate (Pyr), product of the glycolysis and malic enzyme blocks and
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substrate for both the lactate production/export and pyruvate oxidation blocks; (3) NADH/NAD
ratio , product of the glycolysis block, and substrate for both the lactate production/export and
NADH oxidation blocks; (4) mitochondrial membrane potential (ΔΨm),product of both the
pyruvate and NADH oxidation blocks, and substrate for both the mitochondrial H+ leak and
oxidative phosphorylation blocks; (5) ATP/ADP ratio, product of the glycolysis, pyruvate
oxidation, and oxidative phosphorylation blocks, and substrate for both the ATP consumers and
glucose transport/phosphorylation blocks; and (6) NADPH/NADP ratio, product of the oxidative
pentose phosphate pathway and malic enzyme blocks, and substrate for the NADPH oxidation
block. Metabolites shown in Figure 3, but not measured in these experiments are: fructose-6phosphate (F6P), ribulose-5-phosphate (R5P), and the triose-phosphates (TrP, including
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate). Fructose-6-phosphate (F6P) and
G6P are rapidly interconverted due to the near-equilibrium reaction catalyzed by hexose
phosphate isomerase32; thus, G6P and F6P are assumed to form a single functional hexose
phosphate pool whose level is reflected by G6P.Ribulose-5-phosphate and NADPH are products
of the oxidative pentose phosphate pathway, but NADPH is considered to exert most, if not all,
of the feedback inhibition through effects on glucose-6-phosphate dehydrogenase (the first step
in PPP)33. For this reason, R5P was not measured in this study. However, R5P is substrate for the
non-oxidative pentose phosphate pathway, and so the inability to assess the elasticity of this
pathway to its substrate is a limitation of this study, and will introduce some error into the
elasticities of the non-oxidative pentose phosphate pathway to the explicit metabolites. The
triose phosphates were not measured, as these metabolites are not the final products of glycolysis
and are not known to exert significant allosteric effects on the remaining blocks; these implicit
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metabolites are shown to indicate the point of entry of carbon from the non-oxidative pentose
phosphate pathway to glycolysis. Malate, the substrate for the malic enzyme block, was not
measured, as this block was not originally included in the system. It was only after the
experiments were performed that it became apparent through mathematical modeling of

13

C-

lactate labeling that inclusion of this reaction was necessary. Consequently, the loss of
information on the elasticity of the malic enzyme block to its substrate will introduce errors into
the elasticities of this block to the explicit metabolites. For this block, the errors introduced are
expected to be small, as malic enzyme is likely to be regulated primarily by feedback inhibition
through its products NADPH and pyruvate. In contrast to the unmeasured metabolites shown in
Figure 3, each of the explicit metabolites is located at critical branch points between the reaction
blocks and have, in vitro, been shown to be important regulators of glucose metabolism.
The blocks considered important to glucose metabolism in CGNs include: 1) glucose transport
and phosphorylation (GTP); 2) glycolysis (GLY); 3) pyruvate oxidation (PYR); 4) NADH
oxidation (NAO); 5) lactate production and export (LAC); 6) mitochondrial phosphorylation
(PHO); 7) mitochondrial proton leak (PRL); 8) ATP consumption (ATC); 9) oxidative pentose
phosphate pathway (OXPPP); 10) NADPH oxidation (NPO); 11) non-oxidative PPP (NonPPP);
12) mitochondrial export and cytoplasmic decarboxylation of malate by malic enzyme (ME).
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C. Organization of reactions blocks and their Stoichiometric relationships
The metabolic system consisting of those reactions involved in the catabolism of glucose
was simplified into 12 reaction blocks. The organization of each block, and their known
stoichiometric relationships is detailed below.

C.1. Glucose uptake/phosphorylation (GTP)
The GTP block (Fig. 3, J1) includes glucose transport primarily through GLUT-3
transporters (provide reference) and phosphorylation by hexokinase to G6P. For each glucose
molecule taken up from the external buffer, one ATP is consumed and one G6P is produced. The
flux (in glucose units) was measured as the rate of media glucose depletion over 120 min (See
Chapter III Methods).

C.2. Glycolytic (GLY)
The GLY block (Fig. 3, J2) includes the eight reactions from phosphofructokinase to
pyruvate kinase that produce two pyruvate for each G6P consumed. This block also produces
three ATP and two reducing equivalents (NADH). The flux in (G6P units) was calculated as onehalf the rate of glycolytic pyruvate production. Glycolytic pyruvate production was calculated as
the difference between the total rate of LAC and PYR fluxes (i.e. J3+J5) and the sum of
production by the NonPPP and E fluxes (i.e. 1/3(J11+J12)).
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C.3. Lactate production and export (LAC)
The LAC block (Fig. 3, J5) includes lactate production from the reduction of pyruvate
(one lactate produced from one pyruvate with one NADH oxidized) by lactate dehydrogenase
and lactate export through the plasma membrane by the monocarboxylate transporters. The flux
(in pyruvate units) was measured as the rate of media lactate accumulation over 120 min (See
Chapter III Methods).

C.4. NADH oxidation (NAO)
This block (Fig. 4, J4) includes the malate-aspartate shuttle reactions that transfer
glycolytic NADH from the cytosol to the mitochondrial matrix where the redox reactions of
respiratory chain take place. For each NADH oxidized by complex I of the respiratory chain, ten
H+ are translocated to the intermembrane space (thus generating m). However, since the
uptake of glutamate into the matrix in exchange for the efflux of aspartate from the matrix is
coupled with the influx of one H+, the NAO results in the net transport of nine H+ and
consumption of one oxygen atom from the oxidation of one NADH. It was assumed that the
NADH not oxidized by lactate dehydrogenase in the cytosol was oxidized strictly by the NAO
block. Thus, this flux was calculated as the difference between mitochondrial respiration rate and
5 x PYR flux (where PYR flux = J3; i.e., J4 = respiration rate – 5J3; See Section C.5). Note that
this calculation had to agree with mass-balance for NADH: the rate of NADH oxidized by the
NAO was the difference between the rate of NADH produced which is the sum of 2x GLYflux
and one-third NonPPP flux (i.e., 2J2 + 1/3J11) and the rate of NADH consumed via the LAC
block (equal to lactate production).
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C.5. Pyruvate oxidation (PYR)
This block (Fig. 3, J3) includes pyruvate transport into the matrix via the
monocarboxylate transporter oxidation into acetyl CoA, all reactions of the tricarboxylic acid
cycle, and reactions of the respiratory chain. Each pyruvate oxidized in this way results in the
transport of forty-six H+ to the intermembrane space from the resulting four NADH and one
FADH2 produced by the TCA cycle. The TCA cycle also produces one GTP by substrate level
phosphorylation, which was assumed to be converted to ATP by nucleoside diphosphate kinase,
with the ATP subsequently exported from the matrix by the adenine nucleotide transporter. The
latter reaction results in the influx of one H+ from the intermembrane space to the matrix, so the
oxidation of one pyruvate results in a net yield of forty-five H+ transported (thus generating
m) and the synthesis of one cytoplasmic ATP for five oxygen atoms consumed. This flux (in
pyruvate unite) was optimized within a mathematical model that exploited the solver function of
Microsoft Excel (see Table 1). This optimization was based on the stoichiometric constraint
between respiration rate and PYR/NADH, and the malic enzyme rate using the stoichiometry of
oxygen consumed by each block (i.e. five oxygen atoms are consumed for each pyruvate
oxidized by PYR, and one oxygen atom is consumed for each NADH oxidized by NAP such that
respiration rate=5J3+J4).

C.6. Mitochondrial phosphorylation (PHO)
The PHO block (Fig. 3, J6) includes the phosphorylation of matrix ADP catalyzed by
ATP synthase, and the exchange of matrix ATP with cytoplasmic ADP and Pi through the
phosphate and adenine nucleotide transporters. Recent evidence34 indicates that 2.7 H+ are
required for the synthesis of each ATP by ATP synthase, and another H+ is required for its export
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to the cytosol, thus resulting in a stoichiometry of 3.7 H+ used per ATP produced. The flux
calculation depends on knowledge of the H+ leak rate, as this must be subtracted for total rate of
H+ returning to the matrix to assess H+ used for ATP synthesis. Cell respiration (RC) can be
divided into the non-mitochondrial (Rnm) and mitochondrial (Rm) reactions, the latter of which
can be further divided into that used for ATP synthesis (RATP) and for (RL) H+ leak. Accordingly,
RATP is calculated as Rm-RL. The stoichiometry between oxygen consumed for pyruvate and
NADH oxidation and H+ produced (9.0 for pyruvate and NADH) was used to convert the rates
into ATP units (see Sections C.4 and C.5).

C.7. H+ leak (PRL)
The PRL block (Fig. 3, J7) involves all routes that allow H+ return to the matrix without
ATP synthesis (resulting in heat as the product). In principle, the leak rate in oligomycin treated
CGNs is equal to the rate of H+ pumping, which can be determined as product of mitochondrial
respiration rate and the known stoichiometry of H+ pumped for each pyruvate and NADH
oxidized by the respective blocks. However, inhibition of ATP-synthase (by oligomycin)
perturbs the steady-state due to reducing H+ re-entry into the matrix via ATP-synthase. The
resulting imbalance causes ΔΨm to increase and so leak flux increases, as the leak rate is strongly
dependent on the magnitude of m. The leak rate can be determined at lower ΔΨm (equal to
that of the original steady-state) by titrating the respiratory chain with an inhibitor (myxothiazol)
that produces successive new steady states35. The elasticities of the H+ leak block to the explicit
intermediates other than ΔΨm are assumed to be zero since oligomycin will perturb the levels of
the other explicit metabolites in the system. The determined leak flux/ ΔΨm relationship in
25K/FBS was used to calculate the leak flux for all modulations (excluding FCCP) once the ΔΨm
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for each modulation has been measured. In the case of FCCP and 3.5K (apoptotic cells), the
leak/ΔΨm relationship was re-measured (i.e. the H+ leak kinetics were determined by titration
with myxothiazol).

C.8. ATP consumers(ATC)
At any steady-state, ATP consumption rate (Fig. 3, J8) equals the ATP synthesis rate,
where the rate of ATP production is the sum of ATP produced from the GLY,PHO, PYR, and
NonPPP blocks. The rates of ATP synthesis by these blocks were calculated from the known
stoichiometries: three ATP are produced for each G6P consumed by GLY; one ATP is produced
for each pyruvate oxidized by PYR; 0.272 ATP are produced for each H+ consumed by the PHO
block; and 0.67 ATP are produced for each R5P consumed by the NonPPP. Note that the GTP
block consumes one ATP per G6P produced, but this block is not included as part of the ATP
consumers. Consequently, ATP consumer flux was calculated as the difference between the rate
of ATP synthesis by all blocks and its rate of consumption by the GTP block.

C.9. Fluxes modeled from analysis of

13

C-lactate labeling with CGNs

catabolizing 1,213C-glucose
A mathematical model was developed to determine OxPPP, NonPPP, and ME fluxes
from the measured fluxes through GTP, LAC, and the combined PYR/NAO (i.e., respiration
rate), and the measured 13C lactate labeling pattern from CGNs metabolizing1,213C glucose. The
model was developed based on the theoretical pyruvate (and thus lactate) labeling pattern as 1,2
13

C glucose is processed through GLY, the OxPPP, the NonPPP, and further through the TCA

cycle of the PYR block, and the ME block. From analysis of the carbon atom transitions and the
recycling of carbons in the PPP, the processing of 1,213C-glucose through the OxPPP and
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NonPPP will produce eight differentially labeled hexose phosphates (i.e., 13C at positions 1, 2, 3,
1,2, 1,3, 2,3, 1,2,3, and unlabeled) of variable fractional amounts; thus, eight differentially
labeled pyruvates of variable abundance are produced when these hexose phosphates are
subsequently processed through glycolysis. By contrast, the processing of 1,213C-glucose strictly
through glycolysis produces a constant 0.5 fractional amount of unlabeled pyruvate and 2,3

13

C

pyruvate. From analysis of the carbon atom transitions in the TCA cycle, sixteen differentially
labeled malates will be generated, which will generate eight differentially labeled pyruvates
when processed by ME. These carbon atom transitions were used to establish a model in which
the solver function of Microsoft Excel optimized two flux ratios (Table 1). These ratios reflect
the contributions of (a) the NonPPP block to the steady-state labeling of the hexose phosphate
pool (Ratio 1) and (b) the ME block to labeling of the pyruvate pool (Ratio 2). The ratios were
optimized so that the

13

C lactate labeling pattern calculated by the mathematical model agreed

with the observed 13C lactate labeling pattern.

C.9.1. Non-oxidative pentose phosphate pathway (NonPPP)
This block (Figure 3-B, J11) is organized in a way that differs from the standard NonPPP,
as it shares some reactions that are found within the GLY block (similar to the PYR and NAO
blocks that share reactions of the respiratory chain). It includes the reactions (a) that interconvert
the pentose phosphates (ribulose-5-phosphate isomerase and ribulose-5-phosphate epimerase),(b)
that link the pentose phosphates to glycolysis (transketolase and transaldolase) via F6P and TrP,
and (c) that convert the TrP generated by this block to pyruvate (i.e., the last five enzymes of
glycolysis are also included in the NonPPP). Since the TrP were not considered as an explicit
87

metabolite, it was necessary to group some of the glycolytic enzymes into the NonPPP, so that
the resultant pyruvate, NADH, and ATP arising from these TrP were accounted for in the flux
calculations. Thus, the consumption of three R5P yields two F6P, two ATP, one NADH, and one
pyruvate (the latter three products resulting from one TrP processed in glycolysis). In this
respect, the rate of ATP, NADH, and pyruvate production by glycolysis (J2) does not include that
generated from the glycolytic processing of TrP derived from the NonPPP.
Table 1-B. Flux parameters optimized by the solver function of Microsoft Excel. Parameter 1 reflects the
contribution of the NonPPP (J11) and the GTP (J1)to the total 13C labeling pattern of the hexose phosphate pool (G6P
+ F6P). Parameter 2 reflects the contribution of ME (J 12) and GLY (J2) to the total 13C labeling pattern of the
pyruvate pool. Measurement of LAC flux (J5) is necessary to calculate J12.Parameter 3 is the contribution of the PYR
block (J3), and thus the NAO block (J4) to mitochondrial respiration, with the constraint that the PYR consumes
five-times more oxygen per substrate oxidized than does the NAO.
Solver-optimized
parameter
𝐽11

𝐽12

(𝐽11 + 𝐽1 ) (1)

(𝐽12 + 2 ∗ 𝐽2 ) (2)

𝐽3 (3)

Purpose
This ratio was used to determine the probability of the nine different hexose
phosphates reacting in the PPP, which in turn was necessary to calculate the
labeling pattern of F6Ps produced by the PPP. Once optimized, this ratio was
used to calculate J11since J1was measured.
This ratio was used to calculate the contribution of ME flux to labeling of the
pyruvate pool. The carbon atom transitions were assessed through four turns of
the TCA cycle to yield a predicted malate 13C labeling pattern. Once the ratio
was optimized by the solver, it was used to calculate J12, given that J12 + 2*J2 =
J3 + J5.
This flux was optimized within the stoichiometric and flux constraints that
mitochondrial respiration rate = 5*J3 + J4 and J3 J4.

The reactions traditionally defining the NonPPP (i.e., those within items (a) and (b) of the
previous paragraph) are near equilibrium and thus reversible depending on the prevailing
conditions within the cell. For this study, it was assumed that the flux through these reactions
was unidirectional towards the production of F6P and TrP. This assumption is based on studies
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of cortical neurons demonstrating net lactate production from hexose phosphates derived from
the PPP

36,37

or extensive recycling of R5P into the hexose phosphate pool38.The unidirectional

assumption also seems logical from the perspective that neurons are terminally differentiated and
so have a relatively low R5P requirement for nucleotide biosynthesis, but are more critically
dependent on PPP-derived NADPH to protect against oxidative stress36. Thus, R5P in excess of
that needed for nucleotide synthesis is likely produced by the OxPPP, causing the return of these
carbons to glycolysis. The NonPPP flux was calculated from optimized Ratio 1 (Table 1) and the
measured GTP flux (J1) as X*J1/(1 – X), where X is the solver-optimized Ratio 1.

C.9.2. Matrix export and cytoplasmic oxidation of malate by malic enzyme
(ME)
This block (Fig. 3, J12) includes the electroneutral exchange of matrix malate with
cytoplasmic dicarboxylates (e.g., succinate, -ketoglutarate, aspartate) and the oxidative
decarboxylation of carbon four to produce pyruvate and NADPH. This flux is calculated from
optimized Ratio 2 (Table X), given that LAC and PYR fluxes (J 3 and J5) are known (i.e., J12= X
* (J3 + J5), where X is the solver-optimized Ratio 2).

C.9.3. Oxidative pentose phosphate pathway (OxPPP)
This block (Fig. 3, J9) includes the oxidative decarboxylation of G6P by glucose-6phosphate dehydrogenase and 6-phosphogluconate dehydrogenase, . For each G6P oxidized, two
NADPH and one ribulose-5-phosphate are produced. This flux was calculated as the difference
between the total rate of hexose-6-phosphate production (J1+2/3*J11) and its consumption by
GLY (J2)
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C.9.4. NADPH oxidation (NPO)
This block (Fig. 3, J10) includes all reactions consuming NADPH. An important subset of
this block is those reactions that contribute to maintenance of the cellular redox state via
reduction of oxidized thiols and removal of reactive oxygen species. Protein thiols are
susceptible to oxidation by a number of reaction oxygen species (ROS). Thioredoxin and
glutaredoxin catalyze the reduction of a number of these oxidized protein thiols, either through
electrons donated by internal cys residues (thioredoxin) or by cys residues from glutathione
(glutaredoxin). Glutathione peroxidase catalyzes the reduction of H2O2 to H2O using electrons
from glutathione, and so helps protect cells from oxidative stress. The protection afforded by
these enzymes is only possible if the cys residues are re-reduced so that they can continue to act
as catalysts. The reduction of glutathione disulfide or thioredoxin disulfide is accomplished by
glutathione reductase and thioredoxin reductase, respectively. Both of these enzymes use
NADPH as the electron donor; in this way the NADPH consumers act as a defense against
oxidative stress. It has been demonstrated36 that exogenous addition of an oxidant such as H2O2
to neurons substantially stimulates OxPPP flux, and so links the NADPH consumers to the
OxPPP via the NADPH/NADP ratio. The flux is calculated as the sum of twice the OxPPP and
ME fluxes (i.e., 2J9 + J12).
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D. Flux control coefficients and elasticity coefficients of the system’s blocks
Control coefficient and elasticity equations discussed in Section A.2 and A.3.apply
equally well to blocks of reactions21. The control over a process K (where K can be a flux J or a
metabolite concentration M) by a block is the sum of all control coefficients of the individual
reactions within that block over process K:
𝐾
𝐶𝑏𝑙𝑜𝑐𝑘
=

𝑛
𝐾
𝑖=1 𝐶 𝑖

(7)

where i is one of n total reactions within the block contains n.
Similarly, elasticity coefficients for a block having n reactions is the sum of the product of all
elasticities of each reaction i to the explicit metabolite M and the control each reaction has over
flux through the block 21:
𝑏𝑙𝑜𝑐𝑘
𝜀𝑀
=

𝑛
𝑏𝑙𝑜𝑐𝑘
𝑖=1 𝐶𝑖

𝑖
∙ 𝜀𝑀

(8)
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E. In situ block elasticities to the intermediates
When considering a complex system having multiple reactions and metabolites, it is not
possible to directly determine the elasticity of a reaction to each metabolite given that it is
impossible to vary one metabolite while holding the others constant. In the past, a doublemodulation method of Kacser and Burns11 was used to facilitate analysis of a segment in a
pathway that results in determining elasticities to the intermediates within the system. The basis
of that method involved perturbation of the enzymes under investigation by addition of a specific
inhibitor/activator for each enzyme. The resultant perturbation is dependent on the flux control
coefficient of the affected enzyme and the distal enzymes that are responsive to changes in the
intermediates due to their elasticities. This method has been generalized by Giersch39into a
multiple-modulation approach that was applied on a reconstructed enzyme system. However, the
structural information (stoichiometric relationships) of the system wasn‟t considered. The
combined use of top-down control analysis and the multiple modulation approach, along with
complete information about the system‟s structure provide the necessary means to analyze the
control of metabolism in an intact cell 40.
Top-down control analysis has been used by Ainscow and Brand29 for hepatocytes having
five explicit metabolites. They calculated the elasticities and control coefficients for the reaction
blocks by applying the multiple modulation approach, which involves perturbing the original
steady state of a specific block using inhibitors or alternative substrates. A new steady state
develops each time a modulation is applied, thus yielding a set of equations for each block that
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can be solved for the unknown elasticities. As an example, consider a block (b) that responds to a
metabolite M, which will exert a change in the velocity of b (ΔVb) as a result of a finite change
𝑏
in M (ΔM). The elasticity of b to M is estimated as 𝜀𝑀

𝑏
𝜀𝑀

∆𝑉𝑏

≈

∆𝑀

𝑉𝑏

(9)

𝑀

If the block responds to another metabolite (N), then its elasticity toward a finite change in N
while holding M constant can be estimated.

𝜀𝑁𝑏

∆𝑉𝑣

≈

∆𝑁

(10)

𝑉𝑏
𝑁

If the concentration of (M) and (N) both change, block b flux will be affected according to the
magnitude of the metabolite changes and the elasticities of b to M and N. Thus, the flux change
in block b resulting from simultaneous changes in M and N is given by combining equations 10
and 11 and rearranging:

∆𝐽 𝑏
𝐽𝑏

≈

∆𝑀
𝑀

𝑏
∙ 𝜀𝑀
+

∆𝑁
𝑁

∙ 𝜀𝑁𝑏

(11)

The change in rate of b is denoted as a flux (J) rather than velocity (V) to indicate that more than
one metabolite is changing, as when b is embedded within a larger metabolic pathway. In this
way the change in velocity of a block (e.g., glycolysis) embedded in a larger system such as
energy metabolism in situ (Fig. 3) is the sum of changes induced by the 6 explicit intermediates
(assuming no changes to the kinetics of the block).
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∆𝐽 𝐺𝑙𝑦
𝐽 𝐺𝑙𝑦

𝐺𝑙𝑦

≈ 𝜀𝑔6𝑝 ∙

∆𝑔6𝑝
𝑔6𝑝

𝐺𝑙𝑦

+ 𝜀𝑃𝑦𝑟 ∙

∆𝑃𝑦𝑟
𝑃𝑦𝑟

𝐺𝑙𝑦

+ 𝜀𝐴𝑇𝑃 ∙
𝐴𝐷𝑃

∆𝐴𝑇𝑃
𝐴𝑇𝑃

𝐴𝐷𝑃
𝐴𝐷𝑃

𝐺𝑙𝑦

+ 𝜀𝑁𝐴𝐷𝐻 ∙

∆𝑁𝐴𝐷𝐻
𝑁𝐴𝐷𝐻

𝑁𝐴𝐷

𝑁𝐴𝐷
𝑁𝐴𝐷

𝐺𝑙𝑦

+ 𝜀𝑁𝐴𝐷𝑃𝐻 ∙
𝑁𝐴𝐷𝑃

∆𝑁𝐴𝐷𝑃𝐻
𝑁𝐴𝐷𝑃𝐻

𝑁𝐴𝐷𝑃
𝑁𝐴𝐷𝑃

𝐺𝑙𝑦

+ 𝜀∆𝜓𝑚 ∙

Δ(∆𝜑𝑚 )
∆𝜓𝑚

(12)

The unknown elasticities of each block can be solved from a set of 6 different equations,
each produced from a modulation that perturbs the original steady state without directly affecting
the kinetics of the block. The new steady states can be reached by applying different external
manipulations by using the multiple modulation approach39. It is essential to use modulations
that are highly specific to one or more blocks (i.e. specific inhibitor or alternative substrate)
whose elasticities are not being measured. A major goal of this research is to perturb the
metabolism of healthy CGNs in at least six independent ways and to measure the resulting
changes in the metabolite levels and reaction fluxes. By substituting the measured metabolite
concentrations and reaction fluxes in equation 6 for each reaction block at each new steady state,
at least six equations per block will be developed from which the six elasticities can be solved.
From this analysis, six different elasticities for each block (72 total, since the model contains 12
blocks), representing the block‟s responsiveness to changes in the six explicit metabolites within
our CGNs model system, will be determined. Because this method involves making relatively
large, finite perturbations to the system, while elasticity coefficients are strictly defined for
infinitesimally small changes, the calculated elasticites are approximations of the true ones.
The control coefficients for each block can be determined from the elasticities. Since the
structural features of a multi-step metabolic pathway are necessary for calculations of control
coefficients, known values of elasticities, known stoichiometric relationships, and measured
fluxes are used to calculate control coefficients using Reder‟s linear algebra- based method as
follows,

S= - (N. dJo. ε)-1. N. dJ

(13)
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C = I + ε.S

(14)

Where S, N, dJ, I, ε, and C are matrices as follows:
S is 12 column, 6 row concentration control coefficient matrix
N is 12 column, 6 row matrix of reaction stoichiometries
dJ is 12 column, 12 row diagonal matrix of the basal fluxes through each block
ε is 6 column, 12 row elasticities matrix
I is 12 column, 12 row identity matrix
C is 12 column, 12 row of flux control coefficient matrix
The control exerted by a specific block over the flux through other blocks is reflected in a set of
12 control coefficients (total of 144 coefficients) as there are twelve blocks within the system.
Also, the control that each block exerts over each explicit metabolites within the system is
reflected in a set of 6 concentration control coefficients ( total of 72 coefficients) as there are 6
explicit metabolites affected by the twelve blocks of the system. The control coefficients provide
extensive quantitative information regarding the metabolic behavior of healthy CGNs. This
information includes insights into the most important processes controlling mitochondrial
substrate oxidation and ATP synthesis, reducing equivalent production, glycolysis, and cellular
glucose uptake. This deep understanding of CGNs metabolic behavior will then be used to
elucidate the major apoptotic targets within the energy metabolic pathway of CGNs. Also, it can
be considered as scientific record for further investigation of the effect of chemical treatments
(i.e. hormones, hypoxia, and low glucose content in blood) on neurons in general.
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E.1. Modulations to perturb the steady state of the CGNs:
Nine different modulators with known sites of actions were used to affect the metabolic
steady state. The fluxes through each block and metabolite concentrations were determined for
each modulator-treated neurons and healthy neurons. The number of modulations is greater than
the minimal required theoretical set in order to reduce the error in the calculations of elasticities
and control coefficients.

E.1.1. FCCP (0.5 M)
FCCP is a proton ionophoreuncoupler that dissipates ΔΨm by increasing the rate at which
protons leak back into the mitochondrial matrix. This modulation directly affects the kinetics of
the proton leak block, so the data obtained from this modulation cannot be used to calculate the
elasticity of the H+ leak block to m. The metabolite most immediately affected is ΔΨm, which
is predicted to decrease.

E.1.2. Oligomycin (10ng/ml with reduced extracellular Ca2+)
Oligomycin directly affects the kinetics of the mitochondrial phosphorylation block via
inhibition of the Fo proton channel subunit of the ATP synthase. CGNs do not survive for
extended periods with oligomycin, as glycolysis is insufficient to provide ATP at a rate sufficient
to meet the demand. Consequently, [Ca+2]e was reduced from 1.3 mM to 25µM. This has the
effect of reducing ATP demand by lowering Ca+2-ATPase activity. Under these conditions of
lower ATP demand, neurons survive in the presence of oligomycin. Because this modulation
directly affects both the ATC and PHO blocks, the data obtained from this modulation cannot be
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used to calculate the elasticities of these blocks to the metabolites. The metabolites most
immediately affected are ΔΨm (increase) and ATP/ADP (decrease).

E.1.3. Low glucose (0.4 mM)
Under normal conditions the incubation buffer contains a saturating concentration of
glucose (10 mM). CGNs primarily express Glut-3 and 4 transporters with a Km for glucose of 13 mM, so the transport rate should not be limited by the media glucose concentration (and thus is
considered an infinite source whose level does not change sufficiently to affect the GLUTmediated transport rate). Reduction in media glucose concentration to 0.4 mM should
significantly impede glucose transport, and thus will directly affect the kinetics of the GTP block
(in this case glucose is not an infinite source, but a restricted source which does affect GTP
kinetics). The data obtained from this modulation cannot be used to calculate the elasticities of
GTP block to the metabolites. The metabolite most immediately affected is G6P, which is
predicted to decrease.

E.1.4. Lactate (2 mM)
Under normal conditions there is no exogenous lactate added to the media. The addition
of exogenous lactate affects the kinetics of the lactate production and export block by making
transport across the plasma membrane less favorable. The data obtained from this modulation
cannot be used to calculate the elasticities of the lactate block to the metabolites. The metabolites
most immediately affected are pyruvate (increase) and NADH/NAD (increase).
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E.1.5. Trans-androsterone (50 μM)
Trans-androsterone is a competitive inhibitor of the PPP enzyme, glucose-6-phosphate
dehydrogenase (G6PDH)41and therefore directly affects the kinetics of the Ox-PPP block. The
data obtained from this modulation cannot be used to calculate the elasticities of PPP block to
metabolites. The metabolites most immediately affected are G6P (increase) and NADPH/NADP
(decrease).

E.1.6. Dichloroacetate (0.5 mM)
Dichloroacetateis an analoge of acetic acid that inhibits pyruvate dehydrogenase kinase
which inactivates pyruvate dehydrogenase (PDH). This should lead to dephosphorylation and
activation of PDH. The PYR block is thus directly affected. Because the NAO block shares
many of the same enzymes as the PYR block, the kinetics of the NAO block are also directly
affected. The data obtained from this modulation cannot be used to calculate the elasticities of
the PYRand NAO blocks to the metabolites. The metabolite most immediately affected is
pyruvate (decrease) and ΔΨm(increase).

E.1.7. β-hydroxybutyrate(BHB) (2 mM)
β-hydroxybutyrate is the predominant blood ketone body that can be oxidized in the
mitochondrial matrix during times of low glucose in the brain. For these experiments, hydroxybutyrate was added to a final concentration of 2mM as a 50% D/L racemic mixture, so
the metabolizable concentration to which the CGNs were exposed was 1mM (as the L form is
not oxidized).The first step in the oxidation is by -hydroxybutyrate dehydrogenase, which
produces acetoacetate and NADH. Acetoacetate can be further metabolized by 3-oxoacid-CoA
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transferase and acetyl-CoA acetyl transferase 1 to yield two molecules of acetyl-CoA, which can
then enter the TCA cycle (Maurer et al BMC Cancer 2011). Thus, the complete oxidation of hydroxybutyrate generates nine reducing equivalents which, when oxidized by the respiratory
chain, consumes nine oxygen atoms. However, it is well established that not all acetoacetate
generated by -hydroxybutyrate dehydrogenase is further processed, as some acetoacetate is
known to exit cells. The inclusion of-hydroxybutyrate means that mitochondrial respiration rate
is now a function of three substrates instead of two. Partitioning the measured respiration rate
into that due to each of the substrates required modification of the original mathematical model
used to determine PYR and NAO fluxes (see Sections C.4, C.5, and C.9) such that the fraction of
-hydroxybutyrate completely oxidized was now included as a solver-optimized parameter.
Since the oxidation of -hydroxybutyrate leads to an alternative source of NADH, this
modulation will perturb the kinetics of the pyruvate and NADH oxidation blocks. The data
obtained from this modulation cannot be used to calculate the elasticities of the pyruvate and
NADH oxidation blocks to the metabolites. The metabolites most immediately affected are
NADH/NAD (increase), pyruvate (increase), and ΔΨm(increase).

E.1.8. Tert-butyl hydroperoxide (tBHP) (25μM)
Tert-butyl hydroperoxide is a source of exogenous ROS that is an excellent substrate for
glutathione peroxidase. This should cause increased oxidation of GSH, which in turn will
increase NADPH consumption via glutathione reductase. Consequently, tBHP will directly affect
the NADPH consumer block. The data obtained from this block cannot be used to calculate
elasticities of NADPH consumer block to metabolites.
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E.1.9. Cyanide (100 μM)
Cyanide inhibits complex IV (cytochrom c oxidase) of the respiratory chain, and so
directly affects the kinetics of the PYR and NAO blocks. The data obtained from this modulation
cannot be used in calculating the elasticities of these blocks to the metabolites.
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F. Assessing In situ apoptotic stimuli target in CGNs energy metabolism
Trophic factor (serum and high K) deprivation is an apoptotic stimulus that is a
modulator of CGN metabolism31, but with an unknown number of blocks targeted. These blocks
can be identified with knowledge of the elasticities of the blocks to the explicit metabolites.
CGNs deprived of trophic factors undergo a rapid decrease in energy metabolism (as indicated
by decreased mitochondrial respiration), but then maintain a preserved metabolic steady state for
at least 4 hours (unpublished and31).If the kinetics of a block are directly affected (e.g. change in
kcat, or Km to an explicit metabolite), then its flux will change in a way that is independent of
changes in the concentrations of the explicit metabolites. Thus, once the fluxes and metabolites
levels are re-measured after trophic factor deprivation, the elasticities can be used to predict flux
changes based on the new metabolite levels. If the predicted fluxes differ from those measured, it
can be inferred that the kinetics of a block have changed, thus implicating the block as a target.

F.1. Direct effects:
The fractional flux changes of the block(s) directly affected by apoptosis will not equal
the predicted changes. The degree to which a block is affected by trophic factor deprivation
(which is a parameter change designated as Δq) can be estimated by the integrated elasticity
coefficient (IE)29
𝑏𝑙𝑜𝑐𝑘
𝐼𝐸∆𝑞
=

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

−

𝑛
𝑏𝑙𝑜𝑐𝑘
𝑖=1 𝜀𝑥𝑖

∙

∆𝑥 𝑖

(15)

𝑥𝑖
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where n=number of

explicit metabolites, 𝜀𝑥𝑏𝑙𝑜𝑐𝑘
are the elasticities (determined in healthy
𝑖

CGNs) of a block to each metabolite (x), and

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

is the measured flux change induced by

trophic factor deprivation, which includes both direct and indirect effects. Hence, the summation
term

𝑛
𝑏𝑙𝑜𝑐𝑘
𝑖=1 𝜀𝑥 𝑖

∙

∆𝑥 𝑖
𝑥𝑖

represents the combined indirect effects of the changed metabolites on the

flux. Therefore, IE is the fractional flux change which cannot be attributed to the changes in
metabolites and thus reflects direct kinetic changes mediated by other effects such as posttranslational or allosteric modifications (which can affect kcat or Km).

F.2. Indirect effects
The indirect effects represent the propagation of a direct kinetic change on a block to
other blocks in the system. Such propagation results from the change in metabolite
concentrations that are affected by kinetic changes of the primary target(s). The indirect effect
that each metabolite (x) has on a block is quantified as the partial integrated response coefficient
x

𝑏𝑙𝑜𝑐𝑘
𝐼𝑅∆𝑞
and can be compared to the overall measured response

𝑏𝑙𝑜𝑐𝑘
integrated response coefficient (𝐼𝑅∆𝑞
=

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

, which is known as the

). The partial integrated response coefficient

acting through a metabolite (x) is calculated as:
𝑥𝐼𝑅 𝑏𝑙𝑜𝑐𝑘

∆𝑞

= 𝜀𝑥𝑏𝑙𝑜𝑐𝑘 ∙

∆𝑥

(16)

𝑥

Each of these coefficients gives the theoretical fractional flux change of a block due to the
change in a single metabolite caused by q (where all other metabolite concentrations remain
constant). Furthermore, the effect that direct kinetic changes on a block (e.g., block 1) have on
the flux through another block (e.g., block2) can be quantified from the known control that block
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1 exerts on the flux through block2. This is known as the partial integrated response of block2 to
trophic factor deprivation (Δq) mediated by direct kinetic changes in block1
𝑏𝑙𝑜𝑐𝑘 1

𝑏𝑙𝑜𝑐𝑘 2
𝑏𝑙𝑜𝑐𝑘 2
𝑏𝑙𝑜𝑐𝑘 1
𝐼𝑅∆𝑞
= 𝐶𝑏𝑙𝑜𝑐𝑘
1 ∙ 𝐼𝐸∆𝑞

block1

2
IRblock
q

(17)

The partial integrated response acting through a block provides a theoretical measure of the
extent to which block2 flux is changed due to direct kinetic effects on block1 caused by a change
in some parameter (under the condition where no other blocks are affected). The partial response
coefficients are important to understanding how the measured perturbation of different variables
within the system (e.g., the change in the concentration of a particular metabolite, the change in
the kinetics of another block)contribute to the overall change in flux through a block in the
system.
Thus a change in reaction flux due to trophic factor deprivation

∆𝐽 𝑏𝑙𝑜𝑐𝑘

𝑏𝑙𝑜𝑐𝑘
direct kinetic changes 𝐼𝐸∆𝑞
and indirect changes

∆𝑥𝑖
𝑥𝑖

𝑛
𝑖=1

𝜀𝑏𝑙𝑜𝑐𝑘
∙
𝑥𝑖

𝐽 𝑏𝑙𝑜𝑐𝑘

, can be partitioned into

mediated by n metabolites.

The indirect changes can be dissected into those mediated by other blocks in the pathway whose
𝑏𝑙𝑜𝑐𝑘 2
kinetics have been directly affected by apoptosis 𝑏𝑙𝑜𝑐𝑘 1𝐼𝑅∆𝑞

in each of the metabolites

𝑥𝐼𝑅 𝑏𝑙𝑜𝑐𝑘

∆𝑞

= 𝜀𝑥𝑏𝑙𝑜𝑐𝑘 ∙

, and those mediated by changes

∆𝑥
𝑥

In this way, the measured changes in CGN energy metabolism due to apoptotic signaling
can be viewed as a result of a mixture of direct and indirect changes occurring within the system.
Distinguishing and quantifying such changes leads to identification of primary apoptotic targets
within CGNs energy metabolism. For instance, if glycolytic flux is affected by apoptosis through
direct kinetic changes in either GTP or PPP or both, the rate of ATP synthesis could adversely be
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affected, but only because of the metabolite changes (i.e. G6P and NADPH) due to kinetic
targeting of GTP and /or PPP. In this case, the flux change in glycolysis, while critical to ATP
levels, would not be the important mechanistic change to investigate further, as the alteration in
GTP or PPP are the primary sites. Accordingly, comprehensive analysis of the metabolic
behavior of healthy CGNs provides a tool to explain, quantify, and rank most of the observed
metabolic changes that accompany the early stages of apoptosis.
Locating the link between metabolism of neurons and apoptotic signaling opens the door
for research to completely identify the major sites in energy metabolism that facilitate the
occurrence of neurodegenerative diseases and provide a tool for therapeutic strategies for many
neuronal diseases that are associated with disrupted apoptosis regulation.
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CHAPTER 3: APPLICATION OF
METABOLIC CONTROL ANALYSIS TO
CEREBELLAR GRANULE NEURONS

A. Introduction
Apoptosis plays a crucial role in sculpting the developing central nervous system (CNS)
and in maintaining the structure and function of the mature CNS1.Approximately half of
developing CNS neurons die by apoptosis in the process of fine tuning the neuronal circuits 2. In
contrast to its beneficial role in the developing CNS, apoptosis in the mature CNS results in loss
of function in many neuronal circuits that ultimately characterize neurodegenerative diseases.
Outside the nervous system, dysfunctional apoptosis increases the probability that genetically
damaged cells survive to become cancerous 3. Regulation of apoptosis therefore has a substantial
impact on both nervous system development and function. The balance of activities of pro- and
anti-apoptotic Bcl-2 proteins are essential to determining whether a cell remains viable or dies,
but the upstream processes which affect this balance remain unclear. Metabolic changes have
long been known to be associated with apoptosis (physiological and pathological)but it remains
uncertain how important this is to the balance of Bcl-2 protein activities. Additionally, the
mechanisms underlying the metabolic changes have yet to be determined4,5. Understanding how
metabolism is perturbed is fundamental to determining whether such changes might facilitate
apoptosis.
In the CNS, glucose is the major source of energy where neurons consume approximately
25% of total body glucose content6. Glucose metabolism is critical for neuronal survival not only
to provide ATP at a rate sufficient to meet their high energy demand, but also to help defend
against oxidative stress5. In the early stages of neuronal apoptosis (whether physiological or
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pathological), there is a general consensus that glucose metabolism decreases while oxidative
stress occurs due to higher levels of reactive oxygen species (ROS)and/or reduced ROS
scavenging. The changes are thought to be related to one another in many cases of physiological
and pathological apoptosis because mitochondria are the main ROS producer while the OxPPP is
a main source of reducing equivalents used to protect against ROS. In some situations, oxidative
stress (e.g., due to exposure to redox compounds such as paraquat, or to abnormal Fe2+ handling)
can result in oxidative modification to metabolic enzymes and organelles (i.e., mitochondria),
which can perturb metabolism to further promote oxidative stress, and activate apoptosis. In
other cases, metabolic changes (e.g., from xenobiotics or genetic mutations) can affect ROS
production and/or scavenging, which in turn induces apoptosis7.The fact that the relative balance
of pro- and anti-apoptotic protein activities can be influenced by ROS levels and metabolism,
each of which is intimately linked with the other, suggests that metabolic changes, in at least
some instances, may trigger and/or facilitate apoptosis.3,4,8.
There are a number of proposed metabolic processes that may directly or indirectly affect
the balance of pro- and anti-apoptotic protein activities and/or ROS levels. One of these targets is
the proton leak rate which may function as a negative feedback mechanism to limit ROS
production by the mitochondrial respiratory chain9. In general, there are two proposed routes
through which ROS-mediated leak may occur. One of which is the non-protein mediated leak
which includes conformational changes to adenine nucleotide translocase (ANT) at
mitochondrial sites9. The conformational changes in ANT have been suggested to convert ANT
into proton permeable pore. The other route, is an inducible protein-mediated leak, including the
activation of one or more uncoupling proteins (i.e. UCP2, UCP3) and /or conformational changes
to ANT10.
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The other metabolic target is the voltage dependant anion channel (VDAC). A major
function of VDAC is to allow metabolite exchange between the cytoplasm and mitochondrial
compartments and so plays an important role in energy metabolism, but it also has been shown to
interact with Bcl-2 family proteins (particularly pro-apoptotic Bax and Bak;

11

) and thus may

have a role in apoptosis 12.
Hexokinase (HK)catalyzes the first step of glucose metabolism but may also function as a
pro-survival protein in a manner that is independent of catalytic activity. It has been reported as a
downstream target of the pro-survival kinaseAkt13, which is inhibited during apoptosis triggered
by trophic factor deprivation. There is some evidence that Akt-mediated phosphorylation of HK
is important to maintain metabolite exchange across the mitochondrial outer membrane(MOM)
by promoting the physical association of HK, the pro-apoptotic protein Bad, and VDAC on the
cytosolic surface of the MOM14. Additionally, this physical association was found to be
prevented by glycogen synthase kinase (GSK 3β)-mediated VDAC phosphorylation in tumor
cells15. The association of HK and VDAC that may facilitate metabolite exchange and
preferential access of HK to mitochondrial ATP, has been suggested to impede, either directly or
indirectly, the binding of pro-apoptotic proteins to the MOM 16.Hexokinase is also up-regulated
and predominately associated with mitochondria in rapidly growing tumor cells, which are
characterized as having a high glycolytic rate and a high resistance to apoptosis

17,18

. The strong

association of HK with mitochondria is thought to contribute to the high resistance of tumor cells
to apoptosis, possibly by antagonizing Bax/Bak interaction with, or oligomerization within, the
MOM. These findings suggest that HK plays a role in signaling cell survival, although the
mechanism is unclear. One possibility is that HK promotes protection against ROS by increasing
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G6P availability for the pentose phosphate pathway (and thus increasing NADPH/NADP ratio)
or in some way promotes survival by enhancing glycolysis.
Despite extensive research on the mechanisms underlying apoptosis, it remains debatable
whether the metabolic changes associated with physiological and pathological apoptosis are a
central feature driving neuronal cell death. A limitation to most of the mechanistic studies
implicating a specific process (e.g., the phosphorylation state of hexokinase or VDAC; the
interaction of a pro-apoptotic protein with a glycolytic or mitochondrial protein) to a change in
metabolism upon induction of apoptosis is the lack of quantitative information on how important
one or more particular processes are to causing the metabolic change. Moreover, the rate of
cellular ATP consumption is an important determinant of the rate of metabolism by virtue of
affecting the ATP/ADP ratio, which importantly affects both glycolytic and mitochondrial
metabolism. Despite this, changes in ATP demand are uniformly disregarded as a possible
mechanism to account for the metabolic change. This becomes particularly important for models
of physiological apoptosis in the developing nervous system, where the neurons are triggered to
die by trophic factor deprivation.
In apoptotic cerebellar granule neurons (CGNs), decreased cellular ATP demand was
suggested as the primary cause driving the decrease in mitochondrial respiration rate 8.The
decrease in respiration did not appear to be caused by mitochondrial dysfunction due to previous
mechanisms that have been put forward- closure of VDAC and inhibition of the respiratory
chain. Thus, it seemed that physiological apoptosis due to trophic factor deprivation in the
developing nervous system might not be associated with mitochondrial defects, but simply to
decreased ATP demand, which is arguably a change that would not be important in facilitating
apoptosis. Despite this finding, the previous study was limited to investigation of mitochondrial
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function and did not directly measure total cellular ATP consumption; possible defects to other
processes critical to neuronal survival, including glucose catabolism through glycolysis and the
pentose phosphate pathway were not investigated. To understand the role that glucose
metabolism may play in facilitating apoptosis, it is necessary to identify the reactions that are
directly affected by the apoptosis inducer (i.e., to identify sites of metabolic dysfunction).This
requires knowledge of the control the reactions exert over one another, as well as the effect that
key metabolites have on affecting the reaction rates. In this study, MCA was applied to healthy
CGNs to determine the sensitivities of the primary reaction blocks metabolizing glucose to
changes in six key metabolites (i.e., the elasticities were determined).With this information, the
extent to which the reactions control one another was assessed (i.e., the flux control coefficients
were determined). The control structure of healthy neurons was used to quantify and rank the
reactions directly targeted by depriving CGNs of trophic factors to induce apoptosis.
Understanding the routes through which apoptotic signaling acts to perturb energy metabolism
may open a new era for therapeutic strategies for current incurable diseases (i.e.
neurodegenerative diseases, and cancer).
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B. Top-down metabolic control analysis applied to neurons
B.1. A simplified model of glucose metabolism
As described in Chapter 2, CGN glucose metabolism was simplified (Figure 1-C) by
grouping reactions into 12 blocks connected by 6 explicit metabolites. Accordingly, the
distribution of the control among blocks can be feasibly analyzed.

B.2. The reaction stoichiometries of the system (matrix N)
The system‟s structural features are expressed in the stoichiometric relationships (Table
1-C) of the blocks. These relationships were assumed to be a constant feature of the system,
affected by neither the modulations nor trophic factor deprivation. A detailed explanation of the
stoichiometries is provided in Chapter 2, Section C.

B.3. Modulations to perturb the steady state of healthy CGNs:
To determine the elasticities of the blocks to the metabolites, healthy CGNs were exposed
to eight different modulations to perturb the metabolite concentrations and block fluxes. Details
on the modulations used are given in Chapter 2,Section D.1.andsummarized below in Table 2-C.
Table 2-C shows which modulations were used in calculating the elasticities of each block to the
metabolites.
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Figure 1-C. A simplified model of cerebellar granule neurons energy metabolism. Dashed and bold blue arrows
refer to explicit reaction blocks where Jx denotes the flux occurring through the respective blocks and x is the
number of the block as follows; 1) glucose transport and phosphorylation; 2) glycolysis; 3) pyruvate oxidation; 4)
NADH oxidation; 5) lactate production; 6) mitochondrial phosphorylation; 7) proton leak; 8) ATP consumption; 9)
oxidative pentose phosphate pathway; 10) NADPH oxidation; 11) non-oxidative pentose phosphate pathway; 12)
malic enzyme. Asterisks refer to explicit metabolites including; glucose-6-phosphate (G6P), pyruvate (Pyr),
mitochondrial membrane potential (ΔΨm), ATP/ADP ratio, NADH/NAD ratio, and NADPH/NADP ratio. Ribulose-5phosphate (R5P) was not considered as an explicit metabolite, as NADPH is the primary product regulating the
oxidative pentose phosphate pathway. Fructose-6-phosphate (F6P) is not included as an explicit metabolite, but is
assumed to rapidly equilibrate with G6P to form a single pool of hexose phosphates.
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Table 1-C.The stoichiometric relationships of the blocks to the metabolites. The organization of the blocks is shown in
Fig. 1. The abbreviations are: GTP, glucose uptake and phosphorylation; GLY, glycolysis; LAC, lactate production and
export; NAO, glycolytic NADH oxidation; PYR, pyruvate oxidation; PHO, mitochondrial phosphorylation; PRL,
mitochondrial proton leak; ATC,ATP consumers; OxPPP, oxidative pentose phosphate pathway; NonPPP, non-oxidative
pentose phosphate pathway; ME, export and oxidation of matrix malate by cytoplasmic malic enzyme. The explicit
metabolites are glucose-6-phosphate (G6P), NADPH/NADP ratio, NADH/NAD ratio, pyruvate (Pyr), mitochondrial
membrane potential (ΔΨm), and ATP/ADP ratio. Positive numbers denote production of a metabolite, negative numbers
denote consumption of a metabolite, and zeroes denote that block neither consumes nor produces the metabolite.

Blocks

Metabolites
G6P

NADPH

NADH

NADP

NAD

Pyr

ΔΨm

ATP
ADP

GTP

1

0

0

0

0

-1

GLY

-1

0

2

2

0

3

LAC

0

0

-1

-1

0

0

NAO

0

0

-1

0

9

0

PYR

0

0

0

-1

45

1

PHO

0

0

0

0

-3.67

1

PRL

0

0

0

0

-1

0

ATC

0

0

0

0

0

-1

OxPPP

-1

2

0

0

0

0

NonPPP

0.667

0

0.333

0.333

0

0.667

ME

0

1

0

1

0

0
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Table 2-C. The modulations used to calculate the elasticities of each block to the explicit metabolites. B, βhydroxybutyrate (2mM); C, Cyanide (100µM); D, Dicholoroacetate (0.5mM); F, FCCP (0.5µM); G, low glucose
(4mM); L, lactate (2mM); O, Oligomycin (10ng/L); T, Tert-butyhydroperoxide (25µM). obtained from modulations
(modulations not used) that directly affecting certain fluxes are not used in calculating elasticities of those fluxes.

Fluxes

Modulations used

Modulations not used

GTP

O, L, D, B, T, C

G, F

GLY

F,O, G, L, B, T, C

D

LAC

F, G, D, B, T, C

L, O

NAO

F,O, G, L, T,

D, C, B

PYR

F,O, G, L, T

D, C, B

PHO

G, D, B, T, C

O, F, L

PRL

O, G, L, D, B, T, C

F

ATC

G, L, D, B, T, C

O, F

OxPPP

F,O, G, L, D, B, T, C

NonPPP

F,O, G, L, D, B, T, C

D

NPO

F,O, G, L, D, T, C

B

ME

F,O, G, L, D, B, T, C

L, B
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C. Experimental approach
C.1. Cell culture preparation and incubation conditions
Cerebellar granule neurons were obtained from the cerebella of 5-7 day old Wistar rat
pups (Harlan, Indianapolis, IN) killed by decapitation. Cells were dissociated from freshly
dissected cerebella by mechanical disruption in the presence of trypsin and DNase, then washed
and filtered through a 70 μm cell strainer (Becton-Dickinson, Franklin Lakes, NJ) to remove
undissociated tissue. Neurons were plated on either 4-well (1.5 x 106 cells/well) or 2-well (7 x
106 cells/well) (depending on the condition of the experiment) LabTek II chambers (Nunc,
ThermoFisher Scientific, Pittsburgh, PA) previously coated with polyethyleneimine. Cells were
incubated at 37 oC humidified atmosphere of 5% CO2/95% air in a Minimum Essential Media
supplemented with Earl‟s salts (Mediatech, Manassas, VA), 2 mM glutamine, 10% fetal bovine
serum (Hyclone, Logan, UT), and 25 mMKCl. 1β-arabinofuranosyl cytosine (Ara C;10μM) was
added to the culture medium 24 hrs after plating to prevent the proliferation of non neuronal cells
i.e. glial cells. On day 6 cultures were supplemented with 5 mM D-glucose, and the mature
neurons (7 to 10 days) utilized in the experiments.

C.2. Experimental media
For the experiments, healthy cells were exposed to a high K buffer which contained the
following components (in mM unless otherwise noted):
116 NaCl, 25 KCl, 20 TES pH 7.35, 10 glucose, 1.3 MgCl2, 1.3 CaCl2, 1.2 Na2SO4, 0.4 KH2PO4,
0.2 NaHCO3, and 10% v/v heat inactivated 10 kDa dialyzed fetal bovine serum (FBS). Apoptosis
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was induced using buffer lacking trophic factors (hereafter referred to as low K). This differed
from the high K buffer in the following components: 3.5 mM KCl, 137.5 mM NaCl, and 0.3%
w/v fatty acid-free bovine serum albumin (BSA) instead of FBS. For the modulations, the high K
buffer was supplemented with each compound as detailed in Chapter 2, Section D.

C.3. Measurement of the source and sink metabolites external to the system
Neurons seeded in 2-well chambers were incubated in high K buffer a modulation, or in
low K, for 60 min at 37oC, and then used to measure the rates of glucose consumption, lactate
production, and respiration for the same preparation. The measurements were conducted as
paired experiments so that the results of a modulation or low K could be normalized to that of the
high K control.

C.3.1. Respiration rate
Jekabsons19 developed a novel technique that allows measuring of respiration, glucose
consumption and lactate production rates in attached neurons in 2-well Lab-Tek chambers
(Figure 2-C). A custom-made acrylic lid fitted with an oxygen microelectrode (Clark-type) was
used to seal the 2-well Lab-Tek chamber, which contained 2.1 mL of experimental buffer.
stirrer
O2 electrode
acrylic lid
stir bar
cells

Figure 2-C. Cover slip mode respiration measurement. Schematic diagram showing the respirometer used for the in
situ measurement of CGN respiration rate in 2-well LabTek chambers. The chamber is sealed with an acrylic lid with
an inserted micro-oxygen electrode. The magnetic stirrer required for accurate measurement of dissolved oxygen by
the electrode was positioned above the chamber to keep the stir bar from disturbing the cells. [Adapted from
Jekabsons15].
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A stir bar suspended against the lid was used for continuous stirring of the buffer to avoid
oxygen depletion at the electrode tip using a rotating magnet positioned above the lid. The entire
assembly was maintained within a 37oC incubator and the depletion of oxygen in the chamber
(typically 20-40%) was monitored over 30-40 min. With this system, once respiration rate has
been measured, the cells can be used to determine the rate of glucose consumption and lactate
production.

C.3.2. Glucose consumption rate
Immediately following the respiration measurements, the cells were washed once and
incubated in 350 μL of buffer ± modulation for two sequential 60 min intervals at 37oC. To
correct for the evaporation that occurred during the incubation periods, control chambers without
cells were run in parallel. The collected samples were centrifuged for 2 min, 21,000xg at 4oC and
the supernatants stored at -20oC. Triplicate 15 μL aliquots were assayed in 485 μL reaction
buffer containing 100mM triethanolamine pH 7.6, 7mM MgCl2, 2mM ATP, 2mM NADP,
1U/mL hexokinase (HK), and 1U/mL glucose-6-phosphate dehydrogenase (G6PDH). The
reaction mixture was incubated 8 min, and then the change in absorbance at 340nm was
determined with a spectrophotometer (Amersham Ultrospec 3300 pro). Glucose standards (9.0,
9.2, 9.4, 9.6, 9.8, and 10 mM) dissolved in the experimental buffer were run with each assay.

C.3.3. Lactate production rate
Lactate was assayed enzymatically by detecting NADH produced from lactate
dehydrogenase. Triplicate 20 μL aliquots were assayed in 480 μL of reaction buffer containing
100mM glycylglycine, pH 9.0, 100mM glutamate, 1mM NAD, 1 U/mL lactate dehydrogenase,
and 1 U/mL glutamate-pyruvate transaminase. Samples were incubated 70min, then the
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fluorescence

was

determined

(λex

=

340nm,

λem

=

460nm)

with

a

spectrofluorophotometer(Shimadzu RF-1501). Lactate standards (0, 0.2, 0.4, 0.6, 0.8, 1.0, and
1.2 mM) dissolved in the experimental buffer were run with each assay.

C.3.4. 13C lactate labeling from 1,213C glucose
For some experiments, 1,213C glucose was used in the high K buffer  modulation, or
low K buffer. The resulting 13C lactate labeling pattern was used to determine OxPPP, NonPPP,
and ME fluxes from the measured rates of glucose consumption, lactate production, and
respiration (See Chapter 2, Section C.9)

C.3.4a) 13C lactate labeling with 1, 2 13C glucose
Cerebellar granule neurons (7x106 cells per well plated in 2-well Lab-Tek chambers)
were incubated for 1h at 37oC with 600L high K or low K buffer with 9.6mM 1,2 13C glucose.
Cells were then incubated 2h 15min at 37oC with 800L of high K 13C glucose  a modulation or
low K to further equilibrate the central metabolite pools with

13

C while perturbing metabolism.

The cells were washed once, and then incubated 1h, 37oC with 350L of the same buffer.
Parallel controls were run in each experiment and included wells without cells incubated with
each modulation, and cells incubated with each modulation in standard 12C glucose. The samples
were centrifuged 2min, 21,000 xg, 4oC and the supernatants stored at -20oC until processed for
LC-MS/MS.

C.3.4b) Lactate derivatization for LC-MS/MS
Samples and lactate standards (prepared in high K) were derivatized with 3nitrophenylhydrazine as previously described20, with minor modifications. The samples (50L)
were extracted with 100L cold methanol for 30min at -20oC, then centrifuged at 21,000 xg, 121

2oC for 10 min. Supernatants were supplemented with 75L 50mM N-(3-dimethylaminopropyl)N′-ethylcarbodiimide hydrochloride (prepared fresh in 98.5% ethanol, 1.5% pyridine) and 75L
140mM 3-nitrophenylhydrazine (3-NPH) hydrochloride (prepared fresh in 50% ethanol) and
incubated for 2h, 37oC. The derivatized samples were stored at -20oC.

C.3.4c) LC-MS/MS of derivatized lactate
The derivatized samples (10L) were separated on a Waters ACQUITY UHPLC system
using a Synergi Hydro-RP C18 100Å column (100mm × 2.0 mm i.d., 2.5 µm; Phenomenex,
Torrance, CA) maintained at 35oC. Samples were eluted over 5min with a linear gradient of
water (A) /acetonitrile (B) (both with 0.05% formic acid) from 80% A/20% B to 20% A/80% B
using a flow rate of 0.30 mL/min. Each run was followed by a 2min wash with 100% B, and a
3.5min equilibration time in 80% A/20% B. A Waters ACQUITY™ XEVO QTOF Mass
Spectrometer connected to the UHPLC system via an ESI interface (in negative ionization mode,
capillary voltage 2.0 kV; cone voltage 25V). The temperatures of the source and desolvation
were 150oC and 450oC, respectively. Leucine-enkephalin was used as the lock mass, generating
an [M-H]+ ion (m/z 554.2615 Da) and its fragment ions (m/z 236.1035 Da) at a concentration of
2 ng/mL and flow rate of 5 µL/min to ensure accuracy during the MS analysis. Tandem MS/MS
was used with collision energies of 10, 20, 30 and 40 V. Fragment intensities corresponding to
ions 224, 225 and 226 Da (the expected masses for M, M+1, and M+2 derivatized lactate,
respectively) were confirmed, and peak areas of fragment ions 152 Da (3-NPH; 10V collision
energy) corresponding to these masses, were calculated. This analysis yielded linear standard
curves with the

12

C lactate standards. Corrections for background

13

C labeling were applied

based on the results from the controls where the cells were metabolizing 12C glucose.
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C.4. Preparation of cell extracts for measurement of explicit metabolites
The reduced forms of pyridine nucleotides (NADPH, and NADH) are stable in strong
basic media (pH 12.2-12.6) while the oxidized forms are not, so the cells were extracted in
25mM NaOH, 1mM EDTA pH12.4. The oxidized pyridine nucleotides and other metabolites
G6P, Pyr, ATP, and ADP are stable in strong acidic media such as 0.2M perchloric acid. For
both treatments, 7x106 CGNs incubated 4hrs (in 25K± modulation and /or 3.5K buffer) were
rapidly washed with cold PBS containing 10mM glucose. For acidic extraction, 300μL of 0.2M
perchloric acid was added to each well, then the cells were scraped and transferred to microfuge
tubes. The suspensions were homogenized with a battery-powered pestle then centrifuged at 4 oC
for 10mins at 18,000xg. The supernatant was partially neutralized with 4M KOH for 10min on
ice then centrifuged 2 min, 18,000 xg to pellet the precipitate. The supernatant was further
neutralized with 0.5M Tris base to pH 6.6-6.8. The final extract volumes were measured then the
samples were stored at -80 oC.
In parallel, the basic extraction was performed by adding 300 μL of 25mM NaOH, 1mM
EDTA to the cells, scraping the extract into microfuge tubes, homogenizing with a batterypowered pestle, then heating to 60oC for 10 min (to decompose NADP and NAD). The extract
was centrifuged 10 min at 18,000xg at 4oC and the supernatant was partially neutralized with 1
M glycylglycine (pH 5.9) and then titrated to a final pH of 8-8.2 with 1M HCl. The extract
volumes were measured and the samples stored at -80oC.The samples were assayed for NADH
immediately, and for NADPH within 24h.
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C.5. Measurement of the explicit metabolites
C.5.1. Nicotinamide adenine dinucleotide phosphate (NADP and NADPH)
Both NADP (in acidic extraction) and NAPDH (in basic extraction) were assayed by the
same procedure, however NADPH must be assayed within 24h after the extracts prepared to
avoid degradation. Since the concentration of either NADPH or NADP is inherently low in the
extract, an enzymatic reaction with a signal amplification loop based on the reduction of MTT
(3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium Bromide) to a purple formazan
(detected spectrophotometrically at 578nm) in presence of phenazinemethosulphate (PMS) was
used. Duplicate 5 μL (for NADPH) or 20 μL (for NADP) were assayed in 55 μL (1.11X) or in 40
μL (1.5X) reaction buffer respectively. The final reaction buffer contained 70mM
triethanolamine pH 7.2, 1mM EDTA, 5mM MgCl2, 1mM isocitrate, 0.25mM MTT, and 2mM
PMS. To start the reaction, 0.12 units ofyeast NADP specific isocitrate dehydrogenase (to avoid
interference with NAD)was then added to the reaction mixture at 1 min time interval. Samples
were then incubated either for 75 min (NADP), or 22 min (NADPH), and then the absorbance
was read at 578nm. NADPH standards (0, 50, 100, 200, 350, 500, and 650 nM) were prepared
fresh in glycylglycine and HCl-neutralized 25 mMNaOH, 1 mM EDTA. NADP standards (0, 5,
10, 20, 40, 70, and 100 nM) were prepared in KOH and Tris-neutralized 0.2 M perchloric acid
and stored at -80oC.

C.5.2. ATP and ADP
The concentration of ATP was detected in the neutralized perchloric acid extracts by
measuring the resulting luminescence, produced from the oxidation of luciferinto oxyluciferinin
the presence of ATP and luciferase. The concentration of ADP was further detected in the same
samples by adding pyruvate kinase which catalyzes the conversion of ADP and PEP
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(phosphoenolpyruvate) to pyruvate and ATP. Triplicate 10 μL aliquots were assayed in 40 μL of
1.25x buffer containing 87.5mM Tris acetate, 94mM KCl, 1.25mM EDTA, 12.5mM Mg acetate,
75 μM DTT, 0.125% BSA, supplemented with 1:25 luciferin/luciferase reagent (Sigma, St.
Louis, MO). The resulting luminescence was determined over 60 sec using a tube luminometer
(Turner

Biosystems).

The

reaction

mixture

wasthen

supplemented

with

0.7mM

phophoenolpyruvate and 1U/ml pyruvate kinase. The increase in luminescence above the
residual ATP signalwas determined over 160 sec, and the peak increase used to quantitate ADP.
Individual ATP (0, 2.5, 5, 10, 15, 20, 25, and 30 M) and ADP (0, 0.3, 0.6, 1.0, 1.5, 2.0, 3.0, and
4.0M) standards prepared in neutralized perchloric acid were combined and assayed in parallel.

C.5.3. Glucose-6-phosphate (G6P)
The enzymatic oxidation of G6P by G6PDH and subsequent reduction of NADP to
NADPH was coupled to reduction of resazurin (Abs 601nm) to resorufin (Abs 574nm).
Resorufin is typically measured by fluorescence, but we found greater consistency and
sensitivity evaluating the ratio of resorufin to resazurin by absorbance at 574 and 601 nm,
respectively. Duplicate 40 μLperchloric acid aliquots were assayed in 20 μL 3x assay buffer
containing 300mM triethanolamine (pH 7.3), 0.6mM EDTA, 3mM MgCl2, 0.9mM NAD, 3U/ml
superoxide dismutase, 1.2U/ml glucose-6-phosphate dehydrogenase from L. mesenteroides, 1.2
U/ml 6-phosphogluconate dehydrogenase, 1.2 U/ml diaphorase, and 22.5 μMresazurin. Inclusion
of superoxide dismutase was found to reduce the background and improve the detection
limit.Glucose-6-phosphate standards (0, 0.3, 0.6, 1.0, 2.0, 4.0, and 6.0 M) dissolved in
neutralized perchloric acid were run with the extracts.The reaction was incubated 2h and 20min
in the dark and then the absorbance ratios were determined.
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C.5.4. Pyruvate
Intracellular pyruvate was measured in the presence of pyruvate oxidase which catalyzes
conversion of pyruvate in the presence of phosphate buffer to acetyl-phosphate and H2O2.
Hydrogen peroxide is reduced to water by horseradish peroxidase (HRP) in the presence of the
electron donor luminol, which is oxidized to the unstable form of 3-aminophthalate (3APA,
unstable excited state) that decomposes to a low energy state with resultant emission of light at
425 nm (detected via a tube luminometer). Triplicate 30μL aliquots were assayed in 30μL (2x)
buffers containing 200mM KH2PO4/K2HPO4 (pH 6.8), 4mM MgSO4, 0.8mM EDTA, 100μM
flavin adenine dinucleotide (FAD), 400μM thiamine pyrophosphate, 2mM luminol, 2 U/ml
superoxide dismutase, and 0.4 U/mL horseradish peroxidase. The superoxide dismutase was
included to reduce the background luminescence observed in the cell extracts. Addition of the
extracts (but not the standards) to the assay buffer typically caused a strong but variable increase
in luminescence that decreased to background within 30-45 sec; this artifactual signal was
always monitored to ensure that it fell to background prior to beginning the assay. The
luminescence was then monitored for 60 sec after addition of vehicle (100 mM
KH2PO4/K2HPO4, 1% BSA, pH 6.8- the solvent in which pyruvate oxidase was dissolved)
because this caused variable artifactual signals that were subtracted from the signal measured
over 60 sec upon addition of 0.3 U/ml of pyruvate oxidase to start the reaction.

C.5.5. NADH and NAD
Both NADH (in basic extract) and NAD (in acidic extract) were assayed with the same
procedure. The reaction was initiated by oxidation of ethanol into acetaldehyde in the presence
of alcohol dehydrogenase (ADH). The resulting NADH was then reoxidized in presence of
resazurin and diaphorase to resorufin. For the basic extracts, the oxidation of NADH by
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diaphorase/resazurin provided the source of NAD for use by ADH. The ratio of reduced to
oxidized resorufin/resazurin was detected by absorbance at 574 and 601 nm, respectively.
Duplicate 5μL aliquots were assayed in 55 μL of 100mM glycylglycine (pH 8.8), 0.2mM EDTA,
1mM MgCl2, 250mM ethanol, 1 U/mL superoxide dismutase, 0.4 U/mL diaphorase, and 10μM
resazurin. The reaction was started by addition of 0.24 U of alcohol dehydrogenase, and the
ratiometric detection of reduced/oxidized resazurin was measured by absorbance at 574 and
601nm, respectively after 20min.NADH standards (0, 0.2, 0.4, 0.6, 0.8, 1.0, and 1.5M) were
prepared fresh in glycylglycine/HCl neutralized 25mM NaOH/1 mM EDTA. NAD standards (0,
0.3, 0.6, 1.0, 1.5, 2.0, and 4.0 M) were prepared in KOH/Tris neutralized perchloric acid and
stored at -80oC.

C.5.6. Mitochondrial membrane potential (ΔΨm)
The fluorescent lipophilic cation tetramethylrhodamine methyl ester (TMRM) was used
to determine ΔΨm. TMRM accumulates in the cytoplasm [TMRM]cyto and mitochondria
[TMRM]mito in a Nernstian fashion according to ΔΨp, and ΔΨm respectively21.Mitochondrial
membrane potential is a function of the following ; cytoplasmic and mitochondrial volumes (Vc,
Vm) that have been determined by fluorescence microscopy (unpublished), activity coefficients
(ac, am) which represents non-specific binding of TMRM to cell components, have been
experimentally determined (unpublished), plasma membrane potential ΔΨp (assumed ΔΨp=35mVfor 25K, and -70mV for 3.5K)22, and the free concentrations of TMRM in the cell
[TMRM+]cell and extracellular space [TMRM+]e, (see section D.1.).
Healthy and/or apoptotic neurons were incubated in 1.2mL (1nM TMRM) in 25K/FBS or
3.5K/BSA for 2h, then 600µL aliquots were collected for each sample for initial readings. Cells
were incubated for another 1hr in 700µL (0.8nM TMRM) with treatment (any modulation or
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3.5K/BSA), then 600µL aliquots were collected for final readings. Samples were centrifuged for
2 min at 18,000 xg and the supernatant fluorescence was determined (λex = 550nm, λem = 580nm)
with a spectrofluorophotometer (Shimadzu RF-1501). The total TMRM taken by cells
[TMRM]cellwas calculated by subtracting the initial and final readings. Using the known
cytoplasmic and mitochondrial volumes (Vc, Vm), activity coefficients (ac, am), plasma
membrane potential ΔΨp (assumed ΔΨp=-35mv for 25K, and -70mv for 3.5K)22, and the free
concentrations of TMRM+ in the cell [TMRM+]cell and extracellular space [TMRM+]e, the
ΔΨm(Eq.1)can be determined (see Section D.1.)
m = 61.5*log ([TMRM+]mitofree/[TMRM+]cytofree)

(1)

C.6. Determining mitochondrial H+leak,
Proton leak involves all pathways of H+ influx through the mitochondrial inner
membrane that are not coupled to ATP synthesis. The leak occurs through one or more illdefined influx pathways that are strongly affected by the magnitude of ΔΨm23. Practically, the
leak rate can be measured by blocking ATP synthase with oligomycin then determining the new
steady-state respiration rate, which reflects H+ pumping that exactly opposes the leak rate. Since
oligomycin increases ΔΨm, which increases the leak rate more than without oligomycin,
progressive inhibition of the respiratory chain, with the complex III inhibitor myxothiazol (22,
28, and 34nM), was used to reduce H+ pumping and therefore reduce ΔΨm back to the basal state.
For theseexperiments, respiration rate of 4 x 106 CGNs plated on 22 x 40 mm coverslips was
determined using an RC-30 closed bath chamber (Warner Instruments) with a perfusion-mode
micro-oxygen electrode (Microelectrodes, Inc.) on the downstream side of the chamber for
improved sensitivity, as developed by Jekabsons and Nicholls (2004)19.The cells were
equilibrated in the chamber with high K media for 30-45 min at 37oC to establish basal
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respiration. The perfusate was switched to a high K media supplemented with 1 g/mL
oligomycinand 25 M Ca2+rather than the standard 1.3 mMCa2+(which prevented Ca2+
deregulation from occurring).In a preliminary experiment, it was found that 25 M Ca2+ was the
concentration which kept the cytoplasmic [Ca2+] (as monitored with FURA PE3) in the presence
of oligomycin similar to that measured in the absence of oligomycin. The cells were allowed 2540 min to establish a new steady-state respiration, and were then sequentially titrated with
myxothiazol (22, 28, and 34 nM) in the continued presence of 1µg/mL oligomycin (with 25µM
Ca+2). Parallel experiments with TMRM were run in 2 well LabTek chambers as described in
Section C.5.6 to measure ΔΨm under the same conditions. The resulting plot of leak rate
againstm were used to determine the leak flux for CGNs in high K, as well as the leak flux in
CGNs exposed to all modulations except FCCP (once m for each modulation was measured).
For cells exposed to FCCP or low K, similar titrations with oligomycin and myxothiazol were
performed, except that for low K the media [Ca2+] was kept at 1.3 mM during the titration
because the cells did not Ca2+ deregulate upon addition of oligomycin. The elasticities of the H+
leak block to the explicit metabolites other than ΔΨm were assumed to be zero since oligomycin
perturbs the levels of the other explicit metabolites in the system.
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D. Preliminary results for determination of m and H+ leak
D.1. Determination of cytoplasmic and mitochondrial volumesand TMRM+
activity coefficients to assess m
To determine ΔΨm from TMRM+ uptake experiments, the cytoplasmic and mitochondrial
volumes (Vc, Vm, respectively), and TMRM+ activity coefficients (ac, am, respectively) must be
known.These parameters were measured as detailed below. It should be noted that p is also
required, and was assumed from previously published work22.
Cytoplasmic and mitochondrial volumes were determined by fluorescence microscopy
(similar to a technique developed by Ward et al21). Images of CGNs double-labeled with
TMRM+ and FURA PE3 (the latter as a cytoplasmic marker) were acquired as a series of Z
stacks, in which optical slices were taken through the cells every 0.25 m (typically 30-40
slices). The FURA, TMRM+, and colocalized are asin each slice were determined using the colocalization feature of the Axiovision software to calculate the volumes (Table 3). The volumes
were restricted to the cell bodies (i.e., the neurites were not included) from at least 20 neurons
from three independent preparations exposed to high Koligomycin, or low Koligomycin. The
volume of cells in high K plus oligomycin were determined (but not for the other modulations)
because preliminary studies indicated this modulation caused significant swelling, most likely
due to altered ionic homeostasis from compromised ATP synthesis. For analysis of the
oligomycin effect, single bright field images were taken rather than fluorescent Z-stacks, so it
was assumed that the increase in volume was due to a change in Vc but not Vm. In this case, the
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volume of each cell was calculated from the measured radius, assuming the cells were perfect
spheres. Oligomycin caused the cell volume to increase 1.680.04 (meanSD from two
experiments) fold above that of the controls, and this change was applied to the volumes
measured for the high K controls by double-label Z-stack analysis (Table 3).In contrast,
oligomycin did not affect the cell volume in low K (1.020.11 fold of low K controls from two
independent experiments).
The TMRM+ activity coefficients ac, and am reflect the non-specific binding of the
lipophilic cation to hydrophobic cytoplasmic and mitochondrial components. Assessment of the
free vs. bound TMRM+ is important because the Nernst equation used to calculate m is based
strictly on the free concentration. The cytoplasmic activity coefficient (ac) was measured by the
uptake of TMRM+ in CGNs treated with 0.4g/mL oligomycin, 3M FCCP, and 2M
myxothiazol to abolish m. Assuming that Vc, Vm, and p remain constant, then
ac = [TMRM+]cytofree/([TMRM+]cytofree + [TMRM+]cytobound)

(2)

where the amount of cytoplasmic free TMRM+ (TMRM+cytofree) can be calculated as
TMRM+cytofree=[TMRM+]buffer/10^(∆Ѱp/61.5) * Vc

(3)

Since m=0, [TMRM+]cytofree = [TMRM+]mitofree,
so the amount of cytoplasmic bound TMRM+ is,
TMRM+cytobound={(TMRM+cell-TMRM+cytofree-TMRM+mitofree)* (Vc/(Vc+Vm))}

(4)

From three independent preparations, it was determined that 10.06.9% of cytoplasmic TMRM
was free while the remaining 90% was non-specifically bound (Table 3).The mitochondrial
activity coefficient (am) was assessed in CGNs having a m, but no p. This was
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accomplished by selectively permeabilizing the plasma membrane with40g/mL digitonin in 1.2
mL mitochondrial buffer (120mM KCl, 20mM TES, 1mM EGTA, 2mM MgSO4, 2mM KH2PO4,
5mM malate, 5mM pyruvate, 0.4g/mL oligomycin, and 0.3% fatty acid free BSA, pH 7.3). In
this condition, the mitochondria are in State 4 and thus generate a maximalm, which was
assumed to be 170mV based on previous studies24–26 with isolated mitochondria under similar
conditions (i.e., oxidizing complex I substrates, with phosphate and oligomycin present). The
amount of TMRM+ accumulated in mitochondria can be assessed by measuring the difference in
fluorescence of extracellular buffer between permeabilized cells and control using
spectrofluorophotometer (Shimadzu RF-1501).
sincep = 0, [TMRM+]cytofree = [TMRM+]buffer

(5)

From this the matrix free concentration of TMRM+ can be calculated
[TMRM+]mitofree = [TMRM+]cytofree * 10^(m/61.5)

(6)

The total amount of TMRM in the cytoplasmis
TMRM+cytototal = [TMRM+]cytofree*Vc/ac

(7)

Therefore, the total (bound and free) TMRM+ in the mitochondria is
TMRM+mitototal = TMRM+cell – TMRM+cytototal

(8)

Where TMRM+cell = [TMRM+]media no cells – [TMRM+]media with cells * Vmedia

(9)

The amount of TMRM+ non-specifically bound to the mitochondria is
TMRM+mitobound = TMRM+ mitototal – [TMRM+]mitofree * Vm
So the mitochondrial TMRM+ activity coefficient am is calculated
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(10)

am = TMRM+mitofree/(TMRM+mitofree + TMRM+mitobound)

(11)

D.2. The kinetics of H+ leak to m for CGNs in high K
The leak kinetics to m were determined in high K by titrating oligomycin-treated
CGNs with myxothiazol(Fig.3).Oligomycin increased m from 1696 to 1895 mV (n=4),
while decreasing mitochondrial respiration to 22.31.8 % of the basal rate (which was
1198124pmol O/min x 106 cells, n=3).The H+ leak kinetics became apparent upon titrations
with myxothiazol. From the titration with myxothiazol, 6.7% of high K basal mitochondrial
respiration rate was used to support H+ leak while 93.3% was used for ATP synthesis. For all
subsequent experiments with CGNs in high K, the H+ leak rate was calculated as 6.7% of the
measured mitochondrial respiration rate, which was converted to units of H+ using the H+/O
Stoichiometries for the oxidation of pyruvate and NADH (See Chapter 2, Sections C.4 and
C.5).The kinetic relationship between H+ leak rate and m in high K was used to determine the
leak rate for all modulations used to perturb the metabolism of CGNs in high K, except FCCP.
For each modulation, m was measured, which allowed calculation of the fraction of
mitochondrial respiration driving the leak. Since most of the modulations had minimal effect on
m, the percent of respiration driving the leak was minimally affected (i.e. BHB: 6.5%, CN:
5.0%, DCA: 5.8%, Lac: 7.1%, Low glc: 6.2%, tBHP: 5.0%).
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Table 3-C. Measured parameters (cell volumes and TMRM+ activity coefficients) for ΔΨm calculation.
Cytoplasmic (Vc) and mitochondrial (Vm) volumes of FURA-PE3AM and TMRM+ loaded CGNs in high or
low K were determined using colocalization analysis of Z stacks. The total cell volume (V t) represents the
sum Vc+Vm. Data are mean ± S.E.M. of 49 (high K) or 56 (low K)cells from 3 independent preparations.
Brightfield images were used to determine the effect of 1 g/mL oligomycin on Vt from analysis of 84 cells
in both high and low K(from two independent preparations). Oligomycin affected Vt in high (1.680.04 fold
increase) but not low (1.020.11 fold increase) K. In high K, it was assumed that Vc was the only parameter
affected by oligomycin. The cytoplasmic activity coefficient (ac) was measured by assessing the
sequestration of TMRM+ in CGNs without a ΔΨm(treated with oligomycin, FCCP, and myxothiazol) (n=3).
The mitochondrial TMRM+ activity coefficient (am) was measured by assessing TMRM+ sequestration in
CGNs without a ΔΨp(permeabilized with digitonin and having a maximal ΔΨmby addition of oligomycin
and complex I substrates) (n=3).

Treatment

Vt (fL)

Vm (fL)

Vc (fL)

High K

433±8

19±2

414±8

0.10±0.07

0.16±0.05

Low K

443±8

19±1

424±8

nd

nd

High K + oligo

728

19

709

nd

nd

Low K + oligo

443

19

424

nd

nd
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Figure 3-C. Cerebellar granule neuron mitochondrial H+ leak kinetics in high K .The respiration rate was measured
with a perfusion mode oxygen electrode downstream to an RC-30 chamber. After establishing the basal rate in high
K, the cells were perfused with 1µg/L oligomycin and then titrated with myxothiazol (22, 28, and 34 nM).
Respiration rates were normalized to the basal rate. In parallel, ΔΨm was measured by the uptake of TMRM+ into
cells seeded in Lab-Tek chambers which were treated with the same concentrations of oligomycin and myxothiazol.
The red vertical line represents the respiration used for ATP synthesis, whereas the purple line represents to the
respiration rate used for H+ leak flux. Data are meanSEM of three (for respiration measurements) or four (for m
measurements) experiments.

D.3. The fraction of respiration rate used for H+ leak with 10 ng/mL
oligomycin
For the H+ leak experiments in Section D.2, a saturating concentration (1 g/mL) of
oligomycin was used to ensure complete inhibition of ATP synthase. However, when oligomycin
was used as a modulation to perturb metabolism, a 100-fold lower concentration (10 ng/mL) was
used to minimize possible toxic effects over the longer exposure times which were required for
the modulation experiments. At this lower dose, respiration rate was greater (32.90.8% vs.

135

22.31.8% of basal) while m was less (1.090.03 vs. 1.120.02 fold of basal) than with 1
g/mL oligomycin, indicating that some ATP synthase remained active at the lower dose. The
fraction of respiration rate driving proton leak with 10ng/mL oligomycin was determined from
the original leak kinetics (Figure 3-C ) superimposed upon the kinetics of the substrate oxidation
reactions to m, which is indicated by the linear regression using the basal, low, and high dose
oligomycin conditions (Figure 4-C).

With 10 ng/mL oligomycin, the deviation from the

regression line could be because of error in measurements of respiration rate, m, or both.
Accordingly, the fraction of respiration that drives proton leak with 10ng/L oligomycin could be
from 51-67 %, depending on whether the error is assumed to be in respiration or m,
respectively. For the calculations, it was assumed that the error was with respiration, so 51% of
respiration was for H+ leak and 49% was for ATP synthesis. This fraction was then used in the
calculation of proton leak rate for all 10ng/mL oligomycin-treated neurons.

D.4. The kinetics of H+ leak to m in CGNs treated with 0.5µM FCCP
The protonophore FCCP was used as a modulation to perturb the metabolism of healthy
CGNs. It does so by increasing the mitochondrial inner membrane permeability to H+, and thus
directly affects the kinetics of the H+ leak block to m. As a result, the kinetics of proton leak
to m were re-measured in the presence of FCCP (Figure 5-C).With 0.5 M FCCP, basal
respiration increased 1.420.01-fold (from 645167 to 910232 pmol O/min x 106 cells, n=4)
while m decreased from 1673 to 1584 mV (n=9). Addition of 1 g/mL oligomycin
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Figure 4-C.The fraction of mitochondrial respiration rate used for H + leak in CGNs treated with 10 ng/mL
oligomycin. The basal and 10 ng/mL respiration rates (meanSEM of three experiments, normalized to the basal
state) were determined with a perfusion-mode oxygen electrode as described in the Fig. 3 legend. Parallel
experiments in 2-well Lab-Tek chambers for measuring TMRM uptake were used to determine basal and 10 ng/mL
oligomycinm (meanSEM of four experiments). The high K H+ leak kinetics (Fig. 3)were superimposed with
this data, but adjusted for differences in the mean basal m between the experiments. The regression line (black)
reflects the kinetic response of the mitochondrial substrate oxidation reactions to m with increasing oligomycin.
The red vertical line extended from the substrate oxidation kinetics to the H+ leak kinetics reflects the fraction of
respiration for ATP synthesis (49%)and the purple line represents the fraction used for proton leak (51%).

decreased respiration to 0.630.01 of the basal state (to 406109 pmol O/min x 106 cells,
n=4) and increased m to 1702 mV (n=4). Subsequent titration with myxothiazol resulted in
the expected ohmic-relationship between the leak rate and m (Figure 4-C). From this
relationship, the fraction of respiration rate used for proton leak increased to 37.4%. This fraction
was used for the calculation of proton leak rate for all flux experiments with FCCP-treated
neurons.
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D.5. The kinetics of H+ leak to m in apoptotic CGNs
Due to the unknown effects of low K+ on the kinetics of the leak to m, the leak rate
was re-measured using the oligomycin-myxothiazol titration as detailed for healthy neurons in
high K. Oligomycin increased m from 1725 to 1808 mV (n=7), while decreasing
mitochondrial respiration to 41.43.9 % of the basal low K rate (which was 556111pmol O/min
x 106 cells, n=6). Titration with myxothiazol resulted in a surprisingly ohmic response of the leak
to m (similar to FCCP), indicating that low K directly affects mitochondrial H+ leak. From
the kinetics, the fraction of the basal low K respiration used for proton leak increased to 32.4% in
apoptotic neurons compared to 6.7%in healthy neurons. This fraction was used for the
calculation of proton leak rate for all flux experiments with apoptotic neurons.
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Figure 5-C. The fraction of mitochondrial respiration rate used for H + leak in CGNs treated with 0.5 M FCCP.
Basal respiration rate in high K was measured with a perfusion mode oxygen electrode as described in Fig. 3. The
respiration rates were then measured in presence of 0.5 M FCCP and FCCP with 1µg/L oligomycin. Titration with
myxothiazol (8, 16, 20, 22, and 28nM) was then performed. In parallel, m was measured by TMRM uptake of
CGNs seeded in Lab-Tek chambers and treated with the same concentrations of FCCP, oligomycin, and
myxothiazol. Data are meanSEM of four to nine experiments. The regression line (blue) reflects the ohmic kinetics
of the H+ leak to m with FCCP. The vertical red line indicates the fraction of respiration used for ATP synthesis
(62.6%) and the purple line indicates the fraction of respiration used for H + leak (37.3%).
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Figure 6-C.The fraction of mitochondrial respiration rate used for H + leak in CGNs exposed to low K. Basal
respiration rate was measured with a perfusion mode oxygen electrode after 35-45 min equilibration in low K (see
Fig. 3). The respiration rate was measured after perfusion with1µg/L oligomycin and then sequential titrations with
myxothiazol (24, 30, and 36nM). In parallel, m was measured by TMRM uptake of CGNs seeded in Lab-Tek
chambers and treated with the same concentrations of oligomycin and myxothiazol.
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E. Results and Discussion
E.1. The metabolic steady-state of healthy neurons
The metabolic steady-state of healthy CGNs was determined in high K buffer containing
10 mM glucose as the sole exogenous substrate. In other experiments, the high K buffer was
modified by addition of inhibitors, activators, or alternative substrates designed to perturb the
original steady-state in different waysso that metabolic control analysis could be performed. The
system variables (i.e., block fluxes and metabolite levels) in high K were assessed in parallel
with each modulation so that the effect on the variables could be normalizedto the high K
condition to minimize the variability between cell preparations. It should be noted that the rates
of glucose uptake, lactate production, and mitochondrial respiration were measured for all flux
experiments, while13C-lactate labeling and the fraction of respiration used for H+ leak were
measured in separate experiments. The mean 13C labeling pattern and fraction of respiration used
for H+ leak for each respective condition were applied to the individual measurements of glucose
uptake, lactate production, and respiration to calculate the block fluxes.

E.1.1.13C-lactate labeling from 1,213C-glucose
Table 4-C represents data of mass fractions of the released derivatized lactate from
healthy neurons (control) with or without modulation and apoptotic neurons.
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Table 4-C. Measured labeling pattern of lactate released from 1,213 C-glucose treated neurons. Tandem MS/MS was
used to determine the mass of lactate isotopomers that were confirmed as; unlabeled (M), single labeled (M1), and
double labeled (M2)derivatized lactate. The fraction of each isotopomerto total lactate released are represented as
M/total, M1/total, and M2/total. Data are mean of fraction± S.E.M. of three independent preparations. Fractions
were measured for healthy (high K) neurons± modulation and apoptotic neurons (low K). Modulations are Tertbutyl hydroperoxide (tBHP), FCCP, dichloroacetate (DCA), β-hydroxybutyrate (BHB), cyanide (CN), oligo
(oligomycin), low glucose (Glc), and lactate.

condition

M/total

M1/total

M2/total

High K

0.577±0.011

0.181±0.008

0.240±0.013

25µM tBHP

0.577±0.010

0.179±0.012

0.242±0.022

0.5µM FCCP

0.613±0.020

0.169±0.009

0.216±0.011

0.5mM DCA

0.578±0.012

0.157±0.014

0.263±0.027

2mM BHB

0.618±0.111

0.172±0.016

0.208±0.005

100 µM CN

0.592±0.016

0.169±0.012

0.233±0.021

10ng/L Oligo

0.604±0.026

0.165±0.021

0.229±0.004

0.4mM Glc

0.543±0.020

0.199±0.019

0.257±0.015

2mM Lactate

0.493±0.063

0.188±0.011

0.318±0.052

Low K

0.579±0.008

0.192±0.017

0.227±0.015

In healthy neurons, 57.81.1% of the lactate excreted was unlabeled, while 18.20.8%
and 24.01.3% contained one or two, respectively 13Catoms. In principle, if neurons metabolized
glucose only through glycolysis, then 50% of the lactate excreted should be unlabeled and 50%
should be double labeled. These results indicate that other pathways are involved in metabolizing
glucose to pyruvate. One of these pathways is the oxidative and non-oxidative pentose phosphate
pathway (PPP) which play an important role in neuronal viability by regulating the cellular redox
state

27

. Accordingly, the Ox- and Non-PPP may be a significant pathway for metabolizing

glucose to pyruvate. In the OxPPP, glucose is decarboxylated at the C1 position leading to
formation of single labeled 1

13

C-ribulose-5-phosphate (R5P) from 1,213C-Glc. In the NonPPP,

carbons are exchanged between three moles of R5Pto produce two moles of six carbon fructose6-phosphate (F6P) labeled at carbon 1 and carbons 1 and 3 with

13

C and one mole of unlabeled

three carbon glyceraldehyde-3-phosphate/dihydroxyacetone phosphate (the glycolytic triose
phosphates; TrP). The F6P can be rapidly converted back to G6P through the rapid equilibrium
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reaction catalyzed by hexose phosphate isomerase and thus recycle back through the PPP,
generating addition allabeling of R5P which can exchange carbons again through the NonPPP. In
total, the exchange of carbons between recycled G6P and 1,2

13

C G6P from the external media

can generate eight differentially labeled forms of F6P (than range from unlabeled to tripled
labeled) which can be metabolized through glycolysis to contribute to the lactate labeling. The
three carbon (TrP) from the NonPPP is metabolized by glycolysis and thus also contributes to the
lactate labeling. According to the recycling of F6P and carbon exchange in the NonPPP,a
mathematical model was created which varied the contribution of glycolysis and the Ox/NonPPP
in metabolizing glucose until the calculated lactate labeling pattern matched the measured
labeling pattern (see Chapter 2, Section C.9).However, the model proved incomplete, as it could
not adequately account for the measured lactate labeling pattern. Cytoplasmic malic enzyme,
which oxidizes malate from the TCA cycle to generate pyruvate, is known to be expressed in
neurons, and thus could constitute an additional pathway contributing to the pyruvate (and thus
lactate) labeling pattern. The theoretical labeling of lactate from malic enzyme was incorporated
into the mathematical model such that the solver function in Microsoft Excel varied the
contribution of glycolysis, the Ox/Non-PPP, and malic enzyme to the pyruvate pool, within the
stoichiometric and flux constraints of the system. This was sufficient for the model to precisely
calculate the measured lactate labeling pattern. Most of the modulations had relatively minor
effects on the labeling pattern, suggesting that they did not substantially affect the proportion of
glucose metabolized by each of the three pathways. This was particularly surprising for tBHP,
which was expected to cause a rather substantial increase in single labeled lactate, as the OxPPP
is a major source of this label. A greater concentration of tBHP may have produced more
substantial changes in the labeling pattern, but higher concentrations also increase the likelihood
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of the neurons dying prematurely. Conversely, oligomycin had dramatic effects on increasing
lactate production, and this was expected to reflect a much greater proportion of glucose
metabolized through glycolysis rather than the OxPPP; the expectation was that the proportion of
single-labeled lactate should have fallenmore substantially than it did. Whilelow K has been
associated with oxidative stress, only a minor increase in single-labeled lactatewas observed,
similar to the oxidant tBHP. These data, however, do not indicate the absolute fluxes occurring
through the reactions. To determine the fluxes, the labeling patterns must be used within the
context of the measured rates of glucose uptake, lactate production, and mitochondrial
respiration.

E.2. Fluxes and metabolites in healthy neurons
Table 5 below shows the fluxes for all blocks in healthy neurons as well as those treated
with each modulation. The values were normalized to the paired high K control to reduce the
variability between different cell preparations. The fluxes in control neurons are expressed as the
rate of substrate consumed, except for the phosphorylation block (PHO) which is expressed as
the rate of product (ATP) formed. For the first time, these results provide a comprehensive
metabolic profile of healthy attached monolayer neurons.
According to our results, only 53.7±1.3% of glucose transported into the cell from the
media was metabolized via glycolysis. This percentage is higher than that found in detached
differentiated rat cortical neurons28. Conversely, this is lower than that found by Brekke et al29
(glycolysis is 94% of net glucose metabolism) a finding which was recently described as an over
estimation of glycolysis in intact neurons30. The discrepancy in estimating glycolysis was
attributed to the method used in Brekke et al

29

that may underestimate glucose metabolism

through the PPP (i.e. isotopic labeling of acetyl-CoA at carbon one from 2-13C glucose is not
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exclusively from glycolysis, as the recycling of G6P through the PPP can produce this label). In
this study, assessing the labeling pattern of lactate from 1, 2-13Cglucose as well as the absolute
rates of glucose consumption, lactate production, and mitochondrial pyruvate oxidized provided
a more accurate way to assess glycolytic and PPP fluxes . Our results showed that OxPPP flux
was 87.30.3 % of the rate of glucose uptake, indicating that OxPPP flux was 1.630.05-fold
greater than glycolytic flux.. Of the G6P metabolized through the OxPPP, 48.31.3% % was
returned to the hexose phosphate pool through the NonPPP, leaving 51.71.3% net use by the
pentose cycle (PC; combined Ox- and NonPPP) as well as by nucleotide synthesis. Thus, of the
glucose take up by the neurons, 20.60.5% was used by the PC, 25.71.8% was used for
nucleotide synthesis, and 53.71.3% was used by glycolysis. The glucose used by the PC is
higher than that recently determined in intact primary neurons (PPP is 14% of glucose
metabolized)30, in primary cortical neurons (6% of glucose metabolized)29, and cerebellar
neurons (4% of glucose metabolized)29. Also, it is higher than that reported in in vivo studies on
basal forebrain and intracerebral glioma (3.5% and 6.2%, of glucose metabolized respectively)31.
Furthermore, this ratio (PC/GM) is remarkably lower than that in neuronal suspension (70%)28.
The considerable contribution of the PC to glucose metabolism indicates that glutathione
turnover/recycling may be quite high32 making the production of NADPH via the PPP critical for
maintenance of the redox status of neurons27,31.
The sources of pyruvate in our system are glycolysis, the NonPPP, and cytoplasmic malic
enzyme. Of these, glycolysis was the major source of pyruvate (74.2 ± 0.10%), whereas the
NonPPP, and ME reactions contributions were relatively small (14.3 ± 0.03 % and 11.6 ± 0.13
%, respectively). The production of pyruvate and NADPH from malate and the re-oxidation of
pyruvate by mitochondria, pyruvate recycling, was first reported in 1990 by Cerdan and
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colleagues in brain33. This pathway may be important to maintain neuronal energy demand
during limited substrate (i.e. glucose, ketone bodies, and lactate) supply. McKenna and her group
initially found that the activity of malic enzyme was limited to astrocytes not neurons in cerebral
hemisphere tissue34. Five years later, they found detectable mitochondrial malic enzyme activity
in cerebellar neurons35. Furthermore, the activity of mitochondrial malic enzyme was confirmed
in neurons of perfusion-fixed rat brain36. In agreement with previous studies, our results indicate
that malic enzyme and pyruvate recycling contributes to the NADPH cytosolic pool (data
discussed later in this section) that is important for redox status maintenance35,36.
Interestingly, a substantial amount of the pyruvate produced (74.2± 0.7%) was reduced
to lactate and only 25.8 ± 0.65 % was oxidized by mitochondria. This is substantially higher than
for some in vivo studies (3.5%

37

and 7%

38

of glucose uptake). The percentage of glucose

converted to lactate was suggested to be regional in human brain (i.e. lower in cerebellum and
medial temporal lobes than medial and lateral parietal and prefrontal cortices)39.These findings
support the recent findings that in cultured glutamatergic neurons (i.e. CGNs), glucose utilization
in presence of glucose and glucose plus lactate is correlated with the level of intracellular
calcium40. This intracellular calcium level is important for activity of mitochondrial citric acid
cycle enzyme.
In the light of these results, the mechanism through which neurons favor lactate
production rather than oxidative phosphorylation is at least partly due to a more favorable
gradient for lactate excretion by the plasma membrane monocarboxylate transporters in the
current in vitro studies. Lactate transport is readily reversible depending on the pH and lactate
concentrations across the plasma membrane..For the current experiments, neurons were
incubated in lactate-free buffer, and without glial cells as a major lactate producer, whereas in
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vivo the concentration of extracellular lactate can reach low millimolar levels. Accordingly,
lactate efflux is much more thermodynamically favorable in these cultured neurons. In fact, one
of the modulations used in the present experiments was supplementation of the media with 2mM
lactate, which substantially reduced the rate of lactate extrusion by the CGNs (see Table 5).
The cytoplasmic reducing equivalent, NADPH, in our system was predominately
produced by the PPP (93.4 ± 0.2 %) rather than by ME (6.6 ± 0.2%). This finding confirmed the
leading role of the PPP in maintaining the neuronal redox status through NADPH supply. The
produced NADPH is critical for the reduction of glutathione disulfide by glutathione reductase
27

. The neuronal redox status in turn, is controlling the activity of pro-apoptotic proteins (i.e.

cytochrome c, and caspase) suggesting a crucial role of PPP in mediating the neuronal survival41.
In agreement with this idea, cells with high PPP activity (i.e. tumor cells) were resistant to death
by apoptosis27.
The net rate of ATP production in our cell model was 2043.4 ± 59.0 pmol ATP/min. Of
this, 65.8 ± 0.5% was derived from mitochondria (the PHO block), 23% was from glycolysis (the
GLY block), and 5.9% was from the NonPPP. It should be emphasized that the NonPPP is not
typically an ATP producer, but in this study the ATP producing reactions of glycolysis were
grouped within the NonPPP; thus, in total 28.9% of cellular ATP was derived from the glycolytic
reactions. This percentage of mitochondria-derived ATP is very close to that reported for
activated neurons42.
Metabolites were measured in healthy neurons with or without modulation (Table 6).
First column includes absolute concentrations whereas the other columns contain measured
metabolites in modulation-treated neurons normalized to control (healthy neurons).
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E.3. Modulation-treated neurons
Tables 5, and 6 summarize the fluxes and metabolite concentrations for each modulation.
All modulations caused measurable perturbation in their direct target reactions (see Chapter 2,
Section E.1.). Interestingly, changes occurred not only in the direct targets but also in other
fluxes and metabolites in the system. For example, in β-hydroxybutyrate(BHB)-treated neurons,
the expected change in the rate of NADH and pyruvate oxidation relative to control was
extensive (<0.01±0.02% and 0.61±0.06%, respectively). However, and due to the connected
nature of fluxes by common metabolites, many fluxes and metabolites were notably changed. As
discussed in Chapter 2, Section E.1.7., BHB can be oxidized by mitochondrial hydroxybutyrate dehydrogenase into acetoacetate to generate NADH; the acetoacetate can be
excreted or further oxidized in the TCA cycle, which was taken into account in our model.
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Table 5-C.Measured and calculated fluxes of CGNs in high K ± modulation. Block fluxes of glucose uptake (GTP) and lactate production (LAC) were
determined by enzymatic assays. The other blocks including NADPH oxidation (NPO), malic enzyme (ME),oxidative phase of pentose phosphate
pathway (PPP) (OXPPP), and non-oxidative PPP (NonPPP) were calculated using excel solver function which was optimized to the observed labeling
pattern of 13 C-lactate in 25K CGNs ± modulation. Other blocks including; glycolysis (GLY), NADH oxidation (NAO), pyruvate oxidation (PYR),
mitochondrial phosphorylation (PHO), and ATP consumers (ATC) were calculated using the known stoichiometries of the system. High K data are
mean ± S.E.M. (n=63). Data of High K + modulation (β-hydroxybutyrate, BHB; cyanide, CN; DCA, dichloroacetate; FCCP; low glucose, lactate, and
tert-butylhydroperoxide, tBHP) are normalized to control. Data are geometric mean ± S.E.M. (n=6 *the n was variable depending on the modulation).

The measured rate of BHB consumed was 84.5±7.1 pmol/min. Of this, 58.57.1
pmol/min was oxidized to acetoacetate, while 31.0±3.91 pmol/min was completely oxidized
within the TCA cycle. Since BHB provided a third source of mitochondrial substrate, the
mathematical model was modified to take into account the additional source. Accordingly, the
mitochondrial contribution to total cellular ATP production increased to 76.3±1.2% whereas
glycolytic ATP (from both GLY and NonPPP) was reduced to 20.6±1.3%. The additional
mitochondrial substrate directly affected the rate of consumption of pyruvate and glycolytic
NADH. Our results indicated a notable decrease in the rate of pyruvate oxidation relative to
control (0.62±0.06) causing accumulation of pyruvate as measured 1.46±0.34 fold. Glycolytic
rate decreased (0.77±0.02) while its substrate G6P increased 1.52±0.22 fold. Apparently,
accumulated G6P was not only due to low glycolysis, but also because 30% less G6P was used
by the pentose cycle. This reduction of PPP may be caused by increased ME (1.42±0.09 fold
)which provide another source to the cytosolic NADPH pool that was increased in BHB-treated
neurons (16.3±1.6% of total NADPH instead of 6.62 ± 0.22% in control).The expected change in
NADH and pyruvate oxidation due to BHB modulation was propagated throughout the system
by the virtue of connectedness.
Likewise, the addition of cyanide (100µM), inhibitor of the respiratory chain complex IV,
caused a remarkable decrease in the kinetics of PYR and NAO (0.54±0.52 and 0.51±0.45,
respectively) that propagated throughout the system by the virtue of connectedness. The
inhibition of complex IV of respiratory chain prevents electron transfer for the reduction of
oxygen molecules to water causing low mitochondrial ATP yield (22.1±2.0% Vs 65.8±0.5% for
control). Consequently, glycolytic ATP was increased (57.9±2.3% Vs 26.9±2.5% for control) to
meet cellular demand and to compensate the decrease in mitochondrial ATP. This was noted by
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reduced PYR flux (0.52±0.06 fold) and NAO (0.45±0.13) as well as activated LAC (1.61±0.08
fold). Accordingly, the percent of pyruvate converted to lactate increased to 91.7±0.9% whereas
pyruvate oxidation contribution was reduced to 8.3±0.9%. Also, the cellular level of
NADH/NAD increased 1.58±0.24 fold in response to inhibited PYR and NAO.
Pyruvate dehydrogenase (PDH) was expected to be activated in dichloroacetate (DCA)treated neurons due to the inhibitory effect of DCA on pyruvate dehydrogenase kinase enzyme
(see Chapter 2, Section E.1.6.). Accordingly, blocks that including PDH, PYR and NAO, were
expected to directly activated. Surprisingly, PYR showed minimal response (1.06±0.06 fold)
despite a remarkable decrease in pyruvate (0.29±0.38 of controls). Interestingly and
unexpectedly, the activity of malic enzyme decreased (0.52±0.03) which may partly explain the
decrease in pyruvate level. The shortage in pyruvate supply (i.e. reduced pyruvate recycling)
may influenced the rate of its oxidation regardless of the enzyme activity. In agreement with this,
maintained supply of NADH (GLY= 0.97±0.03) was coupled with activated NAO (1.69±0.48) in
DCA-treated neurons. Despite only a modest increase in PYR flux, this was sufficient to
significantly increase the percentage of ATP generated by the mitochondria(69.3±2.2% Vs
64.1±0.5% in control) and decreased the ATP derived from glycolysis (25.5±2.3% Vs
30.8±0.6% in control) to cellular ATP pool. Despite the measured inhibition in ME and marginal
change in PYR, the fraction of pyruvate oxidized by mitochondria increased to 31.1±3.1% from
25.8±0.7% in the controls.
The addition of 0.5 µM FCCP, the proton ionophore uncoupler, to healthy neurons
caused, as expected, extensive increase in the proton leak rate (9.71±1.13 fold). This perturbation
caused further changes in fluxes through changes in common metabolites. For example, the
decrease in m (0.93±0.01 fold) due to increased proton leak caused activation of GTP
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(1.64±0.26) and hence GLY (1.77±0.07) to compensate for the loss in proton motive force. Low
substrate (H+) due to perturbed proton motive force may reduce the activity of ATP-synthase and
hence PHO block. Our results, however, showed slightly greater PHO flux (1.17±0.14 fold)
which is likely an artifact of errors in measurement of the leak rate with FCCP. The fact that
ATP/ADP ratio declined (0.85±0.09) suggests that PHO activity was compromised despite the
inability to detect it in these experiments.

Despite this, the contribution of PHO to ATP

synthesis decreased to 52.53.4% and the contribution by glycolysis increased to 41.7±3.8%)
because GLY and NonPPP fluxes were more strongly increased. Stimulation of mitochondrial
substrate oxidation indirectly by FCCP was also reflected in more pyruvate being oxidized rather
than reduced to lactate (compare 56.5% of pyruvate to lactate with FCCP vs. 75% for controls).
Addition of lactate (2mM) to CGNs, as expected (see Chapter 2, Section E.1.4.), caused
lactate production and transportation to be less favorable (0.42±0.08) which directly caused the
observed accumulation of pyruvate (1.37±0.34). As a result, the percent of pyruvate oxidized by
mitochondria increased (39.7±5.1% Vs 25.8±0.7% for control) while that reduced to lactate
decreased (60.3±5.1% Vs 74.2±0.7% for control). Glycolysis substantially declined (0.50±0.06)
while activating PYR (1.370.06 fold). As a result, the contribution of mitochondria to total
cellular ATP synthesis increased (75.3±3.2% Vs 64.1±0.5% for control). Likewise, inhibition of
glycolysis reduced its contribution to cellular ATP (18.3±3.4% Vs 30.8±0.6% for control).
Low glucose-treated neurons showed an expected reduction in GTP and GLY fluxes
(0.60±0.05 and 0.53±0.06, respectively). This initial perturbation was propagated throughout the
cell by the effect of common metabolites such as G6P (0.57±0.13 fold) and pyruvate (0.36±0.10
fold). However, PYR block was minimally affected by the low pyruvate content as
mitochondrial respiration rate was not affected. As a result, the fraction of pyruvate reduced to
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lactate decreased significantly (54.2±6.7% Vs 74.2±0.7% for control) while the fraction oxidized
by mitochondria increased (45.8±5.16% Vs 25.8±0.7% for control). Since glycolysis was
substantially reduced but mitochondrial substrate oxidation was not, there was a significant shift
to a greater proportion of ATP generated by the mitochondria (76.51.7% vs. 65.80.5% for
controls).
Addition of 10ng/L oligomycin to healthy neurons caused kinetic inhibition of F1F0ATPase and hence inactivation of PHO block (0.15±0.00). This kinetic change resulted in further
change in other fluxes through changes in common metabolites that established new steady state.
Reduced H+ influx into mitochondrial matrix through ATPase increased m, thus increasing
PRL flux (2.20±0.00 fold). Also, the fraction of pyruvate oxidized by the mitochondria was
remarkably decreased (2.6±0.4% Vs 25.8±0.7 for control) while that reduced into pyruvate was
increased (97.4±0.4% Vs 74.2±0.7% for control). Consequently, the glycolytic ATP contribution
to total ATP produced by the cell was substantially increased (88.9±1.8% Vs 30.8±0.6% for
control). In contrast, the mitochondrial ATP yield was notably reduced in oligo-treated cells
(9.6±1.5% Vs 64.1±0.5).
Addition of (25μM) tert-butyl hydroperoxide (tBHP) to neurons was expected to directly
activate NADPH consumers (i.e. glutathione reductase), however, this effect was not pronounced
(1.09±0.12 fold). Consequently, the cellular level of NADPH decreased as observed (0.76±0.17
fold) which should contribute to stimulation of the NADPH producers. Of these producers, is
ME block which was activated 1.11±0.13 fold while the main producer, OxPPP, was slightly
increased (1.09±0.12 fold) . The net glucose metabolized through glycolysis was similar
(59.5±2.9% Vs 57.6±2.5% for control) while that used by the pentose cycle was also unchanged
(22.5±1.0% Vs 22.1±0.9%). Despite a slight increase in NADPH consumption, this modulation
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did not significantly impact the proportion of glucose used for glycolysis or the OxPPP, so the
concentration of oxidant was insufficient to perturb the fluxes as intended.

E.4. Elasticity coefficients of the reaction blocks to the metabolites in healthy
neurons
Table 8 below summarizes the responsiveness of each block to each explicit metabolite.
This study is the first to determine elasticity coefficients in primary neurons. The coefficients
were calculated from the measured fractional flux (𝑑𝐽 𝐽) and metabolite (𝑑𝑥 𝑥 ) changes
induced by the modulations which do not directly affect a block‟s kinetics. For each modulation
that satisfies this criterion, the fractional flux change is a function of the fractional metabolite
changes and the elasticity of the block to each metabolite (Eq. 12). For calculation of the
elasticities to be valid, the number of modulations applied must equal or exceed the
number of explicit metabolites (xm).
𝑑𝐽 𝑖
𝐽𝑖

≈ 𝜀𝑥𝑖 1 ∙

𝑑𝑥 1
𝑥1

+ 𝜀𝑥𝑖 2 ∙

𝑑𝑥 2
𝑥2

+ 𝜀𝑥𝑖 3 ∙

𝑑𝑥 3
𝑥3

+∙∙∙∙∙∙∙∙∙∙∙∙∙ +𝜀𝑥𝑖 𝑚 ∙

𝑑𝑥 𝑚
𝑥𝑚

(12)

In theory, a set of m equations can be solved for the m elasticities, but in practice the presence of
experimental error precluded unique solutions to each set of equations. The elasticities were
estimated using the Microsoft Excel solver function which minimized the error between the
measured and calculated fractional fluxes for all valid modulations (i.e., those not directly
affecting a block)(Eq. 6). Thus, the solver function was used to iteratively adjust the elasticities
to minimize the least squares error.

𝑎𝑙𝑙 𝑚𝑜𝑑

𝑑𝐽 𝑖𝑚𝑜𝑑
𝐽𝑖

−

𝑖
𝑎𝑙𝑙 𝑥 𝜀𝑥 ∙

𝑑𝑥
𝑥

2

𝑚𝑜𝑑 ≥ m

(13)
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Table 6-C. Explicit metabolite concentrations in high K CGNs ± modulation. Explicit metabolites including NADPH/NADP/ NADH/NAD, G6P,
pyruvate, ATP/ADP, and MMP * was not determined by enzymatic assay concentrations were determined by enzymatic assays. High K CGNs data are
mean ± S.E.M (19≤ n ≥23). High K CGNs + modulation data were normalized to control (high K CGNs) and are geometric mean ± S.E.M. (4≤ n ≤10).

Where “mod” is a specific modulation, and “all mod” is all valid modulations used. For
calculating the elasticities some of the valid modulations were not used, and some constraints
were placed on the solver so that the solutions were compatible with established biochemical and
MCA concepts, provided that the least squares error did not exceed 5% of the fractional flux sum
of squares. Essentially, the constraints placed on the solver and the valid modulations excluded
𝑏𝑙𝑜𝑐𝑘
𝑏𝑙𝑜𝑐𝑘
𝑏𝑙𝑜𝑐𝑘
were chosen so that (a) 𝜀𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒
> 0, (b) 𝜀𝑝𝑟𝑜𝑑𝑢𝑐𝑡
< 0, and (c) 𝜀∆𝜑
 was minimized for those

blocks not directly producing or consuming m (Table 7). The first two constraints are based
on principles of enzymology, while the latter constraint was included because m is spatially
restricted to the mitochondrial compartment while many of the blocks are exclusively
cytoplasmic. For GLY, LAC, OxPPP, and NonPPP blocks, their respective elasticities to m
were minimized by assuming that the sum of the absolute values of the elasticities to their
respective substrates and products was greater than to m (for LAC and OxPPP, where each of
these has one substrate and one product) or to the sum of the absolute value to m and
NADPH/NADP (for GLY and NonPPP, where each of these produces/consumes four
metabolites). For GTP, ATC, and NPO blocks, their respective elasticities to m were
minimized by excluding FCCP (for GTP and ATC) or HB (for NPO) from the analysis.
Importantly, after systematic removal of each modulation, exclusion of BHB was the only
𝑁𝑃𝑂
condition under which𝜀𝑁𝐴𝐷𝑃𝐻
> 0, so it appeared that this modulation was directly affecting
𝑁𝐴𝐷𝑃

NPO kinetics.
There were only five modulations available for calculating the six elasticities to each of
the m producers (i.e., PYR and NAO), as one of the intended modulations to inhibit the
OxPPP (androsterone) appeared to directly affect PYR and NAO by virtue of the measured flux
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and metabolite changes (decreased respiration rate, decreased m, and increased lactate
production- data not shown) and thus was excluded. To run the analysis with five equations and
𝑃𝑌𝑅
five unknowns, it was assumed that 𝜀𝑃𝑦𝑟
= 0.17, as determined by Ainscow and Brand43in
𝑃𝑌𝑅
hepatocytes. This assumption was reasonable given that the analysis resulted in𝜀∆𝜑
= −11.7,

which is similar to that determined by Ainscow and Brand (-16.5) despite differences in
𝑁𝐴𝑂
organization of the reaction blocks43.Similarly, for the NAO block it was assumed that 𝜀∆𝜑
=

−23.2, as determined by Ainscow and Brand43. This assumption also seemed reasonable given
𝑁𝐴𝑂
that the analysis resulted in 𝜀𝑁𝐴𝐷𝐻
= 0.41, similar to that determined in hepatocytes (0.74).
𝑁𝐴𝐷

For the PHO block, two valid modulations (FCCP, Lactate) were excluded because of
substantial errors between measured and calculated fluxes with the constraint imposed on the
solver (Table 7). For FCCP, the increase in respiration rate (1.74-fold) stimulated respiratory
chain H+ pumping by 3402 H+ per min., but the measured FCCP leak kinetics and m indicated
an increase of only 2906 H+ used per min. This meant that the calculated PHO block flux
increased 1.17-fold, contrary to the expected decrease due to reduction in m. This unexpected
result likely was from measurement error in the FCCP-induced H+ leak kinetics. With FCCP
excluded, the residual least square error was an unacceptably high 31% of the fractional flux sum
of squares, and this error was largely due to discrepancy between the calculated and measured
PHO flux in the presence of lactate. Most of this error could be attributed to the very small
increase in m with lactate (compared to HB). Exclusion of FCCP and Lactate left only five
𝑃𝐻𝑂
modulations for the analysis, so it was assumed that 𝜀𝑁𝐴𝐷𝐻
= 0 as this was the result obtained
𝑁𝐴𝐷

when FCCP was the only modulation excluded.
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Table 7-C. Solver constraints and excluded valid modulations used in calculating elasticity values. Blocks GTP,
glucose uptake and transportation; GLY, glycolysis; PYR, pyruvate oxidation; LAC, lactate production and
transportation; NAO, NADH oxidation; PHO, oxidative phosphorylation block; PRL, proton leak block; ATC, ATP
consumers; OxPPP, oxidative phase of pentose phosphate pathway (PPP); NPO, NADPH oxidation block; NonPPP,
non-oxidative phase of PPP; ME, malic enzyme block. Solver constraints were set for all blocks except GTP, ATC,
NPO, and ME. Constant values of elasticity (ε) were set for PYR (Pyr = 0.17), NAO (Pyr = -23.2) and PRL (G6P,
NADPH, Pyr, NADH, ATP = 0). Solver constraint for GLY, LAC, OxPPP, and NonPPP, were set to minimize their
respective elasticities to m. Excludes modulations are FCCP, in GTP; DCA, in GLY; oligo, in LAC; FCCP, in
PHO; BHB, foe NPO; and DCA, for NonPPP.

Block
GTP
GLY
PYR

Solver constraint

Valid modulations excluded
FCCP: Excluded to minimize 

None

𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝐴𝑇𝑃,𝑁𝐴𝐷𝐻  ≥

𝜀∆𝜑,𝑁𝐴𝐷𝑃𝐻 

Pyr = 0.17

None
Oligo: Excluded to minimize  and to
reduce the least squares error.

𝜀𝑃𝑦𝑟 ,𝑁𝐴𝐷𝐻  ≥ 𝜀∆𝜑

LAC

DCA: Excluded so that Pyr< 0

 = -23.2

None

PHO

NADH = 0; ATP< 0; ATP 𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝑁𝐴𝐷𝑃𝐻 

FCCP: Excluded due to dJ/J > 0 contrary to
the expected.
Lac: Excluded to reduce the least squares
error.

PRL

G6P, NADPH, Pyr, NADH, ATP = 0

Not Applicable

ATC

None

FCCP: Excluded to minimize  and
because it may directly affect the ATC.

NAO

𝜀𝐺6𝑃,𝑁𝐴𝐷𝑃𝐻  ≥ 𝜀∆𝜑

OxPPP
NPO
NonPPP
ME

None
BHB: Excluded to minimize  and so
NADPH>0.

None

𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝐴𝑇𝑃,𝑁𝐴𝐷𝐻  ≥

𝜀∆𝜑,𝑁𝐴𝐷𝑃𝐻 

DCA: Excluded so that Pyr< 0
BHB and Lac: Excluded as they most likely
substantially change [malate], which could
affect the elasticities, and so NADPH< 0.

None

The least-squares elasticity solutions are shown in Table 8. While some of the elasticities
can be explained by simple enzymology, there were a number of seemingly unexpected results,
some of which are a consequence of how the blocks were organized, and others of which are
more difficult to reconcile within the context of conventional biochemistry. Of the three products
𝐺𝐿𝑌
generated by the GLY block, ATP/ADP exerts the strongest feedback inhibition (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
=-
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𝐺𝐿𝑌
3.09), similar to ATP in hepatocytes (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
= -2.7)43. The inhibition of GLY is notably
𝑃𝐻𝑂
stronger than for PHO (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
= -0.61), the latter of which is considered quite sensitive to
𝑃𝐻𝑂
ATP/ADP. This is similar to the findings reported for hepatocytes (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
= −1.24)43. Thus,

changes in ATP/ADP have a much greater impact on glycolytic flux than on oxidative
phosphorylation. Unexpectedly, the elasticity of GLY to one of its products – NADH/NAD- was
𝐺𝐿𝑌
significantly positive (𝜀𝑁𝐴𝐷𝐻
/𝑁𝐴𝐷 = 1.1), suggesting that unknown sites of allosteric activation

supersedes any possible feedback inhibition. This was not the case in hepatocytes, where
43
𝐺𝐿𝑌
NADH/NAD exerted modest feedback inhibition (𝜀𝑁𝐴𝐷𝐻
/𝑁𝐴𝐷 = -0.23) .

In addition to GLY, ATP/ADP exerted inhibitory effects on a number of blocks not
traditionally considered to respond to adenine nucleotides, including GTP, LAC, NAO, OxPPP,
and NPO. This pleiotropic effect is consistent with a recent study indicating that ATP, ADP, and
AMP may exert allosteric effects on a number of glycolytic enzymes in situ that have not
traditionally been considered to respond to these nucleotides in vitro44. While ATP/ADP is a
substrate for the GTP block, G6P has long been considered the main regulator of hexokinase
(and thus GTP flux), but the current result indicates that ATP/ADP is the more important
negative regulator for the combined activities of GLUT transporters and hexokinase. According
to our system arrangement and grouping, a change in G6P was expected to strongly affect the
activity of both GLY and OxPPP blocks. Interestingly, neither block is particularly responsive to
𝑶𝒙𝑷𝑷𝑷
G6P (𝜺𝑮𝑳𝒀
=0.07), but GLY is more strongly affected than the OxPPP.
𝑮𝟔𝑷 = 0.28 vs. 𝜺𝑮𝟔𝑷

Furthermore, PYR and LAC compete for the substrate pyruvate, but the LAC flux is more
𝑷𝒀𝑹
strongly affected by this metabolite (𝜺𝑳𝑨𝑪
𝑷𝒚𝒓𝒖𝒗𝒂𝒕𝒆 = 0.50 vs 𝜺𝑷𝒚𝒓𝒖𝒗𝒂𝒕𝒆 =0.17). This is consistent with
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the findings in hepatocytes43 and indicates that increased glycolytic supply of pyruvate will
disproportionally increase lactate production over mitochondrial pyruvate oxidation. acetate.
Although m is a common metabolite between PRL and PHO blocks, PHO is about 2.5
𝑃𝐻𝑂
𝑃𝑅𝐿
times more sensitive to small changes in this substrate than PRL (𝜀m
= 16.9 vs 𝜀m
=6.7).

Thus, in neurons, stimulation of mitochondrial substrate oxidation will have a more profound
effect on activating oxidative phosphorylation than proton leak. This differs from hepatocytes,
where PRL and PHO had identical elasticities (6.9)43. It is worth noting that the kinetics of H+
leak to m in neurons was virtually the same as that in hepatocytes43. Here it should be noted
that mitochondrial membrane potential exerted surprisingly strong pleiotropic effects on many of
the blocks not directly producing or consuming it (i.e. GLY, LAC, and NonPPP). Furthermore,
𝐺𝐿𝑌
𝑀𝐸
GLY was strongly stimulated bym (𝜀m
= 4.0), as were the ME (𝜀m
= 4.9), NonPPP
𝑁𝑜𝑛𝑃𝑃𝑃
𝐿𝐴𝐶
(𝜀
= 4.8), and LAC (𝜀m
= 1.6) blocks. These positive elasticities, coupled with
𝑚

feedback inhibition of m on PYR and NAO, promote anaerobic glycolysis and lactate
production. Because m is spatially distinct from most of these blocks (the exception being
ME), the allosteric activator is likely to be a factor which varies with m (e.g., superoxide or
another ROS). Mitochondrial membrane potential exerted inhibitory allosteric effects on the
𝐴𝑇𝐶
𝑂𝑥𝑃𝑃𝑃
𝑁𝑃𝑂
ATC (𝜀m
= -3.1), OxPPP (𝜀m
= -0.94) and NPO (𝜀m
= -0.73). Notably, in hepatocytes
𝐴𝑇𝐶
m exerted stimulatory rather than inhibitory effects on the ATP consumers (𝜀m
= 0.90)43.

𝐴𝑇𝐶
Strikingly, ATC had week responsiveness to its direct substrate ATP/ADP (𝜀𝐴𝑇𝑃
=
𝐴𝐷𝑃

0.11), this in contrast to the much greater responsiveness of the ATP consumers to ATP in
𝐴𝑇𝐶
hepatocytes (𝜀𝐴𝑇𝑃
= 2.68)43. This can partly explained by the differences in the explicit
𝐴𝐷𝑃
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metabolite (ATP/ADP neurons vs ATP hepatocytes). This observation, however, indicates that
neuronal ATP consumption rate is relatively insensitive to small changes in ATP/ADP ratio.
Both NADPH consumers were subject to feedback inhibition by NADPH/NADP,
𝑂𝑥𝑃𝑃𝑃
𝑀𝐸
although the OxPPP was more sensitive to this than ME (𝜀NADPH
/NADP = -0.87 vs. 𝜀NADPH /NADP

= -0.56), which is not surprising given that the OxPPP accounted for 91% of NADPH
production. Interestingly, the elasticities of GLY, LAC, NonPPP, PYR, NAO, ME, and ATC to
NADPH/NADP were opposite in sign to their elasticities to m. Thus, increased
NADPH/NADP promotes mitochondrial substrate oxidation and ATP consumption while
reducing glycolysis and lactate production. The antagonistic effects of NADPH/NADP and m
on these blocks are intriguing given that high NADPH/NADP promotes NADPH consumption
𝑁𝑃𝑂
(𝜀NADPH
/NADP = 0.39). High NADPH consumption in turn promote protection of protein thiols

from ROS and increased ROS scavenging, while increased m has been linked to greater ROS
production (at least in isolated mitochondria). Hence it is possible that these effects are mediated
through ROS.
It should be noted that the elasticities of the NonPPP generally parallel those for GLY.
This is a consequence of the lower portion of glycolysis (all reactions converting the triose
phosphates to pyruvate) being grouped within the NonPPP. It is likely that there is some error in
the NonPPP elasticities since the effect of the substrate (ribulose-5-phosphate, ribose-5phosphate, and xyulose-5-phosphate)on the flux was not quantified. Nonetheless, because of the
way the block was organized, the strongest metabolite effects on the NonPPP are most likely the
glycolytic products, which would most likely minimize the error associated with not determining
the substrate elasticity.
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Table 8-C. Elasticity coefficients of blocks to metabolites. Blocks are; glucose uptake and phosphorylation (GTP), pyruvate oxidation (PYR), lactate
production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of
pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). Metabolites are
glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial membrane potential (∆Ѱ m), ATP/ADP, and NADPH/NADP. Subscripts
denote the percent of Mote Carlo simulated values that have an opposite sign to the values obtained. Values without subscript were assumed to be
constant values. Between parenthesis is the range of 90% confidence interval of the simulated values. The least square elasticity solutions are
represented as Error%

E.5. Concentration control coefficients for healthy neurons
The concentration control coefficients quantify the extent to which each reaction controls
𝑥
the concentration of a specific metabolite (x) within the system boundaries (𝐶𝐸1
). Here it should

be noted that the metabolite controlled by a block is not necessarily limited to the block‟s
substrate or product, as it can be controlled by virtue of the influence the block exerts on one or
more of the producers or consumers of the metabolite. Mathematically, a concentration control
coefficient is the fractional change in metabolite x (dx/x) due to a fractional change in flux (dJ/J)
through a block
𝑥
𝐶𝐸1
= 𝑑𝐽

𝑑𝑥 𝑥
𝑏𝑙𝑜𝑐𝑘

(14)

𝐽 𝑏𝑙𝑜𝑐𝑘

A reaction block is expected to exert the most control over a metabolite that is either a substrate
or a product. Reactions typically exert positive control over their products so that a more active
flux increases the metabolite. Similarly, reactions typically exert negative control over their
substrates so that a more active flux decreases the metabolite. Table 9 summarizes the control
that each block exerts over the metabolites. The results indicate that the explicit metabolites were
not only controlled by the blocks that produce and consume the metabolites, but also by more
distant blocks through their effects on other metabolites that affect the producers/consumers.
Glucose-6-phosphate is produced by GTP and the NonPPP, and consumed by GLY and
OxPPP, so most of the control of this metabolite was expected to reside with these blocks. Both
𝐺6𝑃
𝐺6𝑃
G6P consumers exerted similarly large, negative control over G6P (𝐶𝐺𝐿𝑌
= −1.61, 𝐶𝑂𝑥𝑃𝑃𝑃
=
𝐺6𝑃
−1.68), but the ATC also contributed (𝐶𝐴𝑇𝐶
= −0.54) because of the large negative elasticities

of GLY and OxPPP to ATP/ADP (i.e., the ATC negatively affected ATP/ADP, which in turn
stimulated both of the G6P consumers). Positive control by the two G6P producers balanced only
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𝐺6𝑃
𝐺6𝑃
half of the negative control by the two consumers (𝐶𝐺𝑇𝑃
= 1.26, 𝐶𝑁𝑜𝑛𝑃𝑃𝑃
= 0.39). The
𝐺6𝑃
𝐺6𝑃
remaining positive control was due to LAC (𝐶𝐿𝐴𝐶
= 1.05), NPO (𝐶𝑁𝑃𝑂
= 0.55), and NAO
𝐺6𝑃
(𝐶𝑁𝐴𝑂
= 0.44). The LAC block positively affected G6P production by both the GTP and

NonPPP primarily through its control over pyruvate (which was most important in affecting the
NonPPP given the negative elasticity of this block to pyruvate), NADH/NAD, and
NADPH/NADP (the latter two were most important in affecting GTP given the positive
elasticity of this block to NADH/NAD and negative elasticity to NADPH/NADP). Positive
control by NAO was primarily mediated through its negative effects on G6P consumption by
both GLY and the OxPPP; the NAO negatively affected G6P consumption primarily by its
positive control over ATP/ADP coupled with the strong negative elasticities of the G6P
consumers to this metabolite. Positive control by NPO was primarily mediated by its negative
effect on the NADPH/NADP ratio, coupled with the relatively large negative elasticities of both
G6P producers (GTP and NonPPP) to NADPH/NADP (i.e., the NPO relieved inhibition by
NADPH/NADP over GTP and NonPPP).
The control pattern over pyruvate was expected to primarily reside within the pyruvate
producers (GLY, NonPPP, and ME) and consumers (LAC and PYR). The positive control of the
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

producers (𝐶𝐺𝐿𝑌

𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

= 0.62) almost balanced the negative

𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

= −0.58). Glycolysis was the primary

= 0.52,𝐶𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 =0.93𝐶𝑀𝐸
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

control of the consumers (𝐶𝐿𝐴𝐶

= −1.33, 𝐶𝑃𝑌𝑅

source of pyruvate (accounting for 74% of pyruvate production), so it was surprising that the
NonPPP exerted more control over pyruvate than GLY; this was primarily a consequence of the
NonPPP having negative control over ATP/ADP, which promoted pyruvate production by
glycolysis because of the strong negative elasticity of GLY to ATP/ADP. Surprisingly, the GTP
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒

block exerted strongest positive control over pyruvate (𝐶𝐺𝑇𝑃
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= 1.56) which was primarily

𝐴𝑇𝑃/𝐴𝐷𝑃

due to its negative effect on ATP/ADP (𝐶𝐺𝑇𝑃

= −0.42) and its strong positive effect on

𝐺6𝑃
G6P (𝐶𝐺𝑇𝑃
= 1.26) coupled with the elasticities of GLY to both metabolites. Negative control
𝐺6𝑃
by NPO (𝐶𝑁𝑃𝑂
= −1.12) exceeded that for PYR primarily because of the large negative

elasticity of LAC to NADPH/NADP and the strong negative control the NPO exerted over
NADPH/NADP (i.e., consumption of NADPH by NPO relieves inhibition on LAC to stimulate
pyruvate consumption).
Control over NADH/NAD by both the NADH producers (GLY and NonPPP) and
consumers (LAC, NAO) were opposite to that expected. Both producers had negative control
𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

(𝐶𝐺𝐿𝑌

𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

(𝐶𝑁𝐴𝑂

𝑁𝐴𝐷𝐻
𝑁𝐴𝐷
= −0.34; 𝐶𝑁𝑜𝑛𝑃𝑃𝑃
= −0.05) while both consumer share positive control

𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

= 0.12; 𝐶𝐿𝐴𝐶

= 0.10). Negative control by glycolysis was attributed to

strong inhibition of NADH production by the NonPPP and GLY mediated by the control GLY
exerted over G6P and ATP/ADP and the corresponding effects these metabolites had on GLY
and the NonPPP to decrease NADH production. Negative control by the NonPPP was attributed
primarily to stimulation of consumption by LAC because of the control the NonPPP exerted over
pyruvate and ATP/ADP and the corresponding effects these metabolites had on increasing
𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

NADH consumption by the LAC block. Negative control was strongest by PYR (𝐶𝑃𝑌𝑅

=

−0.74) because it stimulated NADH consumption by LAC through effects on NADPH/NADP
and ATP/ADP. NADH consumption was dominated by LAC, but control over NADH/NAD was
positive because of the strong effect this block exerted on increasing NADH production by GLY
and NonPPP because of the strong control LAC exerted over G6P and pyruvate, and the
elasticities of GLY and the NonPPP to these metabolites. Most of the positive control over
𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

NADH/NAD was by the ATC (𝐶𝐴𝑇𝐶

𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

= 0.77), NPO (𝐶𝑁𝑃𝑂
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= 0.22) and GTP

𝑁𝐴𝐷𝐻 /𝑁𝐴𝐷

(𝐶𝐺𝑇𝑃

= 0.18). The latter two blocks exerted their effects by stimulating NADH

production by both GLY and NonPPP: NPO stimulated both GLY and NonPPP (which have
negative elasticities to NADPH/NADP) by negatively affecting NADPH/NADP, while GTP
stimulated the NADH producers primarily through both positive control over G6P and negative
control over ATP. The ATC similarly stimulated NADH production by negatively affecting both
ATP/ADP and NADPH/NADP.
Control of the ATP/ADP ratio was expected to primarily reside within the ATP producers
(GLY, NonPPP, PHO, and PYR) and consumers (ATC and GTP). The GTP block exerted more
𝐴𝑇𝑃
𝐴𝐷𝑃

𝐴𝑇𝑃
𝐴𝐷𝑃

negative control over ATP/ADP than did the ATC(𝐶𝐺𝑇𝑃 = −0.42, 𝐶𝐴𝑇𝐶 = −0.06)which was
unexpected given that the ATC accounted for 86% of the ATP consumed. The stronger control
𝐴𝑇𝐶
by GTP was primarily due to the positive elasticity of the ATC to G6P (𝜀𝐺6𝑃
= 0.38) coupled

with the strong positive control GTP exerted over G6P.The elasticity of the ATC to G6P in this
study was essentially identical to that found in hepatocytes42, and indicates that the concentration
of G6P may be an important effector of cellular ATP consumption. Surprisingly, GLY was the
𝐴𝑇𝑃 /𝐴𝐷𝑃

only ATP producer exerting positive control over ATP/ADP (𝐶𝐺𝐿𝑌

= 0.27).The PHO block
𝐴𝑇𝑃/𝐴𝐷𝑃

synthesized 66% of ATP, but exerted essentially no control over ATP/ADP (𝐶𝑃𝐻𝑂

=

−0.001). There were two effects underlying this lack of control. First, a fractional increase in
PHO activity to increase ATP production is strongly opposed by m consumption because of
the large positive elasticity of the PHO to this metabolite. Second, an increase in PHO activity
stimulates ATP consumption by the ATC through control over G6P and m, and the elasticities
of the ATC to these metabolites (PHO activity tended to increase G6P and decreasem both of
𝐴𝑇𝑃/𝐴𝐷𝑃

which will stimulate the ATC).The PYR block exerted negative control (𝐶𝑃𝑌𝑅
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= −0.20)

primarily because of the strong negative control it had over NADH/NAD, which stimulated ATP
𝐴𝑇𝐶
consumption by reducing inhibition on the ATC (𝜀𝑁𝐴𝐷𝐻
= −0.51). The NonPPP exerted negative
𝑁𝐴𝐷

𝐴𝑇𝑃/𝐴𝐷𝑃

control (𝐶𝑁𝑜𝑛 𝑃𝑃𝑃 = −0.16) despite producing ATP primarily because of the positive control it
had over G6P coupled with the positive elasticity of the ATP consumers to G6P.The OxPPP was
the most notable block not directly producing ATP that positively controlled ATP/ADP
𝐴𝑇𝑃/𝐴𝐷𝑃

(𝐶𝑂𝑥𝑃𝑃𝑃

= 0.34). This occurred because of control exerted by the OxPPP on G6P and m,

which reduced ATP consumption and increased its production by the respective elasticities of the
ATC and PHO to these metabolites .Most of the effect was through strong negative control over
G6P, which substantially impacted ATP consumption by the ATC.
The NADPH/NADP ratio was evenly controlled by the NADPH producers
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃

( 𝐶𝑂𝑥𝑃𝑃𝑃

𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃

= 0.43 𝐶𝑀𝐸

= 0.33), despite the OxPPP accounted for 91% of

NADPH synthesis. This balanced control appeared to result (a) partly from the antagonistic
effect that ME had on the OxPPP because of its control over ATP/ADP and the strong negative
elasticity of the OxPPP to this metabolite, and (b) partly from the stimulatory effect that the
OxPPP had on ME because of the control the OxPPP had on G6P and ATP/ADP and the
elasticity of ME to these metabolites. The GTP block exerted as much positive control as the
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃

OxPPP (𝐶𝐺𝑇𝑃

= 0.46) despite not producing NADPH primarily because of its control

over ATP/ADP and pyruvate to which OxPPP is highly responsive. The NAO block also exerted
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃

notable positive control (𝐶𝑁𝐴𝑂

= 0.28), which was due primarily to its positive effect on

ATP/ADP coupled with the strong negative elasticity of the NADPH consumers to ATP/ADP.As
predicted, the NADPH consumers exerted the most substantial negative control over
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃

NADPH/NADP (𝐶𝑁𝑃𝑂

= −0.94), with some negative control also by the ATC primarily
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because of the strong effect increased ATP consumption had on stimulating the NADPH
consumers.

E.6. Flux control coefficients for healthy neurons
Table10 below represents the control that each block within the system exerts over one
another a term known as flux control coefficient. Mathematically, flux control coefficient is the
differential change in E1 block flux due to infinitesimal change in another block

𝐸1
𝐶𝐸2

𝑑𝐽 𝐸1

= 𝑑𝑉𝐸2

𝐽 𝐸1

(15)

𝑉𝐸2

Some of these coefficients can be rendered to the direct/indirect connection between blocks
through common intermediates whereas others cannot.

E.6.1. Control of Glycolysis and Lactate Excretion
The control over GLY was primarily distributed among OxPPP, GTP, ATC, NPO, GLY, LAC,
𝐺𝐿𝑌
𝐺𝐿𝑌
and ME (with OxPPP, ATC, and GTP exerted most of control (𝐶𝑂𝑥𝑃𝑃𝑃
= −1.9, 𝐶𝐴𝑇𝐶
=
𝐺𝐿𝑌
1.07 𝑎𝑛𝑑 𝐶𝐺𝑇𝑃
= 1.3)). Most of the negative control by the OxPPP was through its positive

control on ATP/ADP rather than its negative control over G6P as might be expected. This was
because of the much stronger elasticity of GLY to ATP/ADP than to G6P.Glycolysis was one of
𝐺𝐿𝑌
only two blocks that exerted negative control over its own flux (𝐶𝐺𝐿𝑌
= −0.61).This was due to

the concerted effects that consumption of G6P and production of ATP, NADH, and pyruvate had
on restraining its activity (i.e., the changes in these metabolites together overcame the intrinsic
positive control a block has over its own flux).
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Table 9.-C Concentration control coefficients of metabolites to blocks. Blocks are; glucose uptake and phosphorylation (GTP), pyruvate oxidation
(PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC),
oxidative-phase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
Metabolites are glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial membrane potential (∆Ѱ m), ATP/ADP, and
NADPH/NADPSubscripts denote the percent of Mote Carlo simulated values that have an opposite sign to the values obtained. Between
parenthesis is the range of 90% confidence interval of the simulated values.

𝐺𝐿𝑌
Interestingly, the negative control by ME (𝐶𝑀𝐸
= −0.42) was mainly due to the positive

control it had on ATP rather than pyruvate. It is notable that PHO ranked as the weakest negative
controller, but this was not by positive control over ATP (since it had none), but by negative
control over NADH/NAD and m. The positive control by the ATC was primarily mediated
through NADH/NAD rather than through ATP/ADP, as the ATC had much stronger control over
the former than the latter metabolite. The positive control by GTP was about 96% mediated by
through effects on ATP/ADP level coupled with the strong negative elasticity of GLY to
𝐺𝐿𝑌
ATP/ADP. The NADPH consumers also exerted significant positive control (𝐶𝑁𝑃𝑂
= 0.93)

primarily by consuming NADPH to relieve inhibition this metabolite had on GLY. Strikingly,
𝐺𝐿𝑌
the pyruvate consumer, LAC, exerted strong positive control over GLY (𝐶𝐿𝐴𝐶
= 0.7) rather than
𝐺𝐿𝑌
the other pyruvate consumer, PYR, (𝐶𝑃𝑌𝑅
= 0.02). The control by LAC was mediated by the

strong positive control over G6P as well as the strong negative control over pyruvate coupled
with the elasticity of GLY to these metabolites. These results indicate that small changes in LAC
have much stronger effects on activation of GLY than do changes in PYR. Similar to
hepatocytes42, the Pasteur Effect (negative control of glycolysis by increased mitochondrial
activity), was observed in neurons, as the net control of the mitochondrial processes (PHO,
NAO, PRL, PYR,) over GLY was substantial (-0.57; compare to -0.26 for hepatocytes42).
Lactate production and export was controlled primarily by OxPPP, GTP, ATC, NPO, and
𝐿𝐴𝐶
GLY. Negative control was dominated by the OxPPP (𝐶𝑂𝑥𝑃𝑃𝑃
= −2.2) mainly due to the

positive control over ATP/ADP and NADPH/NADP, to which LAC has high negative
elasticities. Surprisingly, GLY was the second strongest negative controller despite being the
primary supplier of substrates to LAC. The negative control was mediated through ATP/ADP, as
LAC had a considerable negative elasticity to this metabolite. Positive control largely resided in
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𝐿𝐴𝐶
𝐿𝐴𝐶
𝐿𝐴𝐶
𝐿𝐴𝐶
GTP (𝐶𝐺𝑇𝑃
= 1.49), ATC (𝐶𝐴𝑇𝐶
= 1.2), NPO (𝐶𝑁𝑃𝑂
= 1.2), and LAC (𝐶𝐿𝐴𝐶
= 0.74). Control

by GTP was mediated through negative control over ATP/ADP and positive control over
pyruvate, coupled with the high elasticity of LAC to these metabolites. The ATC and NPO
exerted positive control primarily through effecting NADH/NAD and NADPH/NADP,
respectively. Notably, the control of PYR over LAC was minimal because the negative effects
mediated through pyruvate and NADH/NAD were largely offset by the positive effects mediated
through NADPH/NADP and ATP/ADP. It is noteworthy that the control over LAC is most
dependent on the reactions that control the levels of ATP and NADPH since LAC is most
responsive to these metabolites. Thus, lactate production is not simply a consequence of greater
glycolytic production of pyruvate and NADH.

E.6.2. Control of Mitochondrial Substrate Oxidation
According to our developed model, pyruvate and cytosolic NADH are transported and
oxidized in mitochondria by citric acid cycle (for pyruvate) and respiratory chain reactions (for
pyruvate and cytosolic NADH). Accordingly, the control over both fluxes is critical for
mitochondrial respiration.
Positive control over PYR was distributed among many of the blocks (PHO, ME, PYR,
OxPPP, NAO, and ATC), while negative control was principally restricted to NPO and LAC.
𝑃𝑌𝑅
The most prominent control was exerted by PHO (𝐶𝑃𝐻𝑂
= 0.3) which was caused by negative

control overm coupled with the high negative elasticity of PYR to m. Proton leak, the other
𝑃𝑌𝑅
m consumer, had far less positive control (𝐶𝑃𝑅𝐿
= 0.03) because its rate of consumption was
𝑃𝑌𝑅
𝑃𝑌𝑅
only 7% of that of PHO. Positive control by the NADPH producers (𝐶𝑂𝑥𝑃𝑃𝑃
= 0.18, 𝐶𝑀𝐸
=

0.21) was primarily the result of the relative strong positive elasticity of PYR to
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𝑃𝑌𝑅
NADPH/NADP; similarly, negative control by the NADPH consumers (𝐶𝑁𝑃𝑂
= −0.24) was

also primarily mediated through NADPH/NADP. The NAO shares many of the same reactions
with the PYR, so it was not surprising that the NAO positively controlled PYR. The ATP
𝑃𝑌𝑅
consumers had lesser control (𝐶𝐴𝑇𝐶
= 0.13), and this occurred almost exclusively through

positive control of the ATC over NADH/NAD.The LAC blocks was the second strongest (yet
𝑃𝑌𝑅
relatively weak) negative controller of PYR (𝐶𝐿𝐴𝐶
= −0.05), and this occurred primarily

through negatively controlling the concentration of pyruvate.
Positive control over NAO was largely distributed among LAC, PHO, and GTP, while
negative control was primarily through GLY, ME, and OxPPP. The control by GLY was greatest
𝑁𝐴𝑂
(𝐶𝐺𝐿𝑌
= −1.63)because of its control over ATP/ADP coupled with the strong negative

elasticity of NAO to ATP/ADP. Interestingly, the negative control exerted by OxPPP and ME
𝑁𝐴𝑂
𝑁𝐴𝑂
was identical (𝐶𝑂𝑥𝑃𝑃𝑃
= −0.76, 𝑎𝑛𝑑 𝐶𝑀𝐸
= −0.77) and resulted primarily from the control of

both fluxes over ATP/ADP, and m coupled with the elasticity of NAO to these metabolites.
Despite the fact that LAC was the primary NADH consumer, it had strongest positive control
𝑁𝐴𝑂
over NAO (𝐶𝐿𝐴𝐶
= 1.14),which was mediated mainly by the negative control over m and

pyruvate coupled with the strong negative elasticity of NAO to these metabolites. The strong
𝑁𝐴𝑂
control by PHO (𝐶𝑃𝐻𝑂
= 1.02) was expected because of its consumption of m and the high

negative elasticity of NAO to m(which was assumed as -23.2 from hepatocytes42).

E.6.3. Control of Mitochondrial ATP Synthesis
Mitochondrial ATP production and export (PHO) was controlled mainly by its own
𝑃𝐻𝑂
kinetics (𝐶𝑃𝐻𝑂
= 0.43). The m producers were the next most important positive
𝑃𝐻𝑂
𝑃𝐻𝑂
controllers(𝐶𝑃𝑌𝑅
= 0.22, 𝐶𝑁𝐴𝑂
= 0.17) primarily because of their effects on m and pyruvate.
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ATP consumption is generally assumed as the primary controller of mitochondrial
𝑃𝐻𝑂
phosphorylation, but ranked as slightly less important (𝐶𝐴𝑇𝐶
= 0.16) than the m producers.

Notably, the ATC had much stronger control over GLY, and so from these control coefficients it
can be calculated that glycolytic ATP synthesis would provide 60% of the additional ATP
required upon an increase in neuronal ATP consumption, while mitochondrial phosphorylation
would provide 24% of it. Because the NonPPP also produces ATP through the same reactions as
glycolysis, total glycolytic provision of the additional ATP consumed would thus be 75%.A
similar result was found for hepatocytes, except that the contribution was more evenly split (55%
from ATP and 45% from mitochondrial phosphorylation)42.The NPO and GLY blocks exerted
𝑃𝐻𝑂
𝑃𝐻𝑂
strongest negative control over PHO (𝐶𝑁𝑃𝑂
= −0.20, 𝐶𝐺𝐿𝑌
= −0.19)through effects on m

(for NPO),and ATP/ADP and pyruvate (for GLY).
𝑃𝑅𝐿
The proton leak flux (PRL) exerted a strong control over itself (𝐶𝑃𝑅𝐿
= 0.98) due to its
𝑃𝑅𝐿
𝑃𝑅𝐿
inherent kinetics. Similarly, the negative control by NPO and PHO (𝐶𝑁𝑃𝑂
= −0.30and 𝐶𝑃𝐻𝑂
=

−0.28), were mediated by control that each block had on m. Importantly this uncoupling
𝑃𝐻𝑂
pathway had only small negative control(𝐶𝑃𝑅𝐿
= −0.03) over mitochondrial phosphorylation,

raising the possibility that additional mild uncoupling to potentially reduce ROS production
might not be as detrimental as has been suggested by a previous44.

E.6.4. Control of ATP Consumption
Positive control over ATC was primarily evenly distributed among GTP, ATC, LAC, and
PHO, while negative control was primarily through OxPPP and GLY. The negative control by
𝐴𝑇𝐶
OxPPP(𝐶𝑂𝑥𝑃𝑃𝑃
= −0.64) was mediated by the strong negative control over G6P. Negative
𝐴𝑇𝐶
control by GLY (𝐶𝐺𝐿𝑌
= −0.45)occurred by the same means as the OxPPP. Similarly, positive
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𝐴𝑇𝐶
control by GTP (𝐶𝐺𝑇𝑃
= 0.40, ) was mainly mediated by the strong positive control over G6P.

Thus, the relative rates of G6P production and consumption together represent a primary
controller of ATP turnover. The kinetics of the ATC exerted as much control over their own
𝐴𝑇𝐶
𝐴𝑇𝐶
𝐴𝑇𝐶
consumption as did LAC and PHO (𝐶𝐴𝑇𝐶
= 0.35, 𝐶𝐿𝐴𝐶
= 0.35, 𝐶𝑃𝐻𝑂
= 0.32). The latter two

blocks exerted positive control through controlling G6P (LAC, PHO) and m (PHO). Here it is
noteworthy that, in neurons, the consumption of ATP was controlled by reactions that controlled
G6P production and consumption rather than ATP/ADP. Accordingly, a fractional change in
cytoplasmic glucose metabolism appears to affect the rate of ATP consumption in parallel by the
virtue of changes in G6P. This pattern of shared control among ATP producer on ATC was
reported in hepatocytes, however, the control of OxPPP was not considered42.

E.6.5. Control of NADPH Production
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
Positive control of the OxPPP was primarily by GTP (𝐶𝐺𝑇𝑃
= 1.21), NPO (𝐶𝑁𝑃𝑂
=
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
0.80), ATC (𝐶𝐴𝑇𝐶
= 0.76), and the NonPPP (𝐶𝑁𝑜𝑛𝑃𝑃𝑃
= 0.38).The NonPPP and GTP

primarily mediated their effects by negative control over ATP/ADP (coupled with the negative
elasticity of OxPPP to it).As expected, positive control by NPO was almost exclusively through
negatively affecting NADPH/NADP, while the ATC acted through both NADH/NAD and
NADPH/NADP. It was anticipated that the OxPPP would have strong positive control over its
own flux, but, it was the only other block besides GLY to exert negative control over itself.
However, the Monte Carlo simulation indicated that there was considerable uncertainty with this
coefficient, as 76% of the simulations yielded positive control. From this perspective, it is likely
that this coefficient is an artifact. With that in mind, negative control was exerted primarily by
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
GLY (𝐶𝐺𝐿𝑌
= −0.89), NAO (𝐶𝑁𝐴𝑂
= −0.49), and ME (𝐶𝑀𝐸
= −0.47). The negative
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control by GLY was mediated by positive control over ATP/ADP and negative control over
G6P, although the former effect dominated because of the strong negative elasticity of OxPPP to
ATP/ADP. It is worth noting that, since they compete for the same substrate, the OxPPP was
about twice as strong in negatively controlling GLY compared to negative control of the OxPPP
𝑂𝑥𝑃𝑃𝑃
by GLY. The negative control of NAO (𝐶𝑁𝐴𝑂
= −0.47) was mainly through positive control

over NADPH/NADP and ATP/ADP coupled with the negative elasticity of OxPPP to these
metabolites. Malic enzyme negatively controlled OxPPP through positively affecting
NADPH/NADP.
𝑀𝐸
𝑀𝐸
Positive control of ME was dominated by GLY (𝐶𝐺𝐿𝑌
= 1.84), ME (𝐶𝑀𝐸
= 1.34), and
𝑀𝐸
OxPPP (𝐶𝑂𝑥𝑃𝑃𝑃
= 1.25).Control by GLY and OxPPP occurred by strong negative control over

G6P and positive control over ATP/ADP ratio each of which is coupled with the strong elasticity
of ME to these metabolites. The OxPPP was expected to exert negative control through NADPH,
but this effect was much smaller than the stimulatory influence G6P and ATP/ADP had. This
positive control suggests that a change in OxPPP due to high NADPH demand (i.e. high ROS)
will stimulate ME to also produce NADPH despite the low contribution of ME to the NADPH
pool. The reactions within ME, which includes the dicarboxylate transporter and cytoplasmic
malic enzyme, intrinsically had strong control over its own flux. Negative control by LAC
𝑀𝐸
(𝐶𝐿𝐴𝐶
= −1.4) dominated and was mediated by the negative control over pyruvate (coupled with

the positive elasticity of ME to it), and the positive control over G6P (coupled with the negative
𝑀𝐸
elasticity of ME to it). The negative control of GTP over ME (𝐶𝐺𝑇𝑃
= −0.82)was because of the

positive control over G6P, and the negative control over ATP. Both NPO and PHO exerted
𝑀𝐸
𝑀𝐸
negative control over ME (𝐶𝑁𝑃𝑂
= −0.6, 𝑎𝑛𝑑 𝐶𝑃𝐻𝑂
= −0.5). The negative control by NPO was

mediated through effects on pyruvate primarily, but also through G6P and m. Note that
175

positive control by the OxPPP dominates over negative control by NPO, and NPO exerts
sufficiently large control over the OxPPP such that stimulation of the OxPPP through the NPO
due to higher ROS levels will stimulate ME via increased OxPPP flux.

E.6.6. Control of NADPH Oxidation
𝑁𝑃𝑂
𝑁𝑃𝑂
Positive control over NPO was primarily through GTP (𝐶𝐺𝑇𝑃
= 1.02), ATC (𝐶𝐴𝑇𝐶
=
𝑁𝑃𝑂
0.69), and NPO (𝐶𝑁𝑃𝑂
= 0.67). The positive control by GTP was primarily mediated by the

negative control over ATP coupled with the strong negative elasticity of NPO to ATP. Also, The
control exerted by ATP consumers was mediated through positive control of the NADH/NAD
ratio and negative control of the ATP/ADP ratio and G6P. Both GLY and OxPPP, substrate
𝑁𝑃𝑂
𝑁𝑃𝑂
producers, were negatively controlling NPO to the same extent (𝐶𝐺𝐿𝑌
= −0.65, 𝑎𝑛𝑑 𝐶𝑂𝑥𝑃𝑃𝑃
=

−0.50, respectively). Interestingly, this control pattern for both blocks was mediated by the same
mechanism including the positive effect both blocks had over ATP/ADP and their negative
effects over NADH/NAD coupled with the strong elasticity of NPO to these metabolites. Since
the OxPPP produces the substrate for NPO, it was expected to exert positive control over the
NPO, but the positive effect of providing substrate was far outweighed by the negative effects of
ATP and NADH. However, Monte Carlo analysis indicated that there was a 77% probability that
the control coefficient was positive, so as with OxPPP control over itself, there was considerable
uncertainty in the control exerted by the OxPPP over NPO. Control by ME over NPO was also
negative, again because of the positive effect it had on ATP/ADP. Thus, high cellular energy
charge appears to be the most important negative effector of NADPH consumption in healthy
neurons.
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E.6.7. Control of Non-Oxidative PPP
Since the NonPPP shares many of the same reactions with GLY, the control pattern of the
two blocks was expected to be similar, and generally this was the case, with the exception of the
positive control the NonPPP exerted over itself. Excluding the inherent control, the top four
𝑁𝑜𝑛𝑃𝑃𝑃
𝑁𝑜𝑛𝑃𝑃𝑃
positive controllers of the NonPPP were the same as for GLY (𝐶𝐺𝑇𝑃
= 1.60, 𝐶𝑁𝑃𝑂
=
𝑁𝑜𝑛𝑃𝑃𝑃
𝑁𝑜𝑛𝑃𝑃𝑃
1.55, 𝐶𝐿𝐴𝐶
= 1.32, 𝐶𝐴𝑇𝐶
= 1.04). The underlying metabolites through which these blocks

affected the NonPPP was essentially the same (see Section E.6.1). Negative control over
NonPPP

was

dominated

by

𝑁𝑜𝑛𝑃𝑃𝑃
OxPPP(𝐶𝑂𝑥𝑃𝑃𝑃
= −2.7) and

GLY

𝑁𝑜𝑛𝑃𝑃𝑃
(𝐶𝐺𝐿𝑌
= −2.35).

Interestingly, this control pattern was mediated largely by the control over, ATP/ADP and G6P.
The strong negative control by OxPPP may be surprising since the return of carbons from the
OxPPP to glycolysis has been shown to increase upon exposure of cells to an oxidant (i.e., the
pentose cycle increases). The grouping of the NonPPP to include some of the glycolytic
reactions clearly influenced the control pattern to be more similar to that of GLY, including
strong positive control by the GTP, LAC, and ATC.

E.6.8. Control of Glucose Transport and Phosphorylation
The kinetics of the reactions within GTP (GLUT transporters and hexokinase) were most
𝐺𝑇𝑃
important in positively controlling its own flux (𝐶𝐺𝑇𝑃
= 1.12). Another important positive
𝐺𝑇𝑃
controller was the ATC (𝐶𝐴𝑇𝐶
= 0.82) which occurred through influencing NADH/NAD,

G6P,NADPH/NADP, and ATP/ADP. This indicates that the rate of ATP consumption is an
important controller of glucose uptake, consistent with the use of labeled glucose analogues to
assess regional brain metabolism. NADPH consumption by the NPO also exerted notable
𝐺𝑇𝑃
positive control (𝐶𝑁𝑃𝑂
= 0.55) through negatively affecting the NADPH/NADP ratio coupled
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with the negative elasticity of the GTP to this metabolite. Thus, oxidative stress can also
contribute significantly to regional changes in glucose uptake.Interestingly, the control of the
𝐺𝑇𝑃
G6P consumer, GLY, was (𝐶𝐺𝐿𝑌
= -0.13) was less than that of the other G6P consumer, OxPPP,
𝐺𝑇𝑃
(𝐶𝑂𝑥𝑃𝑃𝑃
= −0.50) because the negative effects of ATP and NADH production were largely

balanced by the positive effect of G6P consumption, whereas for the OxPPP the negative effect
through NADPH consumption and ATP dominated over the positive effect through G6P. This
indicates that the process of glucose phosphorylation and transportation is more sensitive to
changes in OxPPP rather than changes in GLY. Similar to the OxPPP, ME exerted negative
𝐺𝑇𝑃
control (𝐶𝑀𝐸
= −0.37) through both positively affecting NADPH/NADP and ATP/ADP. The
𝐺𝑇𝑃
PHO also exerted some negative control (𝐶𝑃𝐻𝑂
= −0.15) through effecting G6P positively and

NADH negatively.
These data provide a quantitative description of the control pattern establishing the
steady-state rate of glucose and mitochondrial metabolism in healthy neurons, and can be used as
a reference to determine the change in neuronal metabolic behavior under any condition (i.e.
stress, hormone, and apoptosis).
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Table 10-C.Flux control coefficients for fluxes over one another. Blocks are; glucose uptake and phosphorylation (GTP), pyruvate oxidation (PYR),
lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidativephase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). Metabolites
are glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial membrane potential (∆Ѱ m), ATP/ADP, and NADPH/NADP. Subscripts
denote the percent of Mote Carlo simulated values that have an opposite sign to the values obtained. Values without subscript were assumed to be
constant values. Between parenthesis is the range of 90% confidence interval of the simulated values

F. Metabolic targets of apoptotic signaling
Trophic factor deprivation (i.e., low K) has previously been shown to acutely decrease
mitochondrial respiration rate8, indicating that one or more reactions within the energy
metabolism model shown in Fig. 1 are targeted by low K. However, the extent to which the
reaction blocks are perturbed has yet to be determined. Thus, the first goal was to re-measure all
reaction fluxes for CGNs in low K. A second, and more informative goal was to use metabolic
control analysis to partition each measured change in flux into that caused by altered reaction
kinetics (e.g. a change in kcator Km) and that caused by perturbation of the metabolites. The latter,
metabolite-mediated effects are unimportant for understanding how apoptosis targets
metabolism, but are nonetheless essential for quantifying the direct effects on the blocks so that
the most important targets can be identified. This approach allowed testing of the hypothesis that
direct kinetic inhibition of the ATP consumer block is the most important change perturbing the
steady-state catabolism of glucose, with the remaining blocks changing primarily as a result of
changes in the explicit metabolites. This hypothesis is based on the observation that low K
decreases plasma membrane Ca2+ cycling via closure of Ca2+ channels, and so should decrease
overall cellular ATP consumption. This analysis additionally serves as a starting point for future
investigations into the molecular mechanisms underlying the kinetic changes.
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F.1. Reaction block fluxes and metabolite levels in apoptotic neurons
The steady-state variables (fluxes and metabolite levels) were measured in apoptotic
neurons (Tables 11&12). Although OxPPP flux decreased (IR = -0.20), there was a small but
significant increase influx relative to the rate of glucose uptake (i.e., OxPPP/GTP; 89.40.7% in
low K vs 87.30.3% in high K), indicating a greater proportion of glucose consumed was used
for NADPH synthesis. While there was a slight decrease in NonPPP flux (IR = -0.06), there was
a significant increase in the fraction of pentose phosphates produced by the OxPPP that was
returned to glycolysis (i.e., [2/3*NonPPP]/OxPPP; 51.42.9% in low K vs 47.21.3% in high
K). The fraction of glucose consumed by the pentose cycle relative to the rate of glucose uptake
also increased (22.91.1% in low K vs 20.60.5% in high K). Relatively less glucose was used
for nucleotide biosynthesis (16.04.1% in low Kvs 17.71.8% in high K).The reported higher
ROS during early apoptotic stages may explain the relative activation of the PPP reactions which
act to maintain cellular redox status26,45,46 but clearly other factors must be superimposed with
this to cause a decrease in the absolute flux.
While GLY flux modestly decreased in low K (IR = -0.10), the fraction of glucose
consumed that was catabolized through GLY increased slightly (56.62.9% in low K vs.
53.51.3% in high K). Since lactate excretion was essentially unchanged in low K (IR = 0.04)
while mitochondrial pyruvate oxidation decreased significantly (IR = -0.37), there was a
significant increase in the proportion of pyruvate reduced to lactate (81.91.1% in low K vs
74.90.7% in high K) indicating that apoptotic neurons became more glycolytic than healthy
neurons. Consequently, a greater percentage of ATP used by neurons in low K was derived from
glycolysis (35.01.3% in low K vs 22.80.5% in high K); this increase was slightly greater when
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the ATP derived from the NonPPP was also included (44.01.7% in low K vs. 28.70.6% in
high K).

Table11-C. Measured and calculated fluxes in apoptotic neurons (low K). Blocks are; glucose uptake
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation
(NAO), mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidativephase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP
(NonPPP), and malic enzyme (ME). Data of high K CGNs are mean in plom/min *10 6 ± SEM
(n=23). Data of low K CGNs are mean of normalized values to control ± SEM (n=7)
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This also meant that the contribution of mitochondria to ATP production decreased (49.91.6%
in low Kvs 65.80.5% in high K). It is also important to point out that ATP consumer activity
decreased to 54.54.9% of the high K rate, as predicted from the decrease [Ca2+]c in low K. The
decrease in cellular ATP consumption in low K is predicted to have a substantial impact on
decreasing overall glucose catabolism, and this may partly explain the decrease in GLY, OxPPP,
NonPPP, PHO, PYR, and NAO fluxes. Metabolic control analysis was used to determine the
importance of the decreased ATP consumption to the overall measured flux changes.

Table 12-C. Measured concentrations of metabolites in apoptotic neurons (low K). Metabolites are;
glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial membrane potential (∆Ѱ m),
ATP/ADP, and NADPH/NADP. Data of high K CGNs are mean ± SEM (19≤n≤23). Data of low K CGNs
are mean of normalized values to control ± SEM (6≤n≤11)
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F.2. Direct targets of apoptotic signaling: Integrated elasticity analysis
The equation below was used to quantitate the extent to which low K caused direct
kinetic changes to each of the blocks. Such changes are referred to as „integrated elasticities‟
because they reflect the change in activity of a reaction (i.e., this is an enzymatic property, not a
system property) caused by a step change in a parameter19 (in this case the step change from high
to low K) rather than an infinitesimally small change (see Chapter 2, Section F.2.).
𝑏𝑙𝑜𝑐𝑘
𝐼𝐸𝑙𝑜𝑤
𝐾 =

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

−

𝑛
𝑏𝑙𝑜𝑐𝑘
𝑖=1 𝜀𝑥𝑖

∙

∆𝑥 𝑖

(16)

𝑥𝑖

The summation term is the expected change in activity due to metabolite (xi) changes, where n=
the number of explicit metabolites and 𝜀𝑥𝑏𝑙𝑜𝑐𝑘
are elasticities determined in healthy CGNs. The
𝑖
measured fractional flux change of any block

∆𝐽 𝑏𝑙𝑜𝑐𝑘
𝐽 𝑏𝑙𝑜𝑐𝑘

induced by trophic factor deprivation (low

𝐽
K) is referred to as the integrated response of the block to low K (𝐼𝑅𝑙𝑜𝑤
𝐾 ). The change in block

activity due to each of the metabolites is referred to as the partial integrated responses mediated
by each of the fractional changes in the metabolites (these are the individual terms of the
𝐽
summation portion of Eq. 11, and each is denoted as 𝑥 𝐼 𝑅𝑙𝑜𝑤
𝐾 ; see Table 13).Thus, when viewed

in isolation, a step change in trophic factor support perturbs the activity of a block by directly
affecting its kinetics and/or the levels of the explicit metabolites to which the block responds;
quantification of both effects provides an understanding of the importance of each effect for any
block in the system and also highlights which blocks are most strongly targeted by the loss of
trophic factor support. One of the main observations from this analysis was that the ATP
consumer block was directly inhibited, as expected, but cannot account for all of the remaining
flux changes because many blocks exhibited direct kinetic changes. A second main observation
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was that low K targeted kinetic activation of glycolytic ATP synthesis and inhibition of
mitochondrial ATP synthesis.
F.2.1.Kinetic effect on the ATP consumers
𝐴𝑇𝐶
The integrated elasticity (IE) of the ATC to low K (𝐼𝐸𝑙𝑜𝑤
𝐾 =-0.47) was sufficiently large
𝐴𝑇𝐶
to fully account for the measured response (𝐼𝑅𝑙𝑜𝑤
𝐾 = -0.47). However, without taking into

account the control the ATC has over its own flux, it is premature to conclude that the direct
kinetic change by low K entirely explained the decrease in ATP consumption. On the other hand,
and according to our initial hypothesis, this significant direct inhibition was expected, at least in
part, because of the effect low K has on [Ca2+]c8,47.The high K media that promotes CGN
survival maintains the plasma membrane potential (p) in a relatively depolarized state (≈ -35
mV) which promotes opening of voltage-gated L-type Ca2+ channels and Ca2+influx47. As a
consequence, plasma membrane Ca2+-ATPase activity, and thus ATP consumer activity, is
relatively high. Conversely, neurons in low K media are hyperpolarized (p  -75 mV), a
condition that results in closure of voltage-gated L-type Ca2+ channels (Fig. 6). Low [Ca2+]c
reduces Ca2+-ATPase activity and so lowers overall ATC activity. Since [Ca2+]c was not included
as an explicitly metabolite, the decrease in [Ca2+]c from high to low K would manifest as a direct
kinetic change to the ATC.
F.2.2. Kinetic effect on the NADPH consumers
𝑁𝑃𝑂
Low K resulted in decreased NADPH consumption (𝐼𝑅𝑙𝑜𝑤𝐾
= -0.17) despite direct
𝑁𝑃𝑂
kinetic activation by low K (𝐼𝐸𝑙𝑜𝑤𝐾
= 0.31), indicating that the changes in the metabolites

(primarily

ATP /ADP

𝑁𝑃𝑂
𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.38, 𝑎𝑛𝑑

NADH /NAD

𝑁𝑃𝑂
𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.17) which tend to decrease

activity were stronger than the direct stimulation of NPO activity. Despite the decrease in flux,
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CGNs in low K consumed more NADPH relative to the rate of glucose consumed (NPO/GTP =
2.000.00 in low K vs 1.920.00 in high K) or mitochondrial oxygen (NPO/Mito RR =
1.3570.135 vs. 0.9680.087 low vs. high K) used. The kinetic stimulation is consistent with
increased ROS levels tending to increase NADPH consumption via glutathione reductase and
thioredoxin reductase, but is counteracted by the negative effects of the metabolite changes on
these (and perhaps other) NADPH consumers. Thus, despite the established higher ROS in early
stage apoptotic neurons, the lower NADPH consumption indicates that the NADPH-dependent
antioxidant defenses were relatively restrained by the changes to the explicit metabolites.
Here it should be noted that the measurement of flux in high and low K would lead to the
conclusion that this block was not activated, but the MCA allowed the overall response to be
partitioned, which showed kinetic activation despite overall decrease in flux.
F.2.3.Kinetic effects on the pentose cycle and malic enzyme
𝑂𝑥𝑃𝑃𝑃
Despite the lower measured fluxes for OxPPP and NonPPP (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.20, and
𝑁𝑜𝑛𝑂 𝑥𝑃𝑃𝑃
𝐼𝑅𝑙𝑜𝑤
= −0.06), the ratio of OxPPP to glucose uptake only marginally increased in low K
𝐾

(OxPPP/GTP= 0.894 vs 0.873in low vs high K). Also, the rate of pentose phosphate returned to
GLY by NonPPP is higher (NonPPP/GTP = 0.679 vs. 0.582 low vs high K), so the relative rate
of G6P use by the pentose cycle is greater (PC/GTP = 0.226 vs. 0.206low vs high K).
Furthermore, both PPP blocks (OxPPP and NonPPP) were kinetically stimulated in response to
𝑂𝑥𝑃𝑃𝑃
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
the apoptotic stimulus (𝐼𝐸𝑙𝑜𝑤
= 0.89) . Such kinetic activation
𝐾 = 0.56, 𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤 𝐾

suggests stimulation of one or more enzymes within these blocks (i.e. G6P dehydrogenase, and
NonPPP transaldolase/transketolase) by apoptotic stimulus. This kinetic stimulation is
superimposed by inhibition mediated by the indirect effects of changed metabolites including
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𝑂𝑥𝑃𝑃𝑃
ATP/ADP, NADH/NAD, and NADPH/NADP (ATP/ADP𝐼𝑅𝑙𝑜𝑤
𝐾 =-0.35,

0.21, and

NADH/NAD

NADPH/NADP

𝑂𝑥𝑃𝑃𝑃
𝐼𝑅𝑙𝑜𝑤
𝐾 =-

𝑂𝑥𝑃𝑃𝑃
𝐼𝑅𝑙𝑜𝑤
𝐾 =-0.19). The kinetic stimulation of NonPPP by low K was closely

balanced by inhibition due to the changed metabolites including ATP/ADP and NADH/NAD
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
(ATP/ADP𝐼𝑅𝑙𝑜𝑤
=-0.46, and
𝐾

NADH/NAD

𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
𝐼𝑅𝑙𝑜𝑤
= −0.33) such that there was little change
𝐾

𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
in the measured NonPPP flux (𝐼𝑅𝑙𝑜𝑤
= −0.06). This result is consistent with the reported
𝐾

over expression of transaldolase enzymes in response to HIV induced oxidative stress and cell
death in two human CD4b and T cell lines48, although the time course of the current experiments
likely preclude changes in gene expression as a major underlying cause of the kinetic changes.
The kinetic stimulation of OxPPP and NonPPP blocks is a strategy by stressed cells to protect
against ROS and oxidative damage, which may be critical to prevent mitochondrial outer
membrane permeabilization (MOMP), cytochrome c release, and caspase activation

26

. This

suggests that the kinetic stimulation of OxPPP and NonPPP blocks is an upstream event to
MOMP, cytochrome c release, and caspase activation. In neurons, NO, a highly active ROS,
activates glucose-6-phosphate dehydrogenase (G6PDH) which is a primary controller of G6P
oxidation through the OxPPP49.Apoptotic CGNs are characterized by high ROS45,46 that is
required for induction of oxidative stress-mediated cell death. This ROS level may be the
threshold level that can be reached by neurons whose PPP cannot activated to the level necessary
for redox-status maintenance.
𝑀𝐸
The measured flux of ME was increased (𝐼𝑅𝑙𝑜𝑤

𝐾

= 0.12) and exceeded the total kinetic

𝑀𝐸
inhibition due to low K (𝐼𝐸𝑙𝑜𝑤
𝐾 = −0.54). The measured increased activity is a consequence of
𝑀𝐸
the changes in metabolites including ATP/ADP, ∆Ѱm , and pyruvate (∆Ѱm𝐼𝑅𝑙𝑜𝑤
𝐾 = 0.25,
ATP/ADP

pyruvate
𝑀𝐸
𝑀𝐸
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 =0.22, and
𝐾 = 0.16).
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F.2.4. Kinetic effects on glucose uptake, glycolysis, and lactate production
Glucose uptake/phosphorylation and glycolytic fluxes were modestly reduced in low K
𝐺𝑇𝑃
𝐺𝐿𝑌
(𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.20, 𝐼𝑅𝑙𝑜𝑤 𝐾 = −0.10) while lactate production was essentially unchanged. Low K
𝐺𝑇𝑃
𝐺𝐿𝑌
𝐿𝐴𝐶
kinetically stimulated all three blocks (𝐼𝐸𝑙𝑜𝑤
𝐾 = 0.30, 𝐼𝐸𝑙𝑜𝑤 𝐾 = 0.65, 𝐼𝐸𝑙𝑜𝑤 𝐾 = 0.90) but the

effects on glycolysis and lactate production were most significant. The metabolite changes
(primarily ATP/ADP, NADPH/NADP, and NADH/NAD) either exactly opposed (for LAC;
ATP/ADP

GTP

NADPH/NADP
NADH/NAD
𝐿𝐴𝐶
𝐿𝐴𝐶
𝐿𝐴𝐶
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.33,
𝐾 = −0.42
𝐾 = −0.33) or exceeded (for

ATP/ADP

ATP/ADP

NADPH/NADP
NADH/NAD
𝐺𝑇𝑃
𝐺𝑇𝑃
𝐺𝑇𝑃
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.19,
𝐾 = −0.15
𝐾 = −0.18 and GLY

NADPH/NADP
𝐺𝐿𝑌
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.38,

NADH/NAD
𝐺𝐿𝑌
𝐺𝐿𝑌
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.16
𝐾 = −0.33)

the

kinetic

effects. This direct kinetic activation by low K, however, cannot explain the observed high
ATP/ADP level especially in case of limited ATP supply due to early mitochondrial
dysfunction50,51. The high cellular ATP/ADP is at least partly a consequence of the decrease in
ATC flux, but may also be an attempt by apoptotic cell to maintain ATP which is important for
apoptosis to proceed50,52. These findings are consistent with the idea that a threshold level of
ATP is essential for cells to die through apoptosis not necrosis51,52. This threshold level of ATP
is essential for the activity of the pro-apoptotic proteins. One of the most ATP-dependent
enzymes in apoptotic neurons are the proteolytic caspase enzymes that are recruited in the final
executioner phase of apoptosis. In trophic factor-deprived cerebellar granule neurons, caspases
are activated in a time frame between 2-4 hrs without substantial loss of cells53,54. This means
that the glycolytic ATP switch (initiated after 2hr of apoptotic stimuli) either coincides or
precedes caspases activation52. These data indicate that early-stage apoptotic neurons become
increasingly dependent on glycolytic-derived ATP to execute apoptosis as less ATP is
synthesized by mitochondria52.
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Kinetic activation of glycolytic enzymes (e.g. phosphofructokinase-1) in low K is
intriguing, as this pathway is typically thought to be inhibited by trophic factor deprivation. A
possible mechanism for this kinetic effect could involve the p53-induced glycolysis and
apoptosis regulator (TIGAR)

55

. Activation of TIGAR promotes resistance to apoptosis and

inhibition of glycolysis (the latter effect via decreasing F-2,6-bisphosphate, a potent activator of
PFK-1). Accordingly, the inhibition of TIGAR is expected to promote activation of glycolysis
through increasing F-2,6-P2, which, in neurons exposed to low K, is opposed by the changed
metabolites. But this would not explain the IE to LAC block.The findings that apoptosis can be
triggered in different cell lines lacking functional mitochondria was somewhat paradoxical given
the ATP requirement for apoptosis

56,57

. On the other hand, anaerobic glycolysis with lactate

production was found to promote survival of striated muscles under condition of suppressed
mitochondrial ATP synthesis58. Such a puzzle cannot be solved without understanding the
metabolic behavior in healthy cells and to what extent mitochondrial phosphorylation and
glycolysis are coordinately affected during apoptosis.
F.2.5. Kinetic effects on m producers (PYR and NAO)
𝑃𝑌𝑅
There was little kinetic effect of low K on PYR (𝐼𝐸𝑙𝑜𝑤
𝐾 = 0.05) whereas NAO was
𝑁𝐴𝑂
kinetically stimulated (𝐼𝐸𝑙𝑜𝑤
𝐾 = 0.74). Despite the activation, the measured flux was

significantly reduced (𝐼𝑅𝑁𝐴𝑂
𝑙𝑜𝑤 𝐾 = −0.78) due to changes in metabolites including ATP/ADP,
𝑁𝐴𝑂
m, and pyruvate (ATP/ADP𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.44,

m

𝑁𝐴𝑂
𝐼𝑅𝑙𝑜𝑤
𝐾 = −1.2,

pyruvate

𝑁𝐴𝑂
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.17). The

lack of effect on PYR suggests that the respiratory chain (commonly shared by NAO and PYR)
is not included in the kinetic changes due to low K. Kinetic stimulation of NAO may therefore be
through the shuttle reactions (e.g., malate-aspartate shuttle) transferring NADH into the matrix.
Alternatively, a possible kinetic activation in respiratory chain that could activate NADH
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oxidation may not activate PYR because the activation is counteracted by kinetic inhibition in
the citric acid cycle. This conclusion is supported by the finding that pyruvate dehydrogenase is a
specific phosphorylation target for JNK that caused a decline in its activity in primary cortical
neurons

59

. This decline was suggested to cause a shift to anaerobic pyruvate metabolism that

involves lactate accumulation and decreased ATP production. Also, it supports the finding that
mitochondrial pyruvate carrier can repress the Warburg effect and colon cancer cell growth 60.
Irrespective of the mechanism, kinetic inhibition of NAO only accounted for 18% of the
decrease in respiration rate, as pyruvate oxidation was responsible for 95% of the oxygen
consumed by mitochondria. In this respect, the lack of low K targeting of PYR indicates that
most of the 42% decrease in mitochondrial respiration occurred indirectly through the metabolite
changes.
F.2.6. Kinetic effects on the m consumers (PHO and PRL)
𝑃𝐻𝑂
The low K kinetic inhibition in PHO was remarkably high (𝐼𝐸𝑙𝑜𝑤
𝐾 = −1.22), however,
𝑃𝐻𝑂
the measured flux inhibition was notably lower (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.57) indicating indirect

stimulation by the changed metabolites. Notably, 100% of this stimulation was by changes in
𝑃𝐻𝑂
m (m𝐼𝑅𝑙𝑜𝑤
𝐾 = 0.87). The kinetics of proton leak to m in low K were shifted up and

more „ohmic‟ relative to that in high K (compare Fig. 4 with Fig. 3), indicating a substantial
increase in mitochondrial inner membrane proton permeability. Consequently, the proton leak
𝑃𝑅𝐿
block (PRL) was directly activated and ranked as the most affected block (𝐼𝐸𝑙𝑜𝑤
𝐾 = 1.52).
𝑃𝐻𝑂
Inhibition of PHO (𝐼𝐸𝑙𝑜𝑤
𝐾 = −1.22) and stimulation of NAO and OxPPP kinetics accounted for

about 18% of the measured increase in PRL flux because of their control over m, but the
remaining 82% was due to inherent changes in the leak through unknown mechanisms. This
analysis is based on the assumption that the leak is only affected by m and not the other
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explicit metabolites. The mechanism underlying the kinetic change may partly be explained by
the recruitment of apoptotic proteins to the mitochondria and/or to increased oxidative stress. In
trophic factor-deprived neurons, apoptosis is triggered through an intrinsic mechanism which is
characterized by the recruitment of BcL-2 family proteins to mitochondria

61,62

. Although the

mechanism through which the BcL-2 family proteins are regulated during apoptosis remains
controversial63–66, it is known that the activation of Bax and Bak leads to insertion and
oligomerization of these proteins in the mitochondrial outer membrane (MOM)66. It is unclear
how Bax/Bak insertion into the MOM might increase mitochondrial inner membrane (MIM)
proton permeability. One possibility is based on the recent finding that Bax interacts with the
MOM protein VDAC12, while VDAC interacts with the MIM adenine nucleotide translocase
(ANT) at mitochondrial contact sites. Conformational changes to the ANT have been proposed
to convert the ANT into a proton permeable pore9,10,67. Alternatively, increased leak could be
associated with oxidative stress, as different ROS have been shown to increase proton leak
through activation of one or more uncoupling proteins (e.g., UCP2, UCP3) and/or through
conformational changes to ANT9. Reactive oxygen species-mediated proton leak has been
proposed as a negative feedback mechanism to decrease mitochondrial ROS production, and thus
could indicate that the uncoupling is an antioxidant mechanism involved to protect the neuron
from oxidative stress. Note that, if the ANT is affected to function as a H+ carrier rather than
adenine nucleotide carrier, this could also partly explain the large kinetic inhibition of PHO, as
impaired ATP/ADP transport across the MIM would be a substantial impediment to ATP
synthesis. One consequence of the increased leak is reduced efficiency of mitochondrial ATP
synthesis (i.e., lower ATP/O ratio).It can be calculated that, given the rate of respiration in low
K,the observed kinetic stimulation of the leak resulted in a 20% decrease in ATP synthesis by
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Table 13-C.Integrated elasticity (IE) representing extent of kinetic change in metabolic fluxes due to low K stimulus. Blocks are; glucose uptake
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation (PHO),
proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), nonoxidative PPP (NonPPP), and malic enzyme (ME). Metabolites are glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial
membrane potential (∆Ѱm), ATP/ADP, and NADPH/NADP. Subscripts denote the percent of Mote Carlo simulated values that have an opposite
sign to the values obtained. Between parenthesis is the range of 90% confidence interval of the simulated values. The indirect changes in each flux
due to changes in explicit metabolites denoted as integrated response (IR).

PHO. If uncoupling functions to reduce ROS, activation of the leak can be viewed as
anti-apoptotic since relatively high ROS are known to induce apoptosis. On the other hand, if
uncoupling is related to Bax activation/insertion into the MOM, it could have a role in
facilitating apoptosis.
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G. System interactions underlying the flux changes triggered by low K: the
partial integrated responses mediated by each of the blocks
When the kinetics of a block (block 1) have been directly affected by low K, this will
perturb flux through another block (block 2) by virtue of the control that block 1 exerts on block
2 (through effects on the metabolite levels). This is known as the partial integrated response of
block 2 to trophic factor deprivation (low K) mediated by kinetic changes in block1
𝑏𝑙𝑜𝑐𝑘 1

𝑏𝑙𝑜𝑐𝑘 2
𝑏𝑙𝑜𝑐𝑘 2
𝑏𝑙𝑜𝑐𝑘 1
𝐼𝑅𝑙𝑜𝑤
𝐾 = 𝐶𝑏𝑙𝑜𝑐𝑘 1 ∙ 𝐼𝐸𝑙𝑜𝑤 𝐾

block1

2
IRblock
q

(12)

The partial integrated response (Table 14) is a system measure of the extent to which
block 2 flux is changed due to the direct kinetic changes in activity ofblock1 by low K because
𝑏𝑙𝑜𝑐𝑘 2
the strength of the effect depends on the control pattern of the system(i.e., 𝐶𝑏𝑙𝑜𝑐𝑘
1 ,the control

that block1 exerts on block 2;see Table 10). These partial integrated responses indicate how
important kinetic changes to each block in the system are to changing flux through a block of
interest.
G.1.System effect on the ATP consumers
Direct kinetic inhibition of the ATC only accounted for 36% of the decrease in flux
𝐴𝑇𝐶
because of the relatively low control the ATC exerted over its own flux ( 𝐴𝑇𝐶 𝐼 𝑅𝑙𝑜𝑤
𝐾 = −0.17).

Thus, intrinsic changes to the kinetics of the reactions within the ATC (e.g., reduced ATP
consumption as a result of lower Ca2+ cycling) cannot fully explain the reduced ATP
consumption. The effect of other blocks on ATC (Figure 7-C) due to kinetic changes in response
to low K coupled with their control over ATC accounted for the remaining 64% of the flux
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decrease (Table 14-C). One of the major targets of low K that affected the ATC was PHO
𝐴𝑇𝐶
( 𝑃𝐻𝑂 𝐼 𝑅𝑙𝑜𝑤
𝐾 = −0.39) which exerted 81% of the net change in flux. This high negative response

𝑃𝐻𝑂
of ATC to PHO was due to its strong kinetic inhibition(𝐼𝐸𝑙𝑜𝑤
𝐾 = −1.2) in response to trophic
𝐴𝑇𝐶
factor deprivation. The inhibition of ATC by OxPPP ( 𝑂𝑥𝑃𝑃𝑃 𝐼 𝑅𝑙𝑜𝑤
𝐾 = −0.30) and GLY

𝑂𝑥𝑃𝑃𝑃
𝐴𝑇𝐶
( 𝐺𝐿𝑌 𝐼 𝑅𝑙𝑜𝑤
𝐾 = −0.29)was mediated by the relatively high kinetic activation by low K (𝐼𝐸𝑙𝑜𝑤 𝐾 =
𝐺𝐿𝑌
0.56, 𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤
𝐾 = 0.65) coupled with the relatively high control of both blocks over ATC.

Note that most of these effects were mediated through G6P, one of the main stimulators of ATC.
Unexpectedly,

and

despite

the

high

kinetic

change

in

PRL

and

ME

𝑃𝑅𝐿
𝑀𝐸
(𝐼𝐸𝑙𝑜𝑤
𝐾 = 1.52, 𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤 𝐾 = −0.54), PRL and ME effect on ATC was minimal due to the

very low control of each block over ATC.
G.2. System effect on the NADPH consumers
𝑁𝑃𝑂
The inhibition of NPO flux (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.17) was most strongly influenced by low K
𝑁𝑃𝑂
𝑁𝑃𝑂
𝑁𝑃𝑂
targeting of GLY ( GLY 𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.42), ATC ( ATC 𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.33), NAO ( NAO 𝐼 𝑅𝑙𝑜𝑤𝐾
=
𝑁𝑃𝑂
−0.31), and OxPPP ( OxPPP 𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.28) mediated primarily through ATP (for GLY, NAO,

and OxPPP) and NADH (for ATC).These inhibitory effects were offset by the stimulation by
other

low

K

targeted

blocks

(Figure

8-C)

including

𝑁𝑃𝑂
NonPPP( NonPPP 𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.30), NPO (over its own flux,

NPO

GTP

𝑁𝑃𝑂
( GTP 𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.31),

𝑁𝑃𝑂
𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.21) coupled with the

control each block exerted over NPO. Most of these stimulatory effects were mediated by effects
on ATP/ADP level. Note thatdirect kinetic activation of the NPO (possibly because of higher
ROS) only accounted for 18%of the combined stimulatory effects of those blocks which
stimulated NPO, indicating the system effects through other blocks were more important.
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G3. System effects on the pentose cycle and malic enzyme
𝑂𝑥𝑃𝑃𝑃
The decrease in OxPPP (Figure 9-C) and NonPPP(Figure 10-C) (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.20, and
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
𝐼𝑅𝑙𝑜𝑤
= −0.06) were largely exerted by the inhibitory effect of GLY (GLY𝐼𝑅𝑙𝑜𝑤𝐾
=
𝐾
𝐺𝐿𝑌
−0.58) because of glycolytic stimulation (𝐼𝐸𝑙𝑜𝑤𝐾
= 0.65) coupled with its strong negative

control over OxPPP. Other inhibitory effects resulted from the control exerted by OxPPP
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃
(OxPPP𝐼𝑅𝑙𝑜𝑤𝐾
= −0.37), NAO (NAO𝐼𝑅𝑙𝑜𝑤𝐾
= −0.36), and ATC (ATC𝐼𝑅𝑙𝑜𝑤𝐾
= −0.35) over

OxPPP coupled with the low K kinetic change. The inhibitory effect due to kinetic stimulation of
the OxPPP is suspect because of the large uncertainty associated with the negative control this
block had over its own flux. Although the measured decrease in NonPPP was relatively low
𝑁𝑜𝑛𝑃𝑃𝑃
𝑁𝑜𝑛𝑃𝑃𝑃
(𝐼𝑅𝑙𝑜𝑤
= −0.06), the inhibitory effect through GLY (GLY𝐼𝑅𝑙𝑜𝑤𝐾
= −1.52) and OxPPP
𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
(OxPPP𝐼𝑅𝑙𝑜𝑤𝐾
= −1.50) dominated. This is because of the very high control these blocks had

over NonPPP flux. However, the large negative effect exerted by the OxPPP is suspect, as Monte
Carlo analysis indicated that 77% of the simulated partial integrated responses through the
OxPPP were positive, which makes more sense in light of a number of studies showing that the
pentose cycle increases with increasing oxidative stress (i.e., stimulation of the OxPPP by
increased NADPH consumption increases flux through the NonPPP).
𝑀𝐸
The other NADPH producer, ME, was activated (𝐼𝑅𝑙𝑜𝑤𝐾
= 0.12) by low K and the major
𝑀𝐸
targets contributing to this stimulation were OxPPP, GLY, and PHO (OxPPP𝐼𝑅𝑙𝑜𝑤
𝐾 = 0.71,
GLY

𝑀𝐸
𝐼𝑅𝑙𝑜𝑤
𝐾 =1.19, and

PHO

𝑀𝐸
𝐼𝑅𝑙𝑜𝑤
𝐾 0.61) (Figure 11-C). Much of the stimulatory effect was offset

𝑀𝐸
by inhibition through targeting LAC, ME, and GTP (LAC𝐼𝑅𝑙𝑜𝑤
GTP

𝐾

= -1.26,

ME

𝑀𝐸
𝐼𝑅𝑙𝑜𝑤

𝐾

=-0.72, and

𝑀𝐸
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.24). Thus, despite substantial direct kinetic inhibition of ME, kinetic effects

on GLY and OxPPP mediated primarily through G6P were major factors increasing ME flux.
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G.4. System effects on glucose uptake, glycolysis, and lactate production
The decrease in GTP flux (IR = -0.20) largely resulted from low K targeting of ATC
𝑁𝐴𝑂
𝐺𝑇𝑃
𝐺𝑇𝑃
𝐺𝑇𝑃
( 𝐴𝑇𝐶 𝐼 𝑅𝑙𝑜𝑤
𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.32), and OxPPP ( 𝑂𝑥𝑃𝑃𝑃 𝐼 𝑅𝑙𝑜𝑤𝐾
= −0.27). These
𝐾 = −0.39), NAO (

effects (Figure 12-C) were primarily mediated through effects on ATP/ADP and NADH/NAD.
About 75% of these inhibitory effects were offset by stimulatory effects from low K targeting
𝐺𝑇𝑃
𝐺𝑇𝑃
𝐺𝑇𝑃
GTP ( 𝐺𝑇𝑃 𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.33), ME (𝑀𝐸 𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.20) and PHO ( 𝑃𝐻𝑂 𝐼 𝑅𝑙𝑜𝑤𝐾
= 0.19), leaving a

modest, but significant, overall decrease in glucose uptake/phosphorylation.
𝐺𝐿𝑌
Glycolytic flux was mildly reduced in low K (𝐼𝑅𝑙𝑜𝑤
𝐾 =-0.10) primarily because of direct
NAO
𝐺𝐿𝑌
𝐺𝐿𝑌
kinetic stimulation of OxPPP(OxPPP𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = -1.06) and NAO (
𝐾 = -0.24) and inhibition

𝐺𝐿𝑌
𝑂𝑥𝑃𝑃𝑃
of ATC (ATC𝐼𝑅𝑙𝑜𝑤
𝐾 = -0.50) (Figure 13-C). Kinetic stimulation of the OxPPP (𝐼𝐸𝑙𝑜𝑤 𝐾 =

0.56)dominated because of its substantial negative control over glycolysis, which was a function
of its negative control over G6P and positive control over ATP. Kinetic stimulation of glycolysis
𝐺𝐿𝑌
also contributed (GLY𝐼𝑅𝑙𝑜𝑤
𝐾 = -0.39) because of the negative control it had over its own flux

(which was a function of the control over G6P and ATP/ADP, coupled with the elasticities to
these metabolites). Given its central position in the system, it is not surprising that a number of
blocks targeted by low K (LAC, GTP, NPO, NonPPP, ME, and PHO) contributed to
counteracting much of this inhibition, mostly through effects on ATP, G6P, and pyruvate. The
NADPH consumer block was a notable exception, as its positive influence on glycolysis (partial
IR = 0.29) was mediated through negatively affecting NADPH/NADP.
The rate of lactate production and transportation was essentially unchanged
𝐿𝐴𝐶
(𝐼𝑅𝑙𝑜𝑤
𝐾 =0.04) (Figure 14-C). This is due to the strong control that many blocks within the

system had on LAC (OxPPP, ATC, LAC, GTP, GLY, PHO, NPO, NAO). The kinetic
stimulation of OxPPP, GLY, and NAO in response to low K contribute largely to inhibitory
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𝐿𝐴𝐶
effects on LAC (OxPPP𝐼𝑅𝑙𝑜𝑤
𝐾 = −1.25,

GLY

𝐿𝐴𝐶
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.49,

NAO

𝐿𝐴𝐶
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.57). This

LAC
𝐿𝐴𝐶
𝐿𝐴𝐶
inhibition was offset by the stimulatory effect of GTP(GTP𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = 0.44), LAC (
𝐾 =
NonPPP
NPO
𝐿𝐴𝐶
𝐿𝐴𝐶
𝐿𝐴𝐶
0.66) , PHO (PHO𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = 0.44), NonPPP (
𝐾 = 0.44), and NPO (
𝐾 =

0.37) being kinetically changed due to low K coupled with their significant control over LAC.
These effects of the kinetically changed fluxes were mediated by the strong control each flux had
on LAC coupled with the elasticity of LAC to NADH/NAD, NADPH/NADP, ATP/ADP.
G.5. System effects on m producers (PYR and NAO)
𝑃𝑌𝑅
The flux of PYR decreased (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.37) despite no direct effects of low K on
𝑁𝐴𝑂
𝑃𝑌𝑅
PYR(𝐼𝐸𝑙𝑜𝑤
𝐾 = 0.05). On the other hand, low K caused kinetic stimulation to NAO (𝐼𝐸𝑙𝑜𝑤 𝐾 =
𝑁𝐴𝑂
0.74) despite the significant reduction in flux (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.78) (Figures 15-C and 16-C). The

flux inhibition of NAO and PYR was largely affected by the low K kinetic changes of PHO
PHO
𝑁𝐴𝑂
𝑃𝑌𝑅
(PHO𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −1.25,
𝐾 = −0.38). This influence of PHO on PYR and NAO fluxes

was mainly due to the high control that PHO has on PYR coupled with their strong negative
elasticity to ∆Ѱm. Interestingly, the contribution of other blocks to PYR inhibition was minimal
due to low control each block exerted over PYR. An important finding was that GLY had
essentially no control over pyruvate oxidation by PYR despite the fact that GLY supplied 74% of
the pyruvate for use by mitochondria; this implies that pyruvate supply to mitochondria was not
𝑁𝐴𝑂
important to affecting mitochondrial function. The low K stimulation of GLY ( GLY𝐼𝑅𝑙𝑜𝑤
𝐾 =
𝑁𝐴𝑂
−1.06) and OxPPP (OxPPP𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.43) also contributes to the flux inhibition of NAO due to

the control each flux had on NAO coupled with the strong elasticity to ATP/ADP.
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G.6. System effects on the m consumers (PHO and PRL)
According to the assumption that the leak is not affected by any explicit metabolite
except m, the system effects(discussed in Section F.2.6.) to m were the only indirect
changes in PRL (Figure 17-C).Due to the relatively high control of PHO on its own flux, the low
PHO
𝑃𝐻𝑂
𝑃𝐻𝑂
K kinetic inhibition in PHO (𝐼𝐸𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −1.22)accounted for about 90% (
𝐾 = −0.52)of

𝑃𝐻𝑂
the measured flux inhibition (𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.57) (Figure18-C). The remainder was due to the low

kinetic

stimulation

of

GLY

NPO
𝑃𝐻𝑂
𝑃𝐻𝑂
PRL(PRL𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.05),NPO(
𝐾 = −0.06),

𝑃𝐻𝑂
(GLY𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.12),

and the kinetic inhibition of ME

ATC
𝑃𝐻𝑂
𝑃𝐻𝑂
(ME𝐼𝑅𝑙𝑜𝑤
𝐼𝑅𝑙𝑜𝑤
𝐾 = −0.06), and ATC(
𝐾 = −0.07).

From our findings, we can propose a mechanism (Figure 19-C) of apoptotic stimuli that
drive the observed changes in glucose metabolism. Our initial hypothesis was that decreased
ATP turnover may bring about all other metabolic changes in apoptotic neurons. However, this
change in ATC cannot account for the entire flux change in PHO, PYR, NAO, GLY blocks.
Clearly, application of MCA made it easy to quantify the effect of ATC kinetic changes on each
flux (by the virtue of control of ATC over each block) and to differentiate this from the kinetic
changes due to low K stimulation. Our results confirmed kinetic changes in most of the system
blocks including PRL, GLY PHO, OxPPP. These changes cannot rendered to the initial change
in ATC but rather to kinetic change in enzymes of each block in response to low K stimulus.
These findings didn't prove our initial hypotheses, but implying a directly targeted metabolic
reactions by apoptotic stimulus.
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H. Proposed apoptotic pathway including metabolic direct targets
From our findings, we can propose a mechanism (Figure 19-C) of apoptotic stimuli that
drive the observed changes in glucose metabolism. Our initial hypothesis was that decreased
ATP turnover may bring about all other metabolic changes in apoptotic neurons. However, and
despite the observed kinetic inhibition in ATC, this kinetic change cannot explain the other
kinetic changes in GLY, GTP, PHO, OxPPP, and PRL blocks.
Interestingly, the inhibitory effect that this kinetic change in ATC had on the modest
strong stimulation in PRL was minimal. These findings didn't prove our initial hypotheses, but
implying a directly targeted metabolic reactions by apoptotic stimulus.
Trophic factor deprivation-mediated apoptosis in CGNs is suggested to recruit different
signaling pathways. One of these pathways is Akt/PI3K which is inactivated in response to
trophic factor deprivation leading to activation of pro-apoptotic BcL-2 family proteins specially
Bax and Bak and insertion of these proteins in the MOM68,69. Activation of Bax and Bak and a
consequent insertion into MOM may increase MIM proton permeability, however, the
underlying mechanism remains unclear. Nevertheless, the finding that Bax interacts with VDAC
which is in turn interacts with ANT of MIM12 as well as the proposed conformational changes of
ANT to a proton permeable pore may explain the mechanism of induced proton
permeability9,10,67.
Elevated ROS provide another way for apoptotic signal to proceed. This pathway
involves activation of pentose phosphate pathway (PPP) in neurons as they normally tend to
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maintain their intracellular redox status26. Activated PPP especially OxPPP increases ATP/ADP
production and thus reduces glycolysis activity by the virtue of high negative elasticity of GLY
𝐺𝐿𝑌
to ATP/ADP (OxPPP𝐼𝑅𝑙𝑜𝑤
𝐾 = −1.06).This indirect effect was high to overlap the kinetic

activation in GLY due to apoptotic stimuli leading to the measured net decrease in glycolysis.
Although small, the kinetic activation of GLY is suggested to maintain the threshold level of
ATP that is required for impaired mitochondria neurons to avoid death through the ATPindependent necrotic route. The way through which glycolytic ATP produced and preferred
during apoptosis may help to understand the complementary glycolytic activation in tumor cells.
A possible mechanism is by the inhibition of TIGAR causing increased fructose-2,6bisphosphate that is a potent activator of PFK-155. The reduced GTP and GLY fluxes was one of
the unexpected observations because of the low K kinetic activation. However, the strong
inhibition due to the low K kinetic inhibition of ATC mediated by high control on GLY and GTP
coupled with high elasticity to ATP (for GLY) and to NADH (for GTP).
The low K kinetic changes were expected to be relatively close in both NAO and PYR
since both blocks are sharing many reactions except citric acid cycle and pyruvate/NADH
transportation into mitochondrial matrix. The finding that NAO is kinetically activated despite
no kinetic change in PYR is suggesting a possible activation in the respiratory chain during early
apoptosis which results in stimulated NAO. Such activation in the respiratory chain may be
restrained by a possible suppression in citric acid cycle enzymes.
Applying MCA in this study was of great importance to understand the control
distribution in glucose metabolism in healthy neurons. Importantly, it allows for the first time to
identify and rank the direct kinetic changes in glucose metabolism of apoptotic neurons.
Furthermore, these direct changes were not detectable by simply measuring the flux changes
201

during apoptosis because of the local enzymatic features of the system represented in the
elasticity of enzymes "blocks"

to each explicit metabolite in the system. This effect of

metabolites was at some extent maximal in case of PRL block and ∆Ѱ m. Interestingly, the
system effect (global effect) represented by the control each reaction "block" exerted over the
flux of one another was contributed to the measured fluxes. This global effect was remarkably
high in ATC. In this study, the direct kinetic changes were successfully distinguished from the
indirect changes (caused by enzymatic and system effects) in the proposed model of glucose
metabolism in neurons
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Table 14-C.Integrated response of a block to the kinetic changes in another block due to trophic factor deprivation. Blocks are; glucose uptake and
phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation (PHO), proton leak
(PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP),
and malic enzyme (ME). Subscripts denote the percent of Mote Carlo simulated values that have an opposite sign to the values obtained. Between
parenthesis is the range of 90% confidence interval of the simulated values.

Figure 7-C. Partial integrated response (IR) of ATP consumer (ATC) block tokinetic changes (IE) in each
block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over ATC, 𝐶𝑥𝐴𝑇𝐶 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on ATC
flux. Green arrows are the positive effect on ATC flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 8-C. Partial integrated response (IR) of NADPH consumer (NPO) block tokinetic changes (IE) in each
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over NPO, 𝐶𝑥𝑁𝑃𝑂 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on NPO
flux. Green arrows are the positive effect on NPO flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 9-C. Partial integrated response (IR) of oxidative phase of PPP (OxPPP) block tokinetic changes (IE) in
each block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and
phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO),
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic
enzyme (ME). On the blue arrows, the control that each block exerts over OxPPP, 𝐶𝑥𝑜𝑥𝑃𝑃𝑃 , where x is each
block of the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect
of a block on OxPPP flux. Green arrows are the positive effect on OxPPP flux. Both green and red arrows
thickness reflecting the strength of the response acting through each block
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Figure 10-C. Partial integrated response (IR) of non-oxidative phase of PPP (NonPPP) block tokinetic changes
(IE) in each block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and
phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO),
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic
enzyme (ME). On the blue arrows, the control that each block exerts over NonPPP, 𝐶𝑥𝑁𝑜𝑛𝑃𝑃𝑃 , where x is each
block of the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect
of a block on NonPPP flux. Green arrows are the positive effect on NonPPP flux. Both green and red arrows
thickness reflecting the strength of the response acting through each block
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Figure 11-C. Partial integrated response (IR) of malic enyzme (ME) block tokinetic changes (IE) in each block
of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over ME, 𝐶𝑥𝑀𝐸 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on ME
flux. Green arrows are the positive effect on ME flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 12-C. Partial integrated response (IR) of glucose uptake and transportation (GTP) block tokinetic
changes (IE) in each block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO),
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic
enzyme (ME). On the blue arrows, the control that each block exerts over GTP, 𝐶𝑥𝐺𝑇𝑃 , where x is each block of
the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a
block on GTP flux. Green arrows are the positive effect on GTP flux. Both green and red arrows thickness
reflecting the strength of the response acting through each block
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Figure 13-C.Partial integrated response (IR) of glycolysis (GLY) block to kinetic changes (IE) in each block of
the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation (GTP),
pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation
(PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate pathway (PPP)
(OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). On the blue
arrows, the control that each block exerts over GLY, 𝐶𝑥𝐺𝐿𝑌 , where x is each block of the system. Under the blue
arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on GLY flux. Green
arrows are the positive effect on GLY flux. Both green and red arrows thickness reflecting the strength of the
response acting through each block
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Figure 14-C. Partial integrated response (IR) of lactate production and transportation (LAC) block to kinetic
changes (IE) in each block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO),
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic
enzyme (ME). On the blue arrows, the control that each block exerts over LAC, 𝐶𝑥𝐿𝐴𝐶 , where x is each block of
the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a
block on LAC flux. Green arrows are the positive effect on LAC flux. Both green and red arrows thickness
reflecting the strength of the response acting through each block
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Figure 15-C. Partial integrated response (IR) of pyruvate oxidation (PYR) block to kinetic changes (IE) in each
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over PYR, 𝐶𝑥𝑃𝑌𝑅 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PYR
flux. Green arrows are the positive effect on PYR flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 16-C. Partial integrated response (IR) of NADH oxidation (NAO) block t okinetic changes (IE) in each
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over NAO, 𝐶𝑥𝑁𝐴𝑂 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on NAO
flux. Green arrows are the positive effect on NAO flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 17-C. Partial integrated response (IR) of proton leak (PRL) block to kinetic changes (IE) in each block
of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over PRL, 𝐶𝑥𝑃𝑅𝐿 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PRL
flux. Green arrows are the positive effect on PRL flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 18-C. Partial integrated response (IR) of phosphorylation (PHO) block to kinetic changes (IE) in each
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME).
On the blue arrows, the control that each block exerts over PHO, 𝐶𝑥𝑃𝐻𝑂 , where x is each block of the system.
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PHO
flux. Green arrows are the positive effect on PHO flux. Both green and red arrows thickness reflecting the
strength of the response acting through each block
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Figure 19-C. A proposed mechanism of the apoptotic pathway that triggers direct metabolic changes in apoptotic
CGNs. Apoptotic signaling recruits pro-apoptotic proteins (i.e. BcL-2 family protein) through Akt-mediated
signaling pathway. Activated BcL-2 family proteins induce mitochondrial dysfunction by promoting formation of
proton pores from adenine nucleotide translocase (ANT) leading to increased proton leak rate (PRL) and
dissipated mitochondrial membrane potential (MMP). Dysfunctional mitochondria triggers activation of
glycolysis to achieve a threshold ATP level. One of ATP-dependent pro-apoptotic proteins is caspase enzymes
that trigger proteolysis of cellular contents. Apoptosis can proceed through ROS-mediated signaling pathway.
Activated pentose phosphate pathway may be one of its direct targets which indirectly inactivates glycolysis
through controlling ATP level. A mechanism that may explain the reduced total response of glycolysis to
apoptosis. On the other hand the mechanism through which glucose uptake and phosphorylation block was
activated is poorly understood, however, activated PPP may cause indirect activation of glucose (GTP).Blocks in
green are the metabolic direct targets of apoptosis. Dashed arrows representing the indirect effects of low K
kinetic changes of the system blocks . Green blocks are the major apoptotic targets in glucose metabolic pathway.
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